inbp20190930

0001437749-19-022660.txt : 20191113 0001437749-19-022660.hdr.sgml : 20191113 20191113152738 ACCESSION NUMBER: 0001437749-19-022660 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 53 CONFORMED PERIOD OF REPORT: 20190930 FILED AS OF DATE: 20191113 DATE AS OF CHANGE: 20191113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INTEGRATED BIOPHARMA INC CENTRAL INDEX KEY: 0001016504 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222407475 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-31668 FILM NUMBER: 191213537 BUSINESS ADDRESS: STREET 1: 225 LONG AVENUE STREET 2: BUILDING 15 CITY: HILLSIDE STATE: NJ ZIP: 07205 BUSINESS PHONE: 9739260816 MAIL ADDRESS: STREET 1: 225 LONG AVENUE STREET 2: BUILDING 15 CITY: HILLSIDE STATE: NJ ZIP: 07205 FORMER COMPANY: FORMER CONFORMED NAME: INTEGRATED HEALTH TECHNOLOGIES INC DATE OF NAME CHANGE: 20020912 FORMER COMPANY: FORMER CONFORMED NAME: CHEM INTERNATIONAL INC DATE OF NAME CHANGE: 19960716 10-Q 1 inbp20190930_10q.htm FORM 10-Q inbp20190930_10q.htm

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

____________

FORM 10-Q

☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended September 30, 2019

☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from to

Commission File Number 001-31668

INTEGRATED BIOPHARMA, INC.

(Exact name of registrant, as specified in its charter)

Delaware	22-2407475
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)

225 Long Ave., Hillside, New Jersey	07205
(Address of principal executive offices)	(Zip Code)

(888) 319-6962

(Registrant’s telephone number, including Area Code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Exchange Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
None	None	None

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities and Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes __X__ No ____

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes __X__ No ____

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer 		Accelerated filer 		Non-accelerated filer ☑		Emerging growth company 		Smaller reporting company ☑

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

Indicate by check whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes No __X__

As of November 13, 2019, there were 29,565,943 shares of common stock, $0.002 par value per share (“Common Stock”), of the registrant outstanding.

INTEGRATED BIOPHARMA, INC. AND SUBSIDIARIES

FORM 10-Q QUARTERLY REPORT

For the Three Months Ended September 30, 2019

INDEX

		Page
	Part I. Financial Information
Item 1.	Condensed Consolidated Statements of Operations for the Three Months Ended September 30, 2019 and 2018 (unaudited)	2
	Condensed Consolidated Balance Sheets as of September 30, 2019 and June 30, 2019 (unaudited)	3
	Condensed Consolidated Statement of Stockholders’ Equity (Deficiency) for the Three Months Ended September 30, 2019 and 2018 (unaudited)	4
	Condensed Consolidated Statements of Cash Flows for the Three Months Ended September 30, 2019 and 2018 (unaudited)	5
	Notes to the Condensed Consolidated Financial Statements (unaudited)	6

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	16

Item 3.	Quantitative and Qualitative Disclosures about Market Risk	21

Item 4.	Controls and Procedures	22

	Part II. Other Information

Item 1.	Legal Proceedings	22

Item 1A.	Risk Factors	22

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	22

Item 3.	Defaults Upon Senior Securities	22

Item 4.	Mine Safety Disclosure	23

Item 5.	Other Information	23

Item 6.	Exhibits	23
	Other
Signatures		24

Cautionary Statement Regarding Forward-Looking StatementsCertain statements in this Quarterly Report on Form 10-Q may constitute “forward-looking” statements as defined in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), Section 21E of the Securities Act of 1934, as amended (the “Exchange Act”), the Private Securities Litigation Reform Act of 1995 (the “PSLRA”) or in releases made by the Securities and Exchange Commission (“SEC”), all as may be amended from time to time. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause the actual results, performance or achievements of Integrated BioPharma, Inc. and its subsidiaries (collectively, the “Company”) or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, changes in general economic and business conditions; loss of market share through competition; introduction of competing products by other companies; the timing of regulatory approval and the introduction of new products by the Company; changes in industry capacity; pressure on prices from competition or from purchasers of the Company's products; regulatory changes in the pharmaceutical manufacturing industry and nutraceutical industry; regulatory obstacles to the introduction of new technologies or products that are important to the Company; availability of qualified personnel; the loss of any significant customers or suppliers; and other factors both referenced and not referenced in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2019 (“Form 10-K”), as filed with the SEC. Statements that are not historical fact are forward-looking statements. Forward-looking statements can be identified by, among other things, the use of forward-looking language, such as the words, “plan”, “believe”, “expect”, “anticipate”, “intend”, “estimate”, “project”, “may”, “will”, “would”, “could”, “should”, “seeks”, or “scheduled to”, or other similar words, or the negative of these terms or other variations of these terms or comparable language, or by discussion of strategy or intentions. These cautionary statements are being made pursuant to the Securities Act, the Exchange Act and the PSLRA with the intention of obtaining the benefits of the “safe harbor” provisions of such laws. The Company cautions investors that any forward-looking statements made by the Company are not guarantees or indicative of future performance. Important assumptions and other important factors that could cause actual results to differ materially from those forward-looking statements with respect to the Company, include, but are not limited to, the risks and uncertainties affecting its businesses described in Item 1 of the Company’s Form 10-K and in other securities filings by the Company. Although the Company believes that its plans, intentions and expectations reflected in or suggested by such forward-looking statements are reasonable, actual results could differ materially from a projection or assumption in any of the forward-looking statements. The Company’s future financial condition and results of operations, as well as any forward-looking statements, are subject to change and inherent risks and uncertainties. The forward-looking statements contained in this Quarterly Report on Form 10-Q are made only as of the date hereof and the Company does not have or undertake any obligation to update or revise any forward-looking statements whether as a result of new information, subsequent events or otherwise, unless otherwise required by law.

-1-

ITEM 1. FINANCIAL STATEMENTS

INTEGRATED BIOPHARMA, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except for share and per share amounts)
(Unaudited)

	Three months ended
	September 30,
	2019			2018

Sales, net	$	11,406		$	10,304

Cost of sales		10,007			9,085

Gross profit		1,399			1,219

Selling and administrative expenses		923			814

Operating income		476			405

Other income (expense), net:
Interest expense		(124	)		(200	)
Change in fair value of derivative liabilities		-			9
Other income		21			-
Unrealized loss on investments		(24	)		-
Total other expense, net		(127	)		(191	)

Income before income taxes		349			214

Income tax expense, net		37			55

Net income	$	312		$	159

Basic net income per common share	$	0.01		$	0.01

Diluted net income per common share	$	0.01		$	0.01

Weighted average common shares outstanding - basic	29,565,943	27,218,786
Add: Equivalent shares outstanding - Stock Options	1,158,690	744,818
Weighted average common shares outstanding - diluted	30,724,633	27,963,604

See accompanying notes to condensed consolidated financial statements.

-2-

INTEGRATED BIOPHARMA, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except for share and per share amounts)
(Unaudited)

	September 30,			June 30,
	2019			2019
Assets
Current Assets:
Cash	$	525		$	475
Accounts receivable, net		3,355			4,439
Inventories		9,891			8,819
Other current assets		312			346
Total current assets		14,083			14,079

Property and equipment, net		1,745			1,778
Operating lease right-of-use assets (includes $3,126 and $3,236 with a related party)		3,169			3,284
Deferred tax assets, net		549			534
Security deposits and other assets		95			115
Total Assets	$	19,641		$	19,790

Liabilities and Stockholders' Equity:
Current Liabilities:
Advances under revolving credit facility	$	4,799		$	5,834
Accounts payable (includes $71and $67 due to related party)		5,106			3,855
Accrued expenses and other current liabilities		1,110			1,147
Current portion of long term debt, net		1,053			1,047
Current portion of operating lease liabilities (includes $454 and $450 with a related party)		474			470
Total current liabilities		12,542			12,353

Operating lease liabilities (includes $2,678 and $2,793 with a related party)		2,702			2,822
Long term debt, net		2,177			2,722
Total liabilities		17,421			17,897

Commitments and Contingencies

Stockholders' Equity :
Common Stock, $0.002 par value; 50,000,000 shares authorized;
29,600,843 shares issued and 29,565,943 shares outstanding, respectively		59			59
Additional paid-in capital		50,212			50,197
Accumulated deficit		(47,952	)		(48,264	)
Less: Treasury stock, at cost, 34,900 shares		(99	)		(99	)
Total Stockholders' Equity		2,220			1,893
Total Liabilities and Stockholders' Equity	$	19,641		$	19,790

See accompanying notes to condensed consolidated financial statements.

-3-

INTEGRATED BIOPHARMA, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIENCY) EQUITY

FOR THE THREE MONTHS ENDED SEPTEMBER 30,

(in thousands, except shares)

(unaudited)

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2019:

															Total
	Common Stock				Additional		Accumulated			Treasury Stock					Stockholders'
	Shares		Par Value		Paid-in-Capital		Deficit			Shares		Cost			Equity

Balance, June 30, 2019		29,600,843	$	59	$	50,197	$	(48,264	)		34,900	$	(99	)	$	1,893
Stock compensation expense for
employee stock options		-		-		15		-			-		-			15
Net income		-		-		-		312			-		-			312
Balance, September 30, 2019		29,600,843	$	59	$	50,212	$	(47,952	)		34,900	$	(99	)	$	2,220

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2018:

															Total Stockholders'
	Common Stock				Additional		Accumulated			Treasury Stock					(Deficiency)
	Shares		Par Value		Paid-in-Capital		Deficit			Shares		Cost			Equity

Balance, June 30, 2018		21,170,074	$	42	$	44,773	$	(49,952	)		34,900	$	(99	)	$	(5,236	)
Shares issued upon conversion of CD
Financial, LLC Convertible Note, net		8,230,769		17		5,256		-			-		-			5,273
Net income		-		-		-		159			-		-			159
Balance, September 30, 2018		29,400,843	$	59	$	50,029	$	(49,793	)		34,900	$	(99	)	$	196

See accompanying notes to condensed consolidated financial statements.

-4-

INTEGRATED BIOPHARMA, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands, except share and per share amounts)
(Unaudited)

	Three months ended
	September 30,
	2019			2018
Cash flows provided by operating activities:
Net income	$	312		$	159
Adjustments to reconcile net income to net cash from operating activities:
Depreciation and amortization		91			91
Amortization of operating lease right-of-use assets		116			112
Stock based compensation		15			-
Change in deferred tax assets		(5	)		31
Unrealized loss on investments		24			-
Other, net		5			8
Changes in operating assets and liabilities:
Decrease (increase) in:
Accounts receivable		1,084			415
Inventories		(1,073	)		(1,858	)
Other current assets		-			8
Security deposits and other assets		18			(52	)
(Decrease) increase in:
Accounts payable		1,251			1,861
Accrued expenses and other liabilities		(37	)		(70	)
Operating lease obligations		(116	)		(112	)
Net cash provided by operating activities		1,685			593

Cash flows from investing activities:
Purchase of property and equipment		(58	)		(18	)
Cash contribution in AgroSport LLC		-			(8	)
Net cash used in investing activities		(58	)		(26	)

Cash flows from financing activities:
Advances under revolving credit facility		11,040			10,204
Repayments of advances under revolving credit facility		(12,075	)		(10,400	)
Repayments under term note payables		(482	)		(184	)
Repayments under finance lease obligations		(60	)		(50	)
Net cash used in financing activities		(1,577	)		(430	)

Net increase in cash		50			137
Cash at beginning of period		475			228
Cash at end of period	$	525		$	365

Supplemental disclosures of cash flow information:
Interest paid	$	123	$	201
Income taxes paid	$	-	$	2

See accompanying notes to condensed consolidated financial statements.

-5-

INTEGRATED BIOPHARMA, INC. AND ITS SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts)

(Unaudited)

Note 1. Principles of Consolidation and Basis of Presentation

Basis of Presentation of Interim Financial Statements

The accompanying condensed consolidated financial statements for the interim periods are unaudited and include the accounts of Integrated BioPharma, Inc., a Delaware corporation (together with its subsidiaries, the “Company”). The interim condensed consolidated financial statements have been prepared in conformity with Rule 8-03 of Regulation S-X of the Securities and Exchange Commission (“SEC”) and therefore do not include information or footnotes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States of America. However, all adjustments (consisting only of normal recurring adjustments) which are, in the opinion of management, necessary for a fair presentation of the financial position and operating results for the periods presented have been included. These condensed consolidated financial statements should be read in conjunction with the financial statements and notes thereto, together with Management’s Discussion and Analysis of Financial Condition and Results of Operations, contained in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2019 (“Form 10-K”), as filed with the SEC. The June 30, 2019 balance sheet was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. The preparation of the unaudited condensed financial statements in conformity with these accounting principles requires management to make estimates and assumptions that affect the amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of expenses during the period reported. Ultimate results could differ from the estimates of management. The results of operations for the three months ended September 30, 2019 are not necessarily indicative of the results for the full fiscal year ending June 30, 2020 or for any other period.

Reclassifications. Certain prior year amounts have been reclassified to conform to the current period presentation.

Nature of Operations

The Company is engaged primarily in manufacturing, distributing, marketing and sales of vitamins, nutritional supplements and herbal products. The Company’s customers are located primarily in the United States, Luxembourg and Canada. The Company was previously known as Integrated Health Technologies, Inc. and, prior to that, as Chem International, Inc. The Company was reincorporated in its current form in Delaware in 1995. The Company continues to do business as Chem International, Inc. with certain of its customers and certain vendors.

The Company’s business segments include: (a) Contract Manufacturing operated by Manhattan Drug Company, Inc. (“MDC”), which manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers and specialized health-care providers; (b) Branded Proprietary Products operated by AgroLabs, Inc. (“AgroLabs”), which distributes healthful nutritional products for sale through major mass market, grocery and drug and vitamin retailers, under the following brands: Peaceful Sleep, Green Envy, FiberCal, Wheatgrass and other products which are being introduced into the market (these are referred to as our branded proprietary nutraceutical business and/or products); and (c) Other Nutraceutical Businesses which includes the operations of (i) The Vitamin Factory (the “Vitamin Factory”), which sells private label MDC products, as well as our AgroLabs products, through the Internet, (ii) IHT Health Products, Inc. (“IHT”) a distributor of fine natural botanicals, including multi minerals produced under a license agreement, (iii) MDC Warehousing and Distribution, Inc., a service provider for warehousing and fulfilment services and (iv) Chem International, Inc. (“Chem”), a distributor of certain raw materials for DSM Nutritional Products LLC.

-6-

INTEGRATED BIOPHARMA, INC. AND ITS SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts)

(Unaudited)

Accounting Policies

Accounting Pronouncements Recently Adopted

In October, 2016, the FASB issued ASU No. 2016-16, “Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other than Inventory,” which eliminates the requirement to defer recognition of income taxes on intra-entity transfers until the asset is sold to an outside party. The new guidance requires the recognition of current and deferred income taxes on intra-entity transfers of assets other than inventory, such as intellectual property and property, plant and equipment, when the transfer occurs. The guidance was effective for the Company on July 1, 2019. The standard requires a “modified retrospective” adoption, meaning the standard is applied through a cumulative adjustment in retained earnings as of the beginning of the period of adoption. This new guidance did not have a material impact on the Company’s Condensed Consolidated Financial Statements.

In July 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2017-11, "Earnings Per Share (Topic 260) Distinguishing Liabilities from Equity (Topic 480) Derivatives and Hedging (Topic 815)," which addresses the complexity of accounting for certain financial instruments with down round features. The amendments were effective for the Company on July 1, 2019 for the fiscal year ended June 30, 2020, and the interim periods within it. This new guidance did not have a material impact on the Company’s Condensed Consolidated Financial Statements.

Aside from the adoption of ASUs, as described above, there have been no material changes during fiscal year 2020 in the Company’s significant accounting policies to those previously disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2019.

Significant Accounting Policies

Revenue Recognition. The Company recognizes product sales revenue, the prices of which are fixed and determinable, when title and risk of loss have transferred to the customer, when estimated provisions for product returns, rebates, charge-backs and other sales allowances are reasonably determinable, and when collectability is reasonably assured. Accruals for these items are presented in the consolidated financial statements as reductions to sales. The Company’s net sales represent gross sales invoiced to customers, less certain related charges for discounts, returns, rebates, charge-backs and other allowances. Cost of sales includes the cost of raw materials and all labor and overhead associated with the manufacturing and packaging of the products. Gross margins are affected by, among other things, changes in the relative sales mix among our products and valuation and/or charge off of slow moving, expired or obsolete inventories. To perform revenue recognition for arrangements within the scope of ASC 606, the Company performs the following five steps:

●

identification of the promised goods or services in the contract;

●

determination of whether the promised goods or serves are performance obligations including whether they are distinct in the context of the contract;

●

measurement of the transaction price, including the constraint on variable consideration;

●

allocation of the transaction price to the performance obligations based on estimated selling prices; and

●

recognition of revenue when (or as) the Company satisfies each performance obligation. A performance obligation is a promise to transfer a distinct good or service to the customer and is the unit of account in ASC 606.

Leases. We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets, other current liabilities, and operating lease liabilities on our consolidated balance sheets. Finance leases are included in property and equipment, current portion of long term debt, and long-term debt obligation on our consolidated statement of financial condition.

-7-

INTEGRATED BIOPHARMA, INC. AND ITS SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts)

(Unaudited)

Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. The operating lease ROU asset also includes any lease payments made and excludes lease incentives and initial direct costs incurred. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term.

We have lease agreements with lease and non-lease components, which are generally accounted for separately. For certain equipment leases, such as vehicles, we account for the lease and non-lease components as a single lease component.

Earnings Per Share. Basic earnings per common share amounts are based on weighted average number of common shares outstanding. Diluted earnings per share amounts are based on the weighted average number of common shares outstanding, plus the incremental shares that would have been outstanding upon the assumed exercise of all potentially dilutive stock options, warrants and convertible debt, subject to anti-dilution limitations using the treasury stock method and if converted method.

The following options and potentially dilutive shares for convertible notes payable were not included in the computation of weighted average diluted common shares outstanding as the effect of doing so would be anti-dilutive for the three months ended September 30, 2019 and 2018:

	Three Months Ended
	September 30,
	2019		2018

Anti-dilutive stock options		50,000		150,000
Total anti-dilutive shares		50,000		150,000

Note 2. Inventories

Inventories are stated at the lower of cost or net realizable value using the first-in, first-out method and consist of the following:

	September 30,		June 30,
	2019		2019

Raw materials	$	6,642	$	4,550
Work-in-process		1,823		2,325
Finished goods		1,426		1,944
Total	$	9,891	$	8,819

-8-

INTEGRATED BIOPHARMA, INC. AND ITS SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts)

(Unaudited)

Note 3. Property and Equipment, net

Property and equipment, net consists of the following:

	September 30,			June 30,
	2019			2019

Land and building	$	1,250		$	1,250
Leasehold improvements		1,282			1,282
Machinery and equipment		6,338			6,280
Transportation equipment		6			6
		8,876			8,818
Less: Accumulated depreciation and amortization		(7,131	)		(7,040	)
Total	$	1,745		$	1,778

Depreciation and amortization expense recorded on property and equipment for the three months ended September 30, 2019 and 2018 was $91 and $66, respectively.

Note 4. Senior Credit Facility and other Long Term Debt

As of September 30, 2019 and June 30, 2019, the Company had the following debt outstanding:

	Principal Amount						Interest Rate			Maturity Date
	As of September 30, 2019			As of June 30, 2019
Revolving advances under Senior Credit
Facility with PNC Bank, National Association	$	4,799		$	5,834			*		5/15/2024
Installment Note with PNC Bank		3,069			3,542			*		5/15/2024
Installment Note with PNC Equipment Finance		-			8			4.57	%	7/29/2019
Capitalized lease obligations		209			269			4.01% - 9.38	%	11/01/2019 - 2/1/2021
Total outstanding debt		8,077			9,653
Less: Revolving Advances		(4,799	)		(5,834	)
Prepaid financing costs		(48	)		(50	)
Current portion of long term debt, net		(1,053	)		(1,047	)
Long term debt, net	$	2,177		$	2,722

* See table below

SENIOR CREDIT FACILITY

On May 15, 2019, the Company, MDC, AgroLabs, IHT, IHT Properties Corp. (“IHT Properties”) and Vitamin Factory (collectively, the “Borrowers”) amended the Revolving Credit, Term Loan and Security Agreement (the “Amended Loan Agreement”) with PNC Bank, National Association as agent and lender (“PNC”) and the other lenders party thereto entered into on June 27, 2012, as amended on February 19, 2016 and May 15, 2019.

-9-

INTEGRATED BIOPHARMA, INC. AND ITS SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts)

(Unaudited)

The Amended Loan Agreement provides for a total of $11,585 in senior secured financing (the “Senior Credit Facility”) as follows: (i) discretionary advances (“Revolving Advances”) based on eligible accounts receivable and eligible inventory in the maximum amount of $8,000 (the “Revolving Credit Facility”), and (ii) a term loan in the amount of $3,585 (the “Term Loan”). The Senior Credit Facility is secured by all assets of the Borrowers, including, without limitation, machinery and equipment, real estate owned by IHT Properties, and common stock of iBio owned by the Company. Revolving Advances bear interest at PNC’s Base Rate or the Eurodollar Rate, at Borrowers’ option, plus 2.50%. The Term Loan bears interest at PNC’s Base Rate or the Eurodollar Rate at Borrowers’ option, plus 3.00%.

As of September 30, 2019 and June 30, 2019, the Company had amounts outstanding utilizing the Eurodollar Rate of $4,000 and $4,250 under the Revolving Advances and $2,674 and $3,455 under the Term Note, respectively, with interest rates as of September 30, 2019 and June 30, 2019 as follows (based on the respective base rate plus 2.50% on Revolving Advances and 3.00% on the Term Note in effect as of the respective dates):

	September 30,			June 30,
	2019			2019

Revolving Credit Facility:
Base Rate Interest		5.00	%		5.50	%
Eurodollar Rate		4.554	%		4.881	%
Term Loan:
Base Rate Interest		5.25	%		5.75	%
Eurodollar Rate	5.05363% and 5.04588%			5.381% and 5.3838%

Upon and after the occurrence of any event of default under the Amended Loan Agreement, and during the continuation thereof, interest shall be payable at the interest rate then applicable plus 2%. The Senior Credit Facility matures on May 15, 2024 (the “Senior Maturity Date”).

The principal balance of the Revolving Advances is payable on the Senior Maturity Date, subject to acceleration, based upon a material adverse event clause, as defined, subjective accelerations for borrowing base reserves, as defined or upon the occurrence of any event of default under the Amended Loan Agreement or earlier termination of the Amended Loan Agreement pursuant to the terms thereof. The Term Loan shall be repaid in eighty-four (84) consecutive monthly installments of principal, the first eighty-three (83) of which shall be in the amount of $43, commencing on the first business day of June, 2019, and continuing on the first business day of each month thereafter, with a final payment of any unpaid balance of principal and interest payable on the Senior Maturity Date. The foregoing is subject to customary mandatory prepayment provisions and acceleration upon the occurrence of any event of default under the Amended Loan Agreement or earlier termination of the Amended Loan Agreement pursuant to the terms thereof.

-10-

INTEGRATED BIOPHARMA, INC. AND ITS SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts)

(Unaudited)

The Revolving Advances are subject to the terms and conditions set forth in the Amended Loan Agreement and are made in aggregate amounts at any time equal to the lesser of (x) $8,000 or (y) an amount equal to the sum of: (i) up to 85%, subject to the provisions in the Amended Loan Agreement, of eligible accounts receivables (“Receivables Advance Rate”), plus (ii) up to the lesser of (A) 75%, subject to the provisions in the Amended Loan Agreement, of the value of the eligible inventory (“Inventory Advance Rate” and together with the Receivables Advance Rate, collectively, the “Advance Rates”), (B) 85% of the appraised net orderly liquidation value of eligible inventory (as evidenced by the most recent inventory appraisal reasonably satisfactory to PNC in its sole discretion exercised in good faith) and (C) the inventory sublimit in the aggregate at any one time (“Inventory Advance Rate” and together with the Receivables Advance Rate, collectively, the “Advance Rates”), minus (iii) the aggregate Maximum Undrawn Amount of all outstanding Letters of Credit, minus (iv) such reserves as PNC may reasonably deem proper and necessary from time to time.

The Amended Loan Agreement contains customary mandatory prepayment provisions, including, without limitation the requirement to use any sales proceeds from the sale of iBio Stock to repay the Term Loan and to prepay the outstanding amount of the Term Note in an amount equal to twenty-five percent (25%) of Excess Cash Flow for each fiscal year commencing with the fiscal year ended June 30, 2016, payable upon delivery of the financial statements to PNC referred to in and required by the Amended Loan Agreement for such fiscal year but in any event not later than one hundred twenty (120) days after the end of each such fiscal year, which amount shall be applied ratably to the outstanding principal installments of the Term Loan in the inverse order of the maturities thereof. The Amended Loan Agreement also contains customary representations and warranties, covenants and events of default, including, without limitation, (i) a fixed charge coverage ratio maintenance requirement and (ii) an event of default tied to any change of control as defined in the Amended Loan Agreement. As of September 30, 2019, the Company was in compliance with the fixed charge coverage ratio maintenance requirement and with the required annual payments of 25% of the Excess Cash Flow for each fiscal year commencing with the fiscal year ended June 30, 2016.

In connection with the Senior Credit Facility, the following loan documents were executed: (i) a Stock Pledge Agreement with PNC, pursuant to which the Company pledged to PNC the iBio Stock; (ii) a Mortgage and Security Agreement with PNC with IHT Properties; and (iii) an Environmental Indemnity Agreement with PNC.

OTHER LONG TERM DEBT

Capitalized Lease Obligations. On November 1, 2019, the capitalized lease obligation entered into by the Company on December 22, 2017 with First American Equipment Finance in the amount of $143, which lease was secured by certain machinery and equipment, was satisfied with all payments being made under the capitalized lease obligation. The monthly lease payment was approximately $6 and had an imputed interest rate of 6.56%.

Note 5. Significant Risks and Uncertainties

(a) Major Customers. For the three months ended September 30, 2019 and 2018, approximately 91% and 89% of consolidated net sales, respectively, were derived from two customers. These two customers are in the Company’s Contract Manufacturing Segment and represented approximately 66% and 29% and 61% and 29% in the three months ended September 30, 2019 and 2018, respectively. Accounts receivable from these two major customers represented approximately 87% and 88% of total net accounts receivable as of September 30 and June 30, 2019, respectively. The loss of any of these customers could have an adverse effect on the Company’s operations. Major customers are those customers who account for more than 10% of net sales.

-11-

INTEGRATED BIOPHARMA, INC. AND ITS SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts)

(Unaudited)

(b) Other Business Risks. Approximately 72% of the Company’s employees are covered by a union contract and are employed in its New Jersey facilities. The contract was renewed on September 1, 2018 and will expire on August 31, 2021.

Note 6. Leases and other Commitments and Contingencies

(a) Leases. The Company has operating and finance leases for its corporate and sales offices, warehousing and packaging facilities and certain machinery and equipment, including office equipment. The Company’s leases have remaining terms of less than 1 year to less than 8 years.

The components of lease expense for the three months ended September 30, 2019 and 2018, were as follows:

	2019						2018
	Related Party - Vitamin Realty		Other Leases		Totals		Related Party - Vitamin Realty		Other Leases		Totals

Operating lease costs	$	135	$	39	$	174	$	141	$	22	$	163

Finance Operating Lease Costs:
Amortization of right-of use assets	$	-	$	27	$	27	$	-	$	17	$	17
Interest on operating lease liabilities		-		5		5		-		4		4
Total finance lease cost	$	-	$	32	$	32	$	-	$	21	$	21

Operating Lease Liabilities

Related Party Operating Lease Liabilities. Warehouse and office facilities are leased from Vitamin Realty Associates, LLC (“Vitamin Realty”), which is 100% owned by the Company’s chairman, and a major stockholder and certain of his family members, who are the Co-Chief Executive Officers and directors of the Company. On January 5, 2012, MDC entered into a second amendment of lease (the “Second Lease Amendment”) with Vitamin Realty for its office and warehouse space in New Jersey increasing its rentable square footage from an aggregate of 74,898 square feet to 76,161 square feet and extending the expiration date to January 31, 2026. This Second Lease Amendment provides for minimum annual rental payments of $533, plus increases in real estate taxes and building operating expenses. On May 19, 2014, AgroLabs entered into an amendment to the lease agreement entered into on January 5, 2012, with Vitamin Realty for an additional 2,700 square feet of warehouse space in New Jersey, the term of which was to expire on January 31, 2019 to extend the expiration date to June 1, 2024. This additional lease provides for minimum lease payments of $27 with annual increases plus the proportionate share of operating expenses.

Rent expense, lease amortization costs and interest expense for the three months ended September 30, 2019 and 2018 on these leases were $207 and $202 respectively, and are included in cost of sales, selling and administrative expenses and interest expense in the accompanying Condensed Consolidated Statements of Operations. As of September 30, 2019 and June 30, 2019, the Company had outstanding current obligations to Vitamin Realty of $71 and $67, respectively, included in accounts payable in the accompanying Condensed Consolidated Balance Sheet. Additionally, the Company has operating lease obligations of $3,132 and $3,243 with Vitamin Realty as noted in the accompany Condensed Consolidated Balance Sheet as of September 30, 2019 and June 30, 2019, respectively.

-12-

INTEGRATED BIOPHARMA, INC. AND ITS SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts)

(Unaudited)

Other Operating Lease Liabilities. The Company has entered into certain non-cancelable operating lease agreements expiring up through May, 2023, related to machinery and equipment and office equipment.

As of September 30, 2019, the Company’s right-of-use assets, lease obligations and remaining cash commitment on these leases were as follows:

	Right-of-use Assets		Current Portion of Operating Lease Obligations		Operating Lease Obligations		Remaining Cash Commitment

Vitamin Realty Leases	$	3,126	$	454	$	2,678	$	3,527
Machinery and equipment leases		24		11		13		25
Office equipment leases		19		9		11		20
	$	3,169	$	474	$	2,702	$	3,572

As of June 30, 2019, the Company’s ROU assets, lease obligations and remaining cash commitment on these leases were as follows:

	Right-of-use Assets		Current Portion Operating Lease Obligations		Operating Lease Obligations		Remaining Cash Commitment

Vitamin Realty Leases	$	3,236	$	450	$	2,793	$	3,668
Machinery and equipment leases		26		11		15		27
Office equipment leases		22		9		14		24
	$	3,284	$	470	$	2,822	$	3,719

As of September 30, 2019 and June 30, 2019, the Company’s weighted average discount rate and remaining term on lease liabilities were approximately 3.75% and 3.76% and 6.1 years and 6.4 years, respectively.

Supplemental cash flows information related to leases for the three months ended September 30, 2019, is was follows:

	Related Party - Vitamin Realty		Other Leases		Totals

Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	141	$	24	$	165
Operating cash flows from finance leases		-		5		5
Financing cash flows from finance lease obligations		-		60		60

-13-

INTEGRATED BIOPHARMA, INC. AND ITS SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts)

(Unaudited)

Supplemental cash flows information related to leases for the three months ended September 30, 2018, is was follows:

	Related Party - Vitamin Realty		Other Leases		Totals

Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	94	$	24	$	118
Operating cash flows from finance leases		-		4		4
Financing cash flows from finance lease obligations		-		50		50

The Company did not enter into any lease commitments in the three months ended September 30, 2019.

Maturities of operating lease liabilities as of September 30, 2019 were as follows:

	Operating			Related Party			Capitalized
	Lease			Operating Lease			Lease
Year ending June 30,	Commitment			Commitment			Obligations			Total

2020, remaining	$	27		$	424		$	144		$	595
2021		21			565			90			676
2022		8			565			-			573
2023		-			565			-			565
2024		-			563			-			563
2025		-			533			-			533
Thereafter		-			311			-			311
Total minimum lease payments		56			3,526			234			3,816
Imputed interest		(2	)		(394	)		(25	)		(421	)
Total	$	54		$	3,132		$	209		$	3,395

Total rent expense, lease amortization costs and interest expense, including real estate taxes and maintenance charges, was approximately $257 and $245 for the three months ended September 30, 2019 and 2018, respectively. Rent and lease amortization and interest expense is included in cost of sales, selling and administrative expenses and interest expense in the accompanying Condensed Consolidated Statements of Operations.

(b) Legal Proceedings.

The Company is subject, from time to time, to claims by third parties under various legal theories. The defense of such claims, or any adverse outcome relating to any such claims, could have a material adverse effect on the Company’s liquidity, financial condition and cash flows.

Note 7. Related Party Transactions

See Note 6(a). Leases for related party lease transactions.

-14-

INTEGRATED BIOPHARMA, INC. AND ITS SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts)

(Unaudited)

Note 8. Segment Information and Disaggregated Revenue

The basis for presenting segment results generally is consistent with overall Company reporting. The Company reports information about its operating segments in accordance with GAAP which establishes standards for reporting information about a company’s operating segments.

The Company has divided its operations into three reportable segments as follows: Contract Manufacturing, Branded Proprietary Products and Other Nutraceutical Businesses. The international sales, concentrated primarily in Europe and Canada, for the three months ended September 30, 2019 and 2018 were $1,053 and $1,239, respectively.

Financial information relating to the three months ended September 30, 2019 and 2018 operations by business segment and disaggregated revenues was as follows:

		Sales, Net						Segment
		U.S.		International				Gross					Capital
		Customers		Customers		Total		Profit (Loss)			Depreciation		Expenditures
Contract	2019	$	9,974	$	1,010	$	10,984	$	1,250		$	90	$	58
Manufacturing	2018		8,655		1,197		9,852		1,083			65		18

Branded Proprietary	2019		2		10		12		(3	)		-		-
Products	2018		71		7		78		21			-		-

Other Nutraceutical	2019		377		33		410		152			1		-
Businesses	2018		339		35		374		115			1		-

Total Company	2019		10,353		1,053		11,406		1,399			91		58
	2018		9,065		1,239		10,304		1,219			66		18

	Total Assets as of
	September 30,		June 30,
	2019		2019

Contract Manufacturing	$	17,575	$	17,580
Branded Proprietary Products		413		427
Other Nutraceutical Businesses		1,653		1,783
Total Company	$	19,641	$	19,790

-15-

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANICAL CONDITION AND RESULTS OF OPERATION (dollars in thousands)

Certain statements set forth under this caption constitute “forward-looking statements.” See “Disclosure Regarding Forward-Looking Statements” on page 1 of this Quarterly Report on Form 10-Q for additional factors relating to such statements. The following discussion should also be read in conjunction with the condensed consolidated financial statements of the Company and Notes thereto included herein and the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2019.

The Company is engaged primarily in the manufacturing, distributing, marketing and sales of vitamins, nutritional supplements and herbal products. The Company’s customers are located primarily in the United States, Luxembourg and Canada.

Business Outlook

Our future results of operations and the other forward-looking statements contained in this Quarterly Report on Form 10-Q, including this “Management’s Discussion and Analysis of Financial Condition and Results of Operation”, involve a number of risks and uncertainties—in particular, the statements regarding our goals and strategies, new product introductions, plans to cultivate new businesses, future economic conditions, revenue, pricing, gross margin and costs, competition, the tax rate, and potential legal proceedings. We are focusing our efforts to improve operational efficiency and reduce spending that may have an impact on expense levels and gross margin. In addition to the various important factors discussed above, a number of other important factors could cause actual results to differ significantly from our expectations. See the risks described in “Risk Factors” in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2019.

For the three months ended September 30, 2019, our net sales from operations increased by $1,102 to approximately $11,406 from approximately $10,304 in the three months ended September 30, 2018. Substantially all of the increase in net sales was from the Contract Manufacturing Segment of $1,132, and, to a lesser extent, from our Other Nutraceuticals Segment of $36, offset by a decrease in the Branded Proprietary Products of $66. Net sales increased in our Contract Manufacturing Segment by $1,132 primarily due to increased sales volumes to Life Extension and Herbalife in the amount of $962 and $233, respectively, offset by decreases in our other customers of net $63. For the three months ended September 30, 2019, we had operating income of approximately $476, an increase of approximately $71 from operating income of approximately $405 for the three months ended September 30, 2018. Our profit margins increased from approximately 11.8% of net sales in the three months ended September 30, 2018 to approximately 12.3% of net sales in the three months ended September 30, 2019, primarily as a result of the increased sales in our Contract Manufacturing Segment of approximately $1,132. Our consolidated selling and administrative expenses increased by approximately $109 or approximately 13.5% in the three months ended September 30, 2019 compared to the three months ended September 30, 2018.

Our revenue from our two significant customers in our Contract Manufacturing Segment is dependent on the demand within their respective distribution channels for the products we manufacture for them. As in any competitive market, our ability to match or beat other contract manufacturers pricing for the same items may also alter our outlook and the ability to maintain or increase revenues. We will continue to focus on our core businesses and push forward in maintaining our cost structure in line with our sales and expanding our customer base.

Critical Accounting Policies and Estimates

There have been no changes to our critical accounting policies in the three months ended September 30, 2019, except as disclosed in Note 1. Principles of Consolidation and Basis of Presentation of the Condensed Financial Statements of the Company contained in this Quarterly Report on Form 10-Q. Critical accounting policies and the significant estimates made in accordance with them are regularly discussed by management with our Audit Committee. Those policies are discussed under “Critical Accounting Policies” in our “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in Item 7 of our Annual Report on Form 10-K for the year ended June 30, 2019 and in Note 1. Principles of Consolidation and Basis of Presentation of the Condensed Financial Statements of the Company contained in this Quarterly Report on Form 10-Q.

-16-

Results of Operations (in thousands, except share and per share amounts)

Our results from operations in the following table, sets forth the income statement data of our results as a percentage of net sales for the periods indicated:

	For the three months
	ended September 30,
	2019			2018

Sales, net		100.0	%		100.0	%

Costs and expenses:
Cost of sales		87.7	%		88.2	%
Selling and administrative		8.1	%		7.9	%
		95.8	%		96.1	%
Operating income		4.2	%		3.9	%

Other expense, net
Interest expense		(1.1%	)		(1.9%	)
Unrealized loss in investment in iBio, Inc.		(0.2%	)		0.0	%
Change in fair value of derivative liabilities		-			0.1	%
Other income, net		0.2	%		-
Other expense, net		(1.1%	)		(1.8%	)

Income before income taxes		3.1	%		2.1	%

Income tax expense, net		0.3	%		0.5	%

Net income		2.8	%		1.6	%

-17-

For the Three Months Ended September 30, 2019 compared to the Three Months Ended September 30, 2018

Sales, net. Sales, net, for the three months ended September 30, 2019 and 2018 were $11,406 and $10,304, respectively, an increase of 10.7%, and are comprised of the following:

	Three months ended				Dollar			Percentage
	September 30,				Change			Change
	2019		2018		2019 vs 2018			2019 vs 2018
	(amounts in thousands)
Contract Manufacturing:
US Customers	$	9,974	$	8,655	$	1,319			15.2	%
International Customers		1,010		1,197		(187	)		(15.6%	)
Net sales, Contract Manufacturing		10,984		9,852		1,132			11.5	%

Branded Nutraceutical Products:
US Customers		2		71		(69	)		(97.2%	)
International Customers		10		7		3			42.9	%
Net sales, Branded Nutraceutical Products		12		78		(66	)		(84.6%	)

Other Nutraceuticals:
US Customers		377		339		38			11.2	%
International Customers		33		35		(2	)		(5.7%	)
Net sales, Other Nutraceuticals		410		374		36			9.6	%

Total net sales	$	11,406	$	10,304	$	1,102			10.7	%

For the three months ended September 30, 2019 and 2018, a significant portion of our consolidated net sales, approximately 91% and 89%, respectively, were concentrated among two customers in our Contract Manufacturing Segment, Life Extension and Herbalife. Life Extension and Herbalife represented approximately 66% and 29% and 61% and 29%, respectively, of our Contract Manufacturing Segment’s net sales in the three months ended September 30, 2019 and 2018, respectively. Innophos and Nature’s Own Nutrition, a UK-based company, (customers of our Other Nutraceutical Businesses), while not significant customers of our consolidated net sales, represented approximately 12% and 5% and 28% and 11% respectively, of the Other Nutraceutical Businesses net sales in the three months ended September 30, 2019 and 2018, respectively. The loss of any of these customers could have a significant adverse impact on our financial condition and results of operations.

The increase in net sales of approximately $1,102 was primarily the result of increased net sales in our Contract Manufacturing Segment by $1,132 primarily due to increased sales volumes to Life Extension and Herbalife in the amounts of $962 and $233, respectively, offset by a combined decrease to our other customers of net $63.

Cost of sales. Cost of sales increased by approximately $922 to $10,007 for the three months ended September 30, 2019, as compared to $9,085 for the three months ended September 30, 2018 or approximately 10%. Cost of sales decreased as a percentage of sales to 87.7% for the three months ended September 30, 2019 as compared to 88.2% for the three months ended September 30, 2018. The increase in the cost of goods sold amount is consistent with the increased net sales of approximately 11%. The decrease in the cost of goods sold as a percentage of net sales, was primarily the result of the increased net sales used to offset the fixed manufacturing overhead. There were no significant changes in the cost of goods sold in our other two segments other than the variances in sales.

Selling and Administrative Expenses. There was an increase in selling and administrative expenses of $109, approximately 13% in the three months ended September 30, 2019 as compared to the three months ended September 30, 2018. As a percentage of sales, net, selling and administrative expenses were approximately 8% in each of the three months ended September 30, 2019 and 2018. The increase was primarily from increases in (i) salaries and employees benefits of approximately $78, as the result of increases in (a) the compensation of our newly appointed

-18-

Co-Chief Executive Officers in May 2019 of $26 in the three months ended September 30, 2019 compared to the three months ended September 30, 2018; (b) other staff salaries of $42 and (c) employee benefits due to increases in salary bases and medical insurance premium costs of $10; (ii) professional and consulting fees of approximately $52 primarily as the result of increased legal fees of approximately $46 from general legal counsel and $6 in other professional consulting services; and (iii) employee stock compensation expense of $15 as a result of issuing stock options in May 2019 with no such expense in the period ended September 30, 2018. These increases were partially offset by offset by a decrease of approximately $25 in amortization expense resulting from the full amortization of intangible assets on October 31, 2018.

Other income (expense), net. Other income (expense), net was approximately $127 for the three months ended September 30, 2019 compared to $191 for the three months ended September 30, 2018, and is composed of:

	Three months ended
	September 30,
	2019			2018
	(dollars in thousands)
Interest expense	$	(124	)	$	(200	)
Change in fair value of derivative liabilities		-			9
Unrealized loss in investments		(24	)		-
Other income		21			-
Other income (expense), net	$	(127	)	$	(191	)

During the three month period ended September 30, 2018, the derivative liability was extinguished, resulting in the carrying value as of June 30, 2018 of $9, compared to a value of $0 as of September 30, 2018, due to the fact that the related derivative liability is no longer outstanding, resulting in a change of $9 for the three months ended September 30, 2018.

Our interest expense for the three months ended September 30, 2019 decreased by $76 from the three month period ended September 30, 2018, primarily as the result of CD Financial, LLC (“CD Financial”) exercising its conversion right to convert a promissory note issued by the Company to CD Financial in the principal amount of $5,350 to equity on July 24, 2018, an interest savings of $30 and the payoff of other related party debt on May 15, 2019 resulting in the reduction of interest expense of $33 in the three months ended September 30, 2019 with additional interest savings resulting from the decrease in the interest rates on our Senior Credit Facility resulting from rate cuts in the federal funds borrowing rates and a 0.25% rate reduction in the refinancing with PNC Bank on May 15, 2019. (See Note 4 to the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q).

Federal and state income tax expense, net. For the three months ended September 30, 2019 and 2018, we had state income tax expense, net of approximately $43 and $27, respectively and a federal income tax benefit of $6 in the three months ended September 30, 2019, compared to a federal tax expense of $28 in the three months ended September 30, 2018. We continue to maintain a reserve on a portion of our deferred tax assets as it has been determined that based upon past losses, the Company’s past liquidity concerns and the current economic environment, it is “more likely than not” that the Company’s deferred tax assets may not be fully realized.

Net income. Our net income for the three months ended September 30, 2019 and 2018 was approximately $312 and $159, respectively. The increase of approximately $153 was primarily the result of increased operating income of $71and decreased interest expense of $76.

-19-

Seasonality

The Company believes that there are non-seasonal factors that may influence the variability of quarterly results including, but not limited to, general economic and industry conditions that affect consumer spending, changing consumer demands and current news on nutritional supplements. Accordingly, a comparison of the Company’s results of operations from consecutive periods is not necessarily meaningful, and the Company’s results of operations for any period are not necessarily indicative of future periods.

Liquidity and Capital Resources

The following table sets forth, for the periods indicated, the Company’s net cash flows used in operating, investing and financing activities, its period end cash and cash equivalents and other operating measures:

	For the three months ended
	September 30,
	2019			2018
	(dollars in thousands)

Net cash provided by operating activities	$	1,685		$	593
Net cash used in investing activities	$	(58	)	$	(26	)
Net cash used in financing activities	$	(1,577	)	$	(430	)

Cash at end of period	$	525		$	365

At September 30, 2019, our working capital was approximately $1,541, a decrease of $185 from our working capital of $1,726 at June 30, 2019. An increase in our current liabilities of $189, offset by the increase of $4 in our current assets, resulted in a net decrease in our working capital of $185 since June 30, 2019.

Operating Activities

Net cash provided by operating activities of $1,685 in the three months ended September 30, 2019 includes net income of approximately $312. After excluding the effects of non-cash expenses, including depreciation and amortization, and changes in the fair value of derivative liabilities and deferred tax assets, the adjusted cash provided from operations before the effect of the changes in working capital components was $558. Net cash provided in our operations in the three months ended September 30, 2019 from our working capital assets and liabilities in the amount of approximately $1,127 was primarily the result of cash provided from a decrease in our accounts receivable of $1,084 and an aggregate increase accounts payable, accrued expenses and other liabilities of $1,214, offset in part, by an increase in inventories of approximately $1,073.

Net cash provided by operating activities of $593 in the three months ended September 30, 2018 includes net income of approximately $159. After excluding the effects of non-cash expenses, including depreciation and amortization, and changes in the fair value of derivative liabilities and deferred tax assets, the adjusted cash provided from operations before the effect of the changes in working capital components was $401. Net cash provided in our operations in the three months ended September 30, 2018 from our working capital assets and liabilities in the amount of approximately $192 was primarily the result of cash provided from a decrease in our accounts receivable of $415 and an aggregate increase accounts payable, accrued expenses and other liabilities of $1,791, offset in part, by an increase in inventories of approximately $1,858.

Investing Activities

Cash used in investing activities in the three months ended September 30, 2019 and 2018, of approximately $58 and $26, respectively, was used primarily for the purchase of machinery and equipment of $58 and $18, respectively.

-20-

Financing Activities

Cash used in financing activities was approximately $1,577 for the three months ended September 30, 2019, and was from repayments of advances under our revolving credit facility of $12,075 and principal payments under our term notes in the amount of $482, offset by advances under our revolving credit facility of approximately $11,040.

Cash used in financing activities was approximately $430 for the three months ended September 30, 2018, and was from repayments of advances under our revolving credit facility of $10,400 and principal payments under our term notes in the amount of $184, offset by advances under our revolving credit facility of approximately $10,204.

As of September 30, 2019, we had cash of $525, funds available under our revolving credit facility of approximately $1,049 and working capital of approximately $1,541. Our working capital includes $4,799 outstanding under our revolving line of credit which is not due until May 2024 but classified as current due to a subjective acceleration clause that could cause the advances to become currently due. (See Note 4 to the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q). Additionally, we had income from operations of approximately $476 in the three months ended September 30, 2019. After taking into consideration our interim results and current projections, management believes that operations, together with the revolving credit facility will support our working capital requirements at least through the period ending November 13, 2020.

Our total annual commitments at September 30, 2019 for long term non-cancelable leases of approximately $565 consists of obligations under operating leases for facilities and operating lease agreements for the rental of warehouse equipment, office equipment and automobiles.

Capital Expenditures

The Company's capital expenditures for the three months ended September 30, 2019 and 2018 were approximately $58 and $18, respectively. The Company has budgeted approximately $450 for capital expenditures for fiscal year 2020. The total amount is expected to be funded from lease financing and cash provided from the Company’s operations.

Off-Balance Sheet Arrangements

The Company has no off-balance sheet arrangements.

Recent Accounting Pronouncements

None.

Impact of Inflation

The Company does not believe that inflation has significantly affected its results of operations.

Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

-21-

Item 4. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed by the Company in the reports it files or submits under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized, and reported within the time periods specified by the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to provide reasonable assurance that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is accumulated and communicated to management, including the Co-Chief Executive Officers and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Under the supervision and with the participation of management, including the Co-Chief Executive Officers and Chief Financial Officer, the Company has evaluated the effectiveness of its disclosure controls and procedures (as such term is defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) as of September 30, 2019, and, based upon this evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that these controls and procedures are effective in providing reasonable assurance of compliance.

Changes in Internal Control over Financial Reporting

No change in our internal control over financial reporting occurred during the three months ended September 30, 2019 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

Item 1. LEGAL PROCEEDINGS

From time to time, we may become involved in various lawsuits and legal proceedings that arise in the ordinary course of business. However, litigation is subject to inherent uncertainties and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently not aware of any such legal proceedings or claims that we believe will have a material adverse effect on our business, financial condition or operating results.

Item 1A. Risk Factors

Not Applicable

Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Recent Sales of Unregistered Securities

None

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

None

Item 3. DEFAULTS UPON SENIOR SECURITIES

None.

-22-

Item 4. MINE SAFETY DISCLOSURE

Not Applicable.

Item 5. OTHER INFORMATION

None.

Item 6. EXHIBITS

(a) Exhibits

Exhibit

Number

31.1	Certification of pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 by Chief Executive Officer.
31.2	Certification of pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 by Chief Financial Officer.
32.1	Certification of periodic financial report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 by Chief Executive Officer.
32.2	Certification of periodic financial report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 by Chief Financial Officer.
101	The following financial information from Integrated BioPharma, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2018, formatted in XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Statements of Operations for the three months ended September 30, 2019 and 2018, (ii) Condensed Consolidated Balance Sheets as of September 30, 2019 and June 30, 2019, (iii) Condensed Consolidated Statement of Changes in Stockholders’ (Deficit) Equity for the three months ended September 30, 2019, (iv) Condensed Consolidated Statements of Cash Flows for the three months ended September 30, 2019 and 2018, and (iv) the Notes to Condensed Consolidated Financial Statements.

-23-

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	INTEGRATED BIOPHARMA, INC.

Date: November 13, 2019	By: /s/ Christina Kay
	Christina Kay,
	Co-Chief Executive Officer

Date: November 13, 2019	By: /s/ Dina L. Masi
	Dina L. Masi,
	Chief Financial Officer & Senior Vice President

-24-

EX-31.1 2 ex_163217.htm EXHIBIT 31.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex_163217.htm

Exhibit 31.1

Certification of Chief Executive Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

We, Christina Kay and Riva Sheppard certify that:

1. We have reviewed this quarterly report on Form 10-Q of Integrated BioPharma, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 13, 2019	By: /s/ Christina Kay
	Name: Christina Kay,
	Title: Co-Chief Executive Officer

	By: /s/ Riva Sheppard
	Name: Riva Sheppard,
	Title: Co-Chief Executive Officer

EX-31.2 3 ex_163218.htm EXHIBIT 31.2 CERTIFICATION OF CHIEF FINANCIAL OFFICE ex_163218.htm

Exhibit 31.2

Certification of Chief Financial Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Dina L. Masi, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Integrated BioPharma, Inc.;

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 13, 2019	By: /s/ Dina L. Masi
	Name: Dina L. Masi
	Title: Chief Financial Officer & Senior Vice President

EX-32.1 4 ex_163219.htm EXHIBIT 32.1 CERTIFICATION OF PERIODIC REPORT CO-CEO ex_163219.htm

Exhibit 32.1

CERTIFICATION OF PERIODIC REPORT

As adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report on Form 10-Q for the first quarter ended September 30, 2019 of Integrated BioPharma, Inc. (the “Company”) as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Christina Kay and Riva Sheppard, Co-Chief Executive Officers of Integrated BioPharma, Inc. certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to their knowledge:

the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

This certification accompanies the Report pursuant to Section 906 of Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

A signed original of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

Dated: November 13, 2019	By: /s/ Christina Kay
	Name: Christina Kay,
	Title: Co-Chief Executive Officer

	By: /s/ Riva Sheppard
	Name: Riva Sheppard,
	Title: Co-Chief Executive Officer

EX-32.2 5 ex_163220.htm EXHIBIT 32.2 CERTIFICATION OF PERIODIC REPORT CFO ex_163220.htm

Exhibit 32.2

CERTIFICATION OF PERIODIC REPORT

As adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report on Form 10-Q for the first quarter ended September 30, 2019 of Integrated BioPharma, Inc. (the “Company”) as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Dina L. Masi, the Senior Vice President and Chief Financial Officer of Integrated BioPharma, Inc. certifies, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to her knowledge:

the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

A signed original of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

Dated: November 13, 2019	By: /s/ Dina L. Masi
	Dina L. Masi
	Chief Financial Officer & Senior Vice President

EX-101.INS 6 inbp-20190930.xml XBRL INSTANCE DOCUMENT false --06-30 Q1 2020 2019-09-30 10-Q 0001016504 29565943 Yes false Non-accelerated Filer INTEGRATED BIOPHARMA INC false true 0.0401 0.0938 2021-02-01 2019-11-01 0.02 2024-05-15 2024-05-15 2019-07-29 32000 32000 21000 21000 -116000 -112000 3527000 25000 20000 3572000 3668000 27000 24000 3719000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Right-of-use Assets</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Current Portion of Operating Lease Obligations</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Operating Lease Obligations</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Remaining Cash Commitment</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 40%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Vitamin Realty Leases</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,126</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">454</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,678</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,527</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Machinery and equipment leases</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Office equipment leases</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,169</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">474</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,702</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,572</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table></div><div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Right-of-use Assets</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Current Portion Operating Lease Obligations</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Operating Lease Obligations</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Remaining Cash Commitment</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 36%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Vitamin Realty Leases</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,236</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">450</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,793</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,668</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Machinery and equipment leases</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">26</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">27</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Office equipment leases</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,284</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">470</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,822</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,719</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> </table></div> P1Y P8Y <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Operating</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Related Party</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Capitalized</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 36%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Lease</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Operating Lease</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Lease</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Year ending June 30,</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Commitment</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Commitment</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Obligations</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Total</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2020, remaining</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">27</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">424</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">144</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">595</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2021</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">565</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">676</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2022</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">565</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">573</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2023</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">565</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">565</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2024</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">563</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">563</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2025</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">533</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">533</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Thereafter</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">311</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">311</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total minimum lease payments</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">56</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,526</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">234</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,816</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Imputed interest</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(394</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(25</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(421</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Total</div></div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">54</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,132</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">209</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,395</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table></div> 3816000 311000 563000 565000 533000 573000 676000 595000 421000 533000 0.85 0.75 0.85 8000000000 0.25 0.25 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Nature of Operations</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The Company is engaged primarily in manufacturing, distributing, marketing and sales of vitamins, nutritional supplements and herbal products. The Company’s customers are located primarily in the United States, Luxembourg and Canada. The Company was previously known as Integrated Health Technologies, Inc. and, prior to that, as Chem International, Inc. The Company was reincorporated in its current form in Delaware in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1995.</div> The Company continues to do business as Chem International, Inc. with certain of its customers and certain vendors.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0pt;margin-top:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The Company’s business segments include: (a) Contract Manufacturing operated by Manhattan Drug Company, Inc. (“MDC”), which manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers and specialized health-care providers; (b) Branded Proprietary Products operated by AgroLabs, Inc. (“AgroLabs”), which distributes healthful nutritional products for sale through major mass market, grocery and drug and vitamin retailers, under the following brands: Peaceful Sleep, Green Envy, FiberCal, Wheatgrass and other products which are being introduced into the market (these are referred to as our branded proprietary nutraceutical business and/or products); and (c) Other Nutraceutical Businesses which includes the operations of (i) The Vitamin Factory (the “Vitamin Factory”), which sells private label MDC products, as well as our AgroLabs products, through the Internet, (ii) IHT Health Products, Inc. (“IHT”) a distributor of fine natural botanicals, including multi minerals produced under a license agreement, (iii) MDC Warehousing and Distribution, Inc., a service provider for warehousing and fulfilment services and (iv) Chem International, Inc. (“Chem”), a distributor of certain raw materials for DSM Nutritional Products LLC.</div></div></div> 84 83 2 2 2 2 3395000 5000 5000 4000 4000 116000 112000 1 60000 60000 50000 50000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="margin-right: 25%; margin-left: 25%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="4" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">September 30,</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">June 30,</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2019</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2019</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 56.8%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Revolving Credit Facility:</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Base Rate Interest</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.00</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">%</td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.50</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Eurodollar Rate</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.554</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">%</td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.881</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Term Loan:</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Base Rate Interest</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.25</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">%</td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.75</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Eurodollar Rate</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.05363% and 5.04588%</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.381% and 5.3838%</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 50%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;">Related Party - Vitamin Realty</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Other Leases</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Totals</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="width: 50%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 12%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 12%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 12%;"> </td> <td style="width: 1%;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 50%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Cash paid for amounts included in the measurement of lease liabilities:</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 12%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 12%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 12%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 50%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Operating cash flows from operating leases</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">141</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">165</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 50%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Operating cash flows from finance leases</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 50%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Financing cash flows from finance lease obligations</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">60</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">60</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div><div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 53%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;">Related Party - Vitamin Realty</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt;">Other Leases</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Totals</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="width: 53%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 13%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 13%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 13%;"> </td> <td style="width: 1%;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 53%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Cash paid for amounts included in the measurement of lease liabilities:</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 13%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 13%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 13%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 53%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Operating cash flows from operating leases</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">94</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">118</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 53%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Operating cash flows from finance leases</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 53%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Financing cash flows from finance lease obligations</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> </table></div>

5106000

3855000

71000

67000

3355000

4439000

1110000

1147000

7131000

7040000

50212000

50197000

15000

50000

150000

50000

150000

74898

76161

2700

17575000

17580000

413000

427000

1653000

1783000

19641000

19790000

14083000

14079000

143000

209000

269000

525000

475000

228000

365000

50000

137000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.</div> Leases and other Commitments and Contingencies</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">(a) </div></div><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Leases. </div></div>The Company has operating and finance leases for its corporate and sales offices, warehousing and packaging facilities and certain machinery and equipment, including office equipment. The Company’s leases have remaining terms of less than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div> year to less than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8</div> years.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The components of lease expense for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> were as follows:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div> <table style="margin-right: 2.5%; margin-left: 2.5%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 25%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="10" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 25%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2019</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="10" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 25%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2018</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 25%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Related Party - Vitamin Realty</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Other Leases</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Totals</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Related Party - Vitamin Realty</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Other Leases</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Totals</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="width: 25%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 9%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 9%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 10%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 9%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 9%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 10%;"> </td> <td style="width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 25%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Operating lease costs</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">135</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">39</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">174</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">141</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">163</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 25%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 9%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 9%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 10%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 9%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 9%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 10%;"> </td> <td style="width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 25%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Finance Operating Lease Costs:</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 10%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 10%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 25%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Amortization of right-of use assets</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">27</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">27</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 25%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Interest on operating lease liabilities</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 25%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total finance lease cost</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">32</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">32</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Operating </div></div><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Lease</div></div><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"> Liabilities</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"> </div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Related Party </div></div><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Operating </div></div><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">L</div></div><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">e</div></div><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">ase</div></div><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"> Liabilities</div></div><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">.</div></div> Warehouse and office facilities are leased from Vitamin Realty Associates, LLC (“Vitamin Realty”), which is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100%</div> owned by the Company’s chairman, and a major stockholder and certain of his family members, who are the Co-Chief Executive Officers and directors of the Company. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 5, 2012, </div>MDC entered into a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">second</div> amendment of lease (the “Second Lease Amendment”) with Vitamin Realty for its office and warehouse space in New Jersey increasing its rentable square footage from an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">74,898</div> square feet to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">76,161</div> square feet and extending the expiration date to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 31, 2026. </div>This Second Lease Amendment provides for minimum annual rental payments of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$533,</div> plus increases in real estate taxes and building operating expenses. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 19, 2014, </div>AgroLabs entered into an amendment to the lease agreement entered into on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 5, 2012, </div>with Vitamin Realty for an additional <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,700</div> square feet of warehouse space in New Jersey, the term of which was to expire on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 31, 2019 </div>to extend the expiration date to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 1, 2024. </div>This additional lease provides for minimum lease payments of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$27</div> with annual increases plus the proportionate share of operating expenses.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Rent expense, lease amortization costs and interest expense for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> on these leases were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$207</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$202</div> respectively, and are included in cost of sales, selling and administrative expenses and interest expense in the accompanying Condensed Consolidated Statements of Operations. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2019, </div>the Company had outstanding current obligations to Vitamin Realty of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$71</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$67,</div> respectively, included in accounts payable in the accompanying Condensed Consolidated Balance Sheet. Additionally, the Company has operating lease obligations of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3,132</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3,243</div> with Vitamin Realty as noted in the accompany Condensed Consolidated Balance Sheet as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2019, </div>respectively.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"> </div></div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-align:justify;"></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Other </div></div><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Operating </div></div><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Lease </div></div><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Liabilities</div></div><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">.</div></div> The Company has entered into certain non-cancelable operating lease agreements expiring up through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May, 2023, </div>related to machinery and equipment and office equipment.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019, </div>the Company’s right-of-use assets, lease obligations and remaining cash commitment on these leases were as follows:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div> <table style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Right-of-use Assets</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Current Portion of Operating Lease Obligations</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Operating Lease Obligations</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Remaining Cash Commitment</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 40%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Vitamin Realty Leases</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,126</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">454</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,678</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,527</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Machinery and equipment leases</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Office equipment leases</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,169</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">474</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,702</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,572</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2019, </div>the Company’s ROU assets, lease obligations and remaining cash commitment on these leases were as follows:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div> <table style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Right-of-use Assets</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Current Portion Operating Lease Obligations</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Operating Lease Obligations</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Remaining Cash Commitment</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 36%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Vitamin Realty Leases</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,236</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">450</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,793</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,668</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Machinery and equipment leases</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">26</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">27</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Office equipment leases</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,284</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">470</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,822</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,719</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0pt;margin-top:0pt;text-align:center;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2019, </div>the Company’s weighted average discount rate and remaining term on lease liabilities were approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.75%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.76%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.1</div> years and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.4</div> years, respectively.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Supplemental cash flows information related to leases for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019, </div>is was follows:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div> <table style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 50%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;">Related Party - Vitamin Realty</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Other Leases</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Totals</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="width: 50%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 12%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 12%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 12%;"> </td> <td style="width: 1%;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 50%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Cash paid for amounts included in the measurement of lease liabilities:</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 12%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 12%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 12%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 50%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Operating cash flows from operating leases</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">141</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">165</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 50%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Operating cash flows from finance leases</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 50%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Financing cash flows from finance lease obligations</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">60</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">60</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td></tr></table></div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Supplemental cash flows information related to leases for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018, </div>is was follows:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div> <table style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 53%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;">Related Party - Vitamin Realty</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt;">Other Leases</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Totals</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="width: 53%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 13%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 13%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 13%;"> </td> <td style="width: 1%;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 53%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Cash paid for amounts included in the measurement of lease liabilities:</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 13%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 13%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 13%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 53%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Operating cash flows from operating leases</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">94</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">118</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 53%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Operating cash flows from finance leases</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 53%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Financing cash flows from finance lease obligations</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The Company did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> enter into any lease commitments in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Maturities of operating lease liabilities as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019 </div>were as follows:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div> <table style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Operating</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Related Party</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Capitalized</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 36%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Lease</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Operating Lease</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Lease</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Year ending June 30,</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Commitment</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Commitment</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Obligations</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Total</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2020, remaining</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">27</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">424</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">144</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">595</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2021</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">565</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">676</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2022</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">565</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">573</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2023</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">565</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">565</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2024</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">563</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">563</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2025</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">533</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">533</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Thereafter</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">311</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">311</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total minimum lease payments</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">56</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,526</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">234</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,816</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Imputed interest</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;" nowrap="nowrap">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(394</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;" nowrap="nowrap">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(25</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;" nowrap="nowrap">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(421</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;" nowrap="nowrap">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Total</div></div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">54</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,132</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">209</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,395</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Total rent expense, lease amortization costs and interest expense, including real estate taxes and maintenance charges, was approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$257</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$245</div> for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> respectively. Rent and lease amortization and interest expense is included in cost of sales, selling and administrative expenses and interest expense in the accompanying Condensed Consolidated Statements of Operations.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:27pt;margin-top:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"> </div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:27pt;margin-top:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">(</div></div><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">b</div></div><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">) Legal Proceedings. </div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 27pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The Company is subject, from time to time, to claims by <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div> parties under various legal theories. The defense of such claims, or any adverse outcome relating to any such claims, could have a material adverse effect on the Company’s liquidity, financial condition and cash flows.</div></div>

0.002

50000000

29600843

29565943

59000

0.91

0.89

0.66

0.29

0.61

0.29

0.02

0.87

0.88

0.72

10007000

9085000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Note </div></div><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div></div></div><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">. </div></div><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Senior Credit Facility and other Long Term Debt</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-top:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"> </div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-align:justify;">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2019, </div>the Company had the following debt outstanding:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-align:justify;"> </div> <div> <table style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td colspan="2" style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Principal Amount</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Interest Rate</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 7.9%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Maturity Date</div> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="2" style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">As of September 30, 2019</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">As of June 30, 2019</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="2" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 35.1%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Revolving advances under Senior Credit</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="2" style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Facility with PNC Bank, National Association</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,799</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,834</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">*</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5/15/2024</div></div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="2" style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Installment Note with PNC Bank</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,069</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,542</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">*</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5/15/2024</div></div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="2" style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Installment Note with PNC Equipment Finance</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.57</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">%</td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7/29/2019</div></div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="2" style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Capitalized lease obligations</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding: 0px; border-bottom: thin solid rgb(0, 0, 0);"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding: 0px; border-bottom: thin solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">209</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding: 0px; border-bottom: thin solid rgb(0, 0, 0);"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding: 0px; border-bottom: thin solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">269</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.01% - 9.38</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">%</td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11/01/2019 - 2/1/2021</div></div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="2" style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total outstanding debt</div> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,077</div></td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,653</div></td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="border-bottom: 1px rgb(0, 0, 0); text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="2" style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Less: Revolving Advances</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(4,799</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,834</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">)</td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="2" style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Prepaid financing costs</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(48</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(50</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">)</td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="2" style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Current portion of long term debt, net</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,053</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;" nowrap="nowrap">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,047</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;" nowrap="nowrap">)</td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 0%; padding: 0px;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 0%; padding: 0px;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="2" style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Long term debt, net</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,177</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,722</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 0%; padding: 0px;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 0%; padding: 0px;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> </tr> <tr> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 144px; padding: 0px; border-bottom: thin solid rgb(0, 0, 0);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 112px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding: 0px;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding: 0px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding: 0px;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding: 0px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 0%; padding: 0px;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 0%; padding: 0px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 144px; padding: 0px;">* See table below</td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 112px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding: 0px;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding: 0px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding: 0px;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding: 0px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 0%; padding: 0px;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 0%; padding: 0px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:4.5pt;margin-top:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">SENIOR CREDIT FACILITY</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-top:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0.2pt;margin-top:0pt;text-align:justify;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 15, 2019, </div>the Company, MDC, AgroLabs, IHT, IHT Properties Corp. (“IHT Properties”) and Vitamin Factory (collectively, the “Borrowers”) amended the Revolving Credit, Term Loan and Security Agreement (the “Amended Loan Agreement”) with PNC Bank, National Association as agent and lender (“PNC”) and the other lenders party thereto entered into on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 27, 2012, </div>as amended on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 19, 2016 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 15, 2019.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0.2pt;margin-top:0pt;text-align:justify;"> </div><div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0.2pt;margin-top:0pt;text-align:justify;">The Amended Loan Agreement provides for a total of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$11,585</div> in senior secured financing (the “Senior Credit Facility”) as follows: (i) discretionary advances (“Revolving Advances”) based on eligible accounts receivable and eligible inventory in the maximum amount of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$8,000</div> (the “Revolving Credit Facility”), and (ii) a term loan in the amount of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3,585</div> (the “Term Loan”). The Senior Credit Facility is secured by all assets of the Borrowers, including, without limitation, machinery and equipment, real estate owned by IHT Properties, and common stock of iBio owned by the Company. Revolving Advances bear interest at PNC’s Base Rate or the Eurodollar Rate, at Borrowers’ option, plus <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.50%.</div> The Term Loan bears interest at PNC’s Base Rate or the Eurodollar Rate at Borrowers’ option, plus <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.00%.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0.2pt;margin-top:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0.2pt;margin-top:0pt;text-align:justify;">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2019, </div>the Company had amounts outstanding utilizing the Eurodollar Rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4,250</div> under the Revolving Advances and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,674</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3,455</div> under the Term Note, respectively, with interest rates as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2019 </div>as follows (based on the respective base rate plus <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.50%</div> on Revolving Advances and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.00%</div> on the Term Note in effect as of the respective dates):</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0.2pt;margin-top:0pt;text-align:justify;"> </div> <div> <table style="margin-right: 25%; margin-left: 25%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="4" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">September 30,</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">June 30,</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2019</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2019</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 56.8%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Revolving Credit Facility:</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Base Rate Interest</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.00</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">%</td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.50</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Eurodollar Rate</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.554</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">%</td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.881</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Term Loan:</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Base Rate Interest</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.25</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">%</td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.75</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Eurodollar Rate</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.05363% and 5.04588%</div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.381% and 5.3838%</div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0.2pt;margin-top:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0.2pt;margin-top:0pt;text-align:justify;">Upon and after the occurrence of any event of default under the Amended Loan Agreement, and during the continuation thereof, interest shall be payable at the interest rate then applicable plus <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2%.</div> The Senior Credit Facility matures on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 15, 2024 (</div>the “Senior Maturity Date”).</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0.2pt;margin-top:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0.2pt;margin-top:0pt;text-align:justify;">The principal balance of the Revolving Advances is payable on the Senior Maturity Date, subject to acceleration, based upon a material adverse event clause, as defined, subjective accelerations for borrowing base reserves, as defined or upon the occurrence of any event of default under the Amended Loan Agreement or earlier termination of the Amended Loan Agreement pursuant to the terms thereof. The Term Loan shall be repaid in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">eighty-four</div> (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">84</div>) consecutive monthly installments of principal, the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">eighty-three</div> (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">83</div>) of which shall be in the amount of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$43,</div> commencing on the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> business day of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June, 2019, </div>and continuing on the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> business day of each month thereafter, with a final payment of any unpaid balance of principal and interest payable on the Senior Maturity Date. The foregoing is subject to customary mandatory prepayment provisions and acceleration upon the occurrence of any event of default under the Amended Loan Agreement or earlier termination of the Amended Loan Agreement pursuant to the terms thereof.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0.2pt;margin-top:0pt;text-align:justify;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0.2pt;margin-top:0pt;text-align:justify;"></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0.2pt;margin-top:0pt;text-align:justify;">The Revolving Advances are subject to the terms and conditions set forth in the Amended Loan Agreement and are made in aggregate amounts at any time equal to the lesser of (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">x</div>) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$8,000</div> or (y) an amount equal to the sum of: (i) up to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">85%,</div> subject to the provisions in the Amended Loan Agreement, of eligible accounts receivables (“Receivables Advance Rate”), plus (ii) up to the lesser of (A) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">75%,</div> subject to the provisions in the Amended Loan Agreement, of the value of the eligible inventory (“Inventory Advance Rate” and together with the Receivables Advance Rate, collectively, the “Advance Rates”), (B) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">85%</div> of the appraised net orderly liquidation value of eligible inventory (as evidenced by the most recent inventory appraisal reasonably satisfactory to PNC in its sole discretion exercised in good faith) and (C) the inventory sublimit in the aggregate at any <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> time (“Inventory Advance Rate” and together with the Receivables Advance Rate, collectively, the “Advance Rates”), minus (iii) the aggregate Maximum Undrawn Amount of all outstanding Letters of Credit, minus (iv) such reserves as PNC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>reasonably deem proper and necessary from time to time.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0.2pt;margin-top:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0.2pt;margin-top:0pt;text-align:justify;">The Amended Loan Agreement contains customary mandatory prepayment provisions, including, without limitation the requirement to use any sales proceeds from the sale of iBio Stock to repay the Term Loan and to prepay the outstanding amount of the Term Note in an amount equal to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">twenty-five</div> percent (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25%</div>) of Excess Cash Flow for each fiscal year commencing with the fiscal year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2016, </div>payable upon delivery of the financial statements to PNC referred to in and required by the Amended Loan Agreement for such fiscal year but in any event <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> later than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one hundred twenty</div> (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">120</div>) days after the end of each such fiscal year, which amount shall be applied ratably to the outstanding principal installments of the Term Loan in the inverse order of the maturities thereof. The Amended Loan Agreement also contains customary representations and warranties, covenants and events of default, including, without limitation, (i) a fixed charge coverage ratio maintenance requirement and (ii) an event of default tied to any change of control as defined in the Amended Loan Agreement. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019, </div>the Company was in compliance with the fixed charge coverage ratio maintenance requirement and with the required annual payments of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25%</div> of the Excess Cash Flow for each fiscal year commencing with the fiscal year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2016.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0.2pt;margin-top:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0.2pt;margin-top:0pt;text-align:justify;">In connection with the Senior Credit Facility, the following loan documents were executed: (i) a Stock Pledge Agreement with PNC, pursuant to which the Company pledged to PNC the iBio Stock; (ii) a Mortgage and Security Agreement with PNC with IHT Properties; and (iii) an Environmental Indemnity Agreement with PNC.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0pt;margin-top:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0pt;margin-top:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">OTHER LONG TERM DEBT</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0pt;margin-top:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0.2pt;margin-top:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Capitalized Lease Obligations. </div>On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 1, 2019, </div>the capitalized lease obligation entered into by the Company on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 22, 2017 </div>with First American Equipment Finance in the amount of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$143,</div> which lease was secured by certain machinery and equipment, was satisfied with all payments being made under the capitalized lease obligation. The monthly lease payment was approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$6</div> and had an imputed interest rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.56%.</div></div></div>

0.025

0.03

0.025

0.03

3585000

0.0457

43000

48000

50000

-5000

31000

549000

534000

95000

115000

91000

66000

90000

65000

1000

91000

9000

71000

67000

0.01

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Earnings Per Share. </div></div>Basic earnings per common share amounts are based on weighted average number of common shares outstanding. Diluted earnings per share amounts are based on the weighted average number of common shares outstanding, plus the incremental shares that would have been outstanding upon the assumed exercise of all potentially dilutive stock options, warrants and convertible debt, subject to anti-dilution limitations using the treasury stock method and if converted method.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The following options and potentially dilutive shares for convertible notes payable were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> included in the computation of weighted average diluted common shares outstanding as the effect of doing so would be anti-dilutive for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018:</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div> <table style="margin-right: 25%; margin-left: 25%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Three Months Ended</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">September 30,</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2019</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2018</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;">Anti-dilutive stock options</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50,000</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">150,000</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total anti-dilutive shares</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: medium double rgb(0, 0, 0); padding: 0px;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: medium double rgb(0, 0, 0); padding: 0px;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50,000</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: medium double rgb(0, 0, 0); padding: 0px;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: medium double rgb(0, 0, 0); padding: 0px;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">150,000</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> </table> </div></div></div>

5000

4000

209000

234000

90000

144000

25000

27000

17000

1250000

1083000

-3000

21000

152000

115000

1399000

1219000

349000

214000

37000

55000

2000

1251000

1861000

-1084000

-415000

1073000

1858000

-37000

-70000

-8000

18000

-52000

1158690

744818

124000

200000

123000

201000

1426000

1944000

9891000

8819000

6642000

4550000

1823000

2325000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 2.5%; margin-left: 2.5%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 25%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="10" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 25%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2019</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="10" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 25%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2018</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 25%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Related Party - Vitamin Realty</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Other Leases</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Totals</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Related Party - Vitamin Realty</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Other Leases</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Totals</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="width: 25%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 9%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 9%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 10%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 9%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 9%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 10%;"> </td> <td style="width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 25%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Operating lease costs</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">135</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">39</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">174</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">141</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">163</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 25%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 9%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 9%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 10%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 9%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 9%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 10%;"> </td> <td style="width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 25%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Finance Operating Lease Costs:</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 10%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 10%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 25%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Amortization of right-of use assets</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">27</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">27</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 25%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Interest on operating lease liabilities</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 25%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total finance lease cost</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">32</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">32</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table></div>

0.0375

0.0376

56000

3526000

311000

563000

565000

8000

565000

21000

565000

27000

424000

2000

394000

17421000

17897000

19641000

19790000

12542000

12353000

4000000

4250000

0.05

0.055

0.04554

0.04881

0.0525

0.0575

0.0505363

0.0504588

0.05381

0.053838

8000000

4799000

5834000

8077000

9653000

1053000

1047000

1053000

1047000

2177000

2722000

4799000

5834000

2674000

3455000

-1577000

-430000

-58000

-26000

1685000

593000

312000

159000

-127000

-191000

4799000

5834000

3069000

3542000

8000

476000

405000

135000

39000

174000

141000

22000

163000

3132000

3243000

54000

454000

450000

11000

9000

474000

11000

9000

470000

2678000

2793000

13000

11000

2702000

15000

14000

2822000

141000

24000

165000

94000

24000

118000

3126000

3236000

24000

19000

3169000

26000

22000

3284000

P6Y36D

P6Y146D

207000

202000

257000

245000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-indent: 0pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.</div> Principles of Consolidation and Basis of Presentation</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"></div></div></div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Basis of Presentation of Interim Financial Statements</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The accompanying condensed consolidated financial statements for the interim periods are unaudited and include the accounts of Integrated BioPharma, Inc., a Delaware corporation (together with its subsidiaries, the “Company”). The interim condensed consolidated financial statements have been prepared in conformity with Rule <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">03</div> of Regulation S-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">X</div> of the Securities and Exchange Commission (“SEC”) and therefore do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> include information or footnotes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States of America. However, all adjustments (consisting only of normal recurring adjustments) which are, in the opinion of management, necessary for a fair presentation of the financial position and operating results for the periods presented have been included. These condensed consolidated financial statements should be read in conjunction with the financial statements and notes thereto, together with Management’s Discussion and Analysis of Financial Condition and Results of Operations, contained in the Company’s Annual Report on Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-K for the fiscal year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2019 (</div>“Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-K”), as filed with the SEC. The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2019 </div>balance sheet was derived from audited financial statements, but does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> include all disclosures required by accounting principles generally accepted in the United States of America. The preparation of the unaudited condensed financial statements in conformity with these accounting principles requires management to make estimates and assumptions that affect the amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of expenses during the period reported.  Ultimate results could differ from the estimates of management.  The results of operations for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019 </div>are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> necessarily indicative of the results for the full fiscal year ending <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2020 </div>or for any other period.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></div></div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"></div></div></div></div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"></div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"></div></div><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Reclassifications.  </div></div>Certain prior year amounts have been reclassified to conform to the current period presentation.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></div></div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"></div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"></div></div></div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Nature of Operations</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The Company is engaged primarily in manufacturing, distributing, marketing and sales of vitamins, nutritional supplements and herbal products. The Company’s customers are located primarily in the United States, Luxembourg and Canada. The Company was previously known as Integrated Health Technologies, Inc. and, prior to that, as Chem International, Inc. The Company was reincorporated in its current form in Delaware in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1995.</div> The Company continues to do business as Chem International, Inc. with certain of its customers and certain vendors.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0pt;margin-top:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The Company’s business segments include: (a) Contract Manufacturing operated by Manhattan Drug Company, Inc. (“MDC”), which manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers and specialized health-care providers; (b) Branded Proprietary Products operated by AgroLabs, Inc. (“AgroLabs”), which distributes healthful nutritional products for sale through major mass market, grocery and drug and vitamin retailers, under the following brands: Peaceful Sleep, Green Envy, FiberCal, Wheatgrass and other products which are being introduced into the market (these are referred to as our branded proprietary nutraceutical business and/or products); and (c) Other Nutraceutical Businesses which includes the operations of (i) The Vitamin Factory (the “Vitamin Factory”), which sells private label MDC products, as well as our AgroLabs products, through the Internet, (ii) IHT Health Products, Inc. (“IHT”) a distributor of fine natural botanicals, including multi minerals produced under a license agreement, (iii) MDC Warehousing and Distribution, Inc., a service provider for warehousing and fulfilment services and (iv) Chem International, Inc. (“Chem”), a distributor of certain raw materials for DSM Nutritional Products LLC.</div> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:center;"></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:center;">                                                                       </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Accounting Policies</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"></div></div></div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Accounting Pronouncements Recently Adopted</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October, 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16,</div> “Income Taxes (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">740</div>): Intra-Entity Transfers of Assets Other than Inventory,” which eliminates the requirement to defer recognition of income taxes on intra-entity transfers until the asset is sold to an outside party. The new guidance requires the recognition of current and deferred income taxes on intra-entity transfers of assets other than inventory, such as intellectual property and property, plant and equipment, when the transfer occurs. The guidance was effective for the Company on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 1, 2019. </div>The standard requires a “modified retrospective” adoption, meaning the standard is applied through a cumulative adjustment in retained earnings as of the beginning of the period of adoption. This new guidance did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have a material impact on the Company’s Condensed Consolidated Financial Statements.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2017, </div>the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,</div> "Earnings Per Share (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">260</div>) Distinguishing Liabilities from Equity (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">480</div>) Derivatives and Hedging (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">815</div>)," which addresses the complexity of accounting for certain financial instruments with down round features. The amendments were effective for the Company on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 1, 2019 </div>for the fiscal year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2020, </div>and the interim periods within it. This new guidance did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have a material impact on the Company’s Condensed Consolidated Financial Statements.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Aside from the adoption of ASUs, as described above, there have been <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> material changes during fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2020</div> in the Company’s significant accounting policies to those previously disclosed in the Company’s Annual Report on Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-K for the fiscal year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2019.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div></div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Significant Accoun</div></div><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">ting P</div></div><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">olicies</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"> </div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0.2pt;margin-top:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"></div></div></div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0.2pt;margin-top:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Revenue Recognition.</div></div> The Company recognizes product sales revenue, the prices of which are fixed and determinable, when title and risk of loss have transferred to the customer, when estimated provisions for product returns, rebates, charge-backs and other sales allowances are reasonably determinable, and when collectability is reasonably assured. Accruals for these items are presented in the consolidated financial statements as reductions to sales. The Company’s net sales represent gross sales invoiced to customers, less certain related charges for discounts, returns, rebates, charge-backs and other allowances. Cost of sales includes the cost of raw materials and all labor and overhead associated with the manufacturing and packaging of the products. Gross margins are affected by, among other things, changes in the relative sales mix among our products and valuation and/or charge off of slow moving, expired or obsolete inventories. To perform revenue recognition for arrangements within the scope of ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606,</div> the Company performs the following <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> steps:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0.2pt;margin-top:0pt;text-align:justify;"> </div> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:36pt;"> </td> <td style="width:18pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0.2pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">●</div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0.2pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">identification of the promised goods or services in the contract;</div> </td> </tr> </table> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:36pt;"> </td> <td style="width:18pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0.2pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">●</div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0.2pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">determination of whether the promised goods or serves are performance obligations including whether they are distinct in the context of the contract;</div> </td> </tr> </table> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:36pt;"> </td> <td style="width:18pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0.2pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">●</div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0.2pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">measurement of the transaction price, including the constraint on variable consideration;</div> </td> </tr> </table> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:36pt;"> </td> <td style="width:18pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0.2pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">●</div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0.2pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">allocation of the transaction price to the performance obligations based on estimated selling prices; and</div> </td> </tr> </table> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:36pt;"> </td> <td style="width:18pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0.2pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">●</div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0.2pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">recognition of revenue when (or as) the Company satisfies each performance obligation. A performance obligation is a promise to transfer a distinct good or service to the customer and is the unit of account in ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606.</div></div> </td> </tr> </table> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"> </div></div></div></div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"></div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"></div></div></div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Leases. </div></div>We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets, other current liabilities, and operating lease liabilities on our consolidated balance sheets. Finance leases are included in property and equipment, current portion of long term debt, and long-term debt obligation on our consolidated statement of financial condition.  </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:center;"></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:center;">                                                                       </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As most of our leases do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. The operating lease ROU asset also includes any lease payments made and excludes lease incentives and initial direct costs incurred. Our lease terms <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term.</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">We have lease agreements with lease and non-lease components, which are generally accounted for separately. For certain equipment leases, such as vehicles, we account for the lease and non-lease components as a single lease component.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"> </div></div></div></div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"></div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"></div></div></div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Earnings Per Share. </div></div>Basic earnings per common share amounts are based on weighted average number of common shares outstanding. Diluted earnings per share amounts are based on the weighted average number of common shares outstanding, plus the incremental shares that would have been outstanding upon the assumed exercise of all potentially dilutive stock options, warrants and convertible debt, subject to anti-dilution limitations using the treasury stock method and if converted method.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The following options and potentially dilutive shares for convertible notes payable were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> included in the computation of weighted average diluted common shares outstanding as the effect of doing so would be anti-dilutive for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018:</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div> <table style="margin-right: 25%; margin-left: 25%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Three Months Ended</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">September 30,</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2019</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2018</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;">Anti-dilutive stock options</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50,000</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">150,000</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total anti-dilutive shares</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: medium double rgb(0, 0, 0); padding: 0px;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: medium double rgb(0, 0, 0); padding: 0px;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50,000</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: medium double rgb(0, 0, 0); padding: 0px;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: medium double rgb(0, 0, 0); padding: 0px;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">150,000</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> </table> </div></div></div>

312000

346000

21000

5000

8000

533000

27000

8000

58000

18000

58000

18000

58000

18000

11040000

10204000

1250000

1282000

6338000

6280000

6000

8876000

8818000

1745000

1778000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 25%; margin-left: 25%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">September 30,</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">June 30,</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2019</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2019</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 62%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Land and building</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,250</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,250</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Leasehold improvements</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,282</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,282</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Machinery and equipment</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,338</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,280</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Transportation equipment</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,876</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,818</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Less: Accumulated depreciation and amortization</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(7,131</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(7,040</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,745</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,778</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 50%; margin-left: 54pt; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Total Assets as of</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">September 30,</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">June 30,</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2019</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2019</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 62%;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 62%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">Contract Manufacturing</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17,575</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17,580</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style="display: inline; font-weight: bold;">Branded Proprietary Products</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">413</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">427</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style="display: inline; font-weight: bold;">Other Nutraceutical Businesses</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,653</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,783</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">Total Company</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,641</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,790</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table></div>

12075000

10400000

60000

50000

482000

184000

-47952000

-48264000

9974000

1010000

10984000

8655000

1197000

9852000

2000

10000

12000

71000

7000

78000

377000

33000

410000

339000

35000

374000

10353000

1053000

11406000

9065000

1239000

10304000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0.2pt;margin-top:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Revenue Recognition.</div></div> The Company recognizes product sales revenue, the prices of which are fixed and determinable, when title and risk of loss have transferred to the customer, when estimated provisions for product returns, rebates, charge-backs and other sales allowances are reasonably determinable, and when collectability is reasonably assured. Accruals for these items are presented in the consolidated financial statements as reductions to sales. The Company’s net sales represent gross sales invoiced to customers, less certain related charges for discounts, returns, rebates, charge-backs and other allowances. Cost of sales includes the cost of raw materials and all labor and overhead associated with the manufacturing and packaging of the products. Gross margins are affected by, among other things, changes in the relative sales mix among our products and valuation and/or charge off of slow moving, expired or obsolete inventories. To perform revenue recognition for arrangements within the scope of ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606,</div> the Company performs the following <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> steps:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0.2pt;margin-top:0pt;text-align:justify;"> </div> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:36pt;"> </td> <td style="width:18pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0.2pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">●</div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0.2pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">identification of the promised goods or services in the contract;</div> </td> </tr> </table> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:36pt;"> </td> <td style="width:18pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0.2pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">●</div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0.2pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">determination of whether the promised goods or serves are performance obligations including whether they are distinct in the context of the contract;</div> </td> </tr> </table> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:36pt;"> </td> <td style="width:18pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0.2pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">●</div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0.2pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">measurement of the transaction price, including the constraint on variable consideration;</div> </td> </tr> </table> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:36pt;"> </td> <td style="width:18pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0.2pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">●</div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0.2pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">allocation of the transaction price to the performance obligations based on estimated selling prices; and</div> </td> </tr> </table> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:36pt;"> </td> <td style="width:18pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0.2pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">●</div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0.2pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">recognition of revenue when (or as) the Company satisfies each performance obligation. A performance obligation is a promise to transfer a distinct good or service to the customer and is the unit of account in ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606.</div></div> </td> </tr> </table></div></div>

1053000

1239000

0.0656

6000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td colspan="2" style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Principal Amount</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Interest Rate</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 7.9%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Maturity Date</div> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="2" style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">As of September 30, 2019</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">As of June 30, 2019</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="2" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 35.1%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Revolving advances under Senior Credit</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="2" style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Facility with PNC Bank, National Association</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,799</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,834</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">*</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5/15/2024</div></div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="2" style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Installment Note with PNC Bank</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,069</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,542</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">*</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5/15/2024</div></div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="2" style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Installment Note with PNC Equipment Finance</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.57</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7/29/2019</div></div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="2" style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Capitalized lease obligations</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding: 0px; border-bottom: thin solid rgb(0, 0, 0);"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding: 0px; border-bottom: thin solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">209</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding: 0px; border-bottom: thin solid rgb(0, 0, 0);"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding: 0px; border-bottom: thin solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">269</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.01% - 9.38</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11/01/2019 - 2/1/2021</div></div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="2" style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total outstanding debt</div> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,077</div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,653</div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="border-bottom: 1px rgb(0, 0, 0); text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="2" style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Less: Revolving Advances</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(4,799</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,834</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="2" style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Prepaid financing costs</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(48</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(50</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="2" style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Current portion of long term debt, net</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,053</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,047</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 0%; padding: 0px;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 0%; padding: 0px;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="2" style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Long term debt, net</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,177</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,722</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 0%; padding: 0px;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 0%; padding: 0px;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> </tr> <tr> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 144px; padding: 0px; border-bottom: thin solid rgb(0, 0, 0);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 112px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding: 0px;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding: 0px;"> </td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding: 0px;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding: 0px;"> </td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 0%; padding: 0px;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 0%; padding: 0px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 144px; padding: 0px;">* See table below</td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 112px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding: 0px;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding: 0px;"> </td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding: 0px;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding: 0px;"> </td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 0%; padding: 0px;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 0%; padding: 0px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 7.5%; margin-left: 7.5%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="10" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Sales, Net</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Segment</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">U.S.</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">International</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Gross</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Capital</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Customers</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Customers</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Total</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Profit (Loss)</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Depreciation</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Expenditures</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 6.6%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">Contract</div></div> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 3.4%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div></div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,974</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,010</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,984</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,250</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">58</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td><div style="display: inline; font-weight: bold;">Manufacturing</div></td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,655</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,197</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,852</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,083</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">65</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">Branded Proprietary</div></div> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div></div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">)</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td><div style="display: inline; font-weight: bold;">Products</div></td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">71</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">78</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">Other Nutraceutical</div></div> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div></div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">377</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">410</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">152</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td><div style="display: inline; font-weight: bold;">Businesses</div></td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">339</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">374</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">115</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">Total Company</div></div> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div></div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,353</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,053</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,406</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,399</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">91</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">58</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,065</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,239</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,304</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,219</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">66</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.</div> Segment Information</div></div><div style="display: inline; font-style: italic;"> </div><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">and Disaggregated Revenue</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0.2pt;margin-top:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:0.2pt;margin-top:0pt;text-align:justify;">The basis for presenting segment results generally is consistent with overall Company reporting. The Company reports information about its operating segments in accordance with GAAP which establishes standards for reporting information about a company’s operating segments.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0.2pt;margin-top:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:0.2pt;margin-top:0pt;text-align:justify;">The Company has divided its operations into <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> reportable segments as follows: Contract Manufacturing, Branded Proprietary Products and Other Nutraceutical Businesses. The international sales, concentrated primarily in Europe and Canada, for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,053</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,239,</div> respectively.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:0.2pt;margin-top:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:0.2pt;margin-top:0pt;text-align:justify;">Financial information relating to the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> operations by business segment and disaggregated revenues was as follows:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0.2pt;margin-top:0pt;text-align:justify;"> </div> <div> <table style="margin-right: 7.5%; margin-left: 7.5%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="10" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Sales, Net</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Segment</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">U.S.</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">International</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Gross</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Capital</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Customers</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Customers</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Total</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Profit (Loss)</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Depreciation</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Expenditures</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 6.6%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">Contract</div></div> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 3.4%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div></div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,974</div></div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,010</div></div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,984</div></div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,250</div></div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90</div></div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">58</div></div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td><div style="display: inline; font-weight: bold;">Manufacturing</div></td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,655</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,197</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,852</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,083</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">65</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">Branded Proprietary</div></div> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div></div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div></div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div></div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12</div></div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3</div></div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"><div style="display: inline; font-weight: bold;">)</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td><div style="display: inline; font-weight: bold;">Products</div></td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">71</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">78</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">Other Nutraceutical</div></div> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div></div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">377</div></div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33</div></div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">410</div></div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">152</div></div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div></div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td><div style="display: inline; font-weight: bold;">Businesses</div></td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">339</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">374</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">115</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">Total Company</div></div> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div></div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,353</div></div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,053</div></div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,406</div></div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,399</div></div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">91</div></div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">58</div></div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,065</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,239</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,304</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,219</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">66</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div> <table style="margin-right: 50%; margin-left: 54pt; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Total Assets as of</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">September 30,</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">June 30,</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2019</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2019</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 62%;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 62%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">Contract Manufacturing</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17,575</div></div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17,580</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style="display: inline; font-weight: bold;">Branded Proprietary Products</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">413</div></div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">427</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style="display: inline; font-weight: bold;">Other Nutraceutical Businesses</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-weight: bold;"> </div></td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,653</div></div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,783</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">Total Company</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,641</div></div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,790</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td></tr></table></div></div>

923000

814000

11585000

15000

29600843

34900

29600843

34900

21170074

34900

29400843

34900

8230769

17000

5256000

5273000

59000

50197000

-48264000

-99000

1893000

59000

50212000

-47952000

-99000

2220000

42000

44773000

-49952000

-99000

-5236000

59000

50029000

-49793000

-99000

196000

34900

99000

-24000

30724633

27963604

29565943

27218786

See table below xbrli:shares xbrli:pure utr:sqft iso4217:USD iso4217:USD xbrli:shares 0001016504 inbp:ManhattanDrugCompanyMember 2012-01-05 2012-01-05 0001016504 inbp:AgrolabsMember 2014-05-19 2014-05-19 0001016504 inbp:FirstAmericanEquipmentFinanceMember 2017-12-22 2017-12-22 0001016504 2018-07-01 2018-09-30 0001016504 us-gaap:EmployeeStockOptionMember 2018-07-01 2018-09-30 0001016504 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-07-01 2018-09-30 0001016504 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember inbp:MajorCustomer1Member inbp:ContractManufacturingMember 2018-07-01 2018-09-30 0001016504 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember inbp:MajorCustomer2Member inbp:ContractManufacturingMember 2018-07-01 2018-09-30 0001016504 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember inbp:TwoCustomersMember 2018-07-01 2018-09-30 0001016504 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember inbp:ContractManufacturingMember 2018-07-01 2018-09-30 0001016504 inbp:UnrelatedPartyMember 2018-07-01 2018-09-30 0001016504 inbp:VitaminRealtyLLCMember 2018-07-01 2018-09-30 0001016504 inbp:BrandedProprietaryProductsMember 2018-07-01 2018-09-30 0001016504 inbp:BrandedProprietaryProductsMember us-gaap:NonUsMember 2018-07-01 2018-09-30 0001016504 inbp:BrandedProprietaryProductsMember country:US 2018-07-01 2018-09-30 0001016504 inbp:ContractManufacturingMember 2018-07-01 2018-09-30 0001016504 inbp:ContractManufacturingMember us-gaap:NonUsMember 2018-07-01 2018-09-30 0001016504 inbp:ContractManufacturingMember country:US 2018-07-01 2018-09-30 0001016504 inbp:OtherNutraceuticalBusinessMember 2018-07-01 2018-09-30 0001016504 inbp:OtherNutraceuticalBusinessMember us-gaap:NonUsMember 2018-07-01 2018-09-30 0001016504 inbp:OtherNutraceuticalBusinessMember country:US 2018-07-01 2018-09-30 0001016504 us-gaap:AdditionalPaidInCapitalMember 2018-07-01 2018-09-30 0001016504 us-gaap:CommonStockMember 2018-07-01 2018-09-30 0001016504 us-gaap:RetainedEarningsMember 2018-07-01 2018-09-30 0001016504 us-gaap:TreasuryStockMember 2018-07-01 2018-09-30 0001016504 inbp:EuropeAndCanadaMember 2018-07-01 2018-09-30 0001016504 us-gaap:NonUsMember 2018-07-01 2018-09-30 0001016504 country:US 2018-07-01 2018-09-30 0001016504 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2018-07-01 2019-06-30 0001016504 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember inbp:TwoCustomersMember 2018-07-01 2019-06-30 0001016504 us-gaap:RevolvingCreditFacilityMember inbp:AmendedLoanAgreementMember 2019-05-15 2019-05-15 0001016504 us-gaap:RevolvingCreditFacilityMember inbp:AmendedLoanAgreementMember us-gaap:EurodollarMember 2019-05-15 2019-05-15 0001016504 inbp:AmendedLoanAgreementMember 2019-05-15 2019-05-15 0001016504 inbp:AmendedLoanAgreementMember inbp:TermLoanMember 2019-05-15 2019-05-15 0001016504 inbp:AmendedLoanAgreementMember inbp:TermLoanMember us-gaap:EurodollarMember 2019-05-15 2019-05-15 0001016504 2019-07-01 2019-09-30 0001016504 us-gaap:EmployeeStockOptionMember 2019-07-01 2019-09-30 0001016504 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2019-09-30 0001016504 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember inbp:TwoCustomersMember 2019-07-01 2019-09-30 0001016504 us-gaap:NumberOfEmployeesGeographicAreaMember us-gaap:UnionizedEmployeesConcentrationRiskMember 2019-07-01 2019-09-30 0001016504 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2019-09-30 0001016504 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember inbp:MajorCustomer1Member inbp:ContractManufacturingMember 2019-07-01 2019-09-30 0001016504 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember inbp:MajorCustomer2Member inbp:ContractManufacturingMember 2019-07-01 2019-09-30 0001016504 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember inbp:TwoCustomersMember 2019-07-01 2019-09-30 0001016504 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember inbp:ContractManufacturingMember 2019-07-01 2019-09-30 0001016504 inbp:UnrelatedPartyMember 2019-07-01 2019-09-30 0001016504 us-gaap:RevolvingCreditFacilityMember inbp:AmendedLoanAgreementMember us-gaap:BaseRateMember 2019-07-01 2019-09-30 0001016504 inbp:AmendedLoanAgreementMember inbp:TermLoanMember us-gaap:BaseRateMember 2019-07-01 2019-09-30 0001016504 inbp:InstallmentNoteWithPNCBankMember 2019-07-01 2019-09-30 0001016504 inbp:PNCEquipmentFinanceLLCMember 2019-07-01 2019-09-30 0001016504 inbp:RevolvingAdvancesMember 2019-07-01 2019-09-30 0001016504 srt:MaximumMember 2019-07-01 2019-09-30 0001016504 srt:MinimumMember 2019-07-01 2019-09-30 0001016504 inbp:ChairmanChiefExecutiveOfficeAndMajorStockholderMember 2019-07-01 2019-09-30 0001016504 inbp:VitaminRealtyLLCMember 2019-07-01 2019-09-30 0001016504 inbp:BrandedProprietaryProductsMember 2019-07-01 2019-09-30 0001016504 inbp:BrandedProprietaryProductsMember us-gaap:NonUsMember 2019-07-01 2019-09-30 0001016504 inbp:BrandedProprietaryProductsMember country:US 2019-07-01 2019-09-30 0001016504 inbp:ContractManufacturingMember 2019-07-01 2019-09-30 0001016504 inbp:ContractManufacturingMember us-gaap:NonUsMember 2019-07-01 2019-09-30 0001016504 inbp:ContractManufacturingMember country:US 2019-07-01 2019-09-30 0001016504 inbp:OtherNutraceuticalBusinessMember 2019-07-01 2019-09-30 0001016504 inbp:OtherNutraceuticalBusinessMember us-gaap:NonUsMember 2019-07-01 2019-09-30 0001016504 inbp:OtherNutraceuticalBusinessMember country:US 2019-07-01 2019-09-30 0001016504 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0001016504 us-gaap:CommonStockMember 2019-07-01 2019-09-30 0001016504 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0001016504 us-gaap:TreasuryStockMember 2019-07-01 2019-09-30 0001016504 inbp:EuropeAndCanadaMember 2019-07-01 2019-09-30 0001016504 us-gaap:NonUsMember 2019-07-01 2019-09-30 0001016504 country:US 2019-07-01 2019-09-30 0001016504 inbp:ManhattanDrugCompanyMember srt:MaximumMember 2012-01-05 0001016504 inbp:ManhattanDrugCompanyMember srt:MinimumMember 2012-01-05 0001016504 inbp:AgrolabsMember 2014-05-19 0001016504 inbp:FirstAmericanEquipmentFinanceMember 2017-12-22 0001016504 2018-06-30 0001016504 us-gaap:LandAndBuildingMember 2018-06-30 0001016504 us-gaap:LeaseholdImprovementsMember 2018-06-30 0001016504 us-gaap:MachineryAndEquipmentMember 2018-06-30 0001016504 us-gaap:TransportationEquipmentMember 2018-06-30 0001016504 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0001016504 us-gaap:CommonStockMember 2018-06-30 0001016504 us-gaap:RetainedEarningsMember 2018-06-30 0001016504 us-gaap:TreasuryStockMember 2018-06-30 0001016504 2018-09-30 0001016504 us-gaap:AdditionalPaidInCapitalMember 2018-09-30 0001016504 us-gaap:CommonStockMember 2018-09-30 0001016504 us-gaap:RetainedEarningsMember 2018-09-30 0001016504 us-gaap:TreasuryStockMember 2018-09-30 0001016504 us-gaap:RevolvingCreditFacilityMember inbp:AmendedLoanAgreementMember 2019-05-15 0001016504 inbp:AmendedLoanAgreementMember 2019-05-15 0001016504 inbp:AmendedLoanAgreementMember inbp:TermLoanMember 2019-05-15 0001016504 2019-06-30 0001016504 inbp:UnrelatedPartyMember 2019-06-30 0001016504 us-gaap:RevolvingCreditFacilityMember inbp:AmendedLoanAgreementMember 2019-06-30 0001016504 us-gaap:RevolvingCreditFacilityMember us-gaap:BaseRateMember 2019-06-30 0001016504 us-gaap:RevolvingCreditFacilityMember us-gaap:EurodollarMember 2019-06-30 0001016504 inbp:TermLoanMember srt:MaximumMember us-gaap:EurodollarMember 2019-06-30 0001016504 inbp:TermLoanMember srt:MinimumMember us-gaap:EurodollarMember 2019-06-30 0001016504 inbp:TermLoanMember us-gaap:BaseRateMember 2019-06-30 0001016504 inbp:AmendedLoanAgreementMember inbp:TermLoanMember 2019-06-30 0001016504 inbp:InstallmentNoteWithPNCBankMember 2019-06-30 0001016504 inbp:PNCEquipmentFinanceLLCMember 2019-06-30 0001016504 inbp:RevolvingAdvancesMember 2019-06-30 0001016504 us-gaap:ConvertibleDebtMember 2019-06-30 0001016504 inbp:MachineryAndEquipmentLeasesMember 2019-06-30 0001016504 inbp:OfficeEquipmentLeasesMember 2019-06-30 0001016504 inbp:VitaminRealtyLLCMember 2019-06-30 0001016504 inbp:BrandedProprietaryProductsMember 2019-06-30 0001016504 inbp:ContractManufacturingMember 2019-06-30 0001016504 inbp:OtherNutraceuticalBusinessMember 2019-06-30 0001016504 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001016504 us-gaap:CommonStockMember 2019-06-30 0001016504 us-gaap:RetainedEarningsMember 2019-06-30 0001016504 us-gaap:TreasuryStockMember 2019-06-30 0001016504 2019-09-30 0001016504 inbp:UnrelatedPartyMember 2019-09-30 0001016504 us-gaap:RevolvingCreditFacilityMember inbp:AmendedLoanAgreementMember 2019-09-30 0001016504 us-gaap:RevolvingCreditFacilityMember us-gaap:BaseRateMember 2019-09-30 0001016504 us-gaap:RevolvingCreditFacilityMember us-gaap:EurodollarMember 2019-09-30 0001016504 inbp:TermLoanMember srt:MaximumMember us-gaap:EurodollarMember 2019-09-30 0001016504 inbp:TermLoanMember srt:MinimumMember us-gaap:EurodollarMember 2019-09-30 0001016504 inbp:TermLoanMember us-gaap:BaseRateMember 2019-09-30 0001016504 inbp:AmendedLoanAgreementMember 2019-09-30 0001016504 inbp:AmendedLoanAgreementMember inbp:TermLoanMember 2019-09-30 0001016504 inbp:InstallmentNoteWithPNCBankMember 2019-09-30 0001016504 inbp:PNCEquipmentFinanceLLCMember 2019-09-30 0001016504 inbp:RevolvingAdvancesMember 2019-09-30 0001016504 us-gaap:ConvertibleDebtMember 2019-09-30 0001016504 us-gaap:LandAndBuildingMember 2019-09-30 0001016504 us-gaap:LeaseholdImprovementsMember 2019-09-30 0001016504 inbp:MachineryAndEquipmentLeasesMember 2019-09-30 0001016504 us-gaap:MachineryAndEquipmentMember 2019-09-30 0001016504 inbp:OfficeEquipmentLeasesMember 2019-09-30 0001016504 us-gaap:TransportationEquipmentMember 2019-09-30 0001016504 srt:MaximumMember 2019-09-30 0001016504 srt:MinimumMember 2019-09-30 0001016504 inbp:VitaminRealtyLLCMember 2019-09-30 0001016504 inbp:BrandedProprietaryProductsMember 2019-09-30 0001016504 inbp:ContractManufacturingMember 2019-09-30 0001016504 inbp:OtherNutraceuticalBusinessMember 2019-09-30 0001016504 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0001016504 us-gaap:CommonStockMember 2019-09-30 0001016504 us-gaap:RetainedEarningsMember 2019-09-30 0001016504 us-gaap:TreasuryStockMember 2019-09-30 0001016504 2019-11-13

EX-101.SCH 7 inbp-20190930.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Condensed Consolidated Statements of Stockholders' (Deficiency) Equity link:calculationLink link:definitionLink link:presentationLink 005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:calculationLink link:definitionLink link:presentationLink 006 - Disclosure - Note 1 - Principles of Consolidation and Basis of Presentation link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note 2 - Inventories link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 3 - Property and Equipment, Net link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 4 - Senior Credit Facility and Other Long Term Debt link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 5 - Significant Risks and Uncertainties link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note 6 - Leases and Other Commitments and Contingencies link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 8 - Segment Information and Disaggregated Revenue link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 1 - Principles of Consolidation and Basis of Presentation (Tables) link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 2 - Inventories (Tables) link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 3 - Property and Equipment, Net (Tables) link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note 4 - Senior Credit Facility and Other Long Term Debt (Tables) link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 6 - Leases and Other Commitments and Contingencies (Tables) link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 8 - Segment Information and Disaggregated Revenue (Tables) link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Note 1 - Principles of Consolidation and Basis of Presentation - Antidilutive Securities Excluded From Weighted Average Diluted Common Shares Outstanding (Details) link:calculationLink link:definitionLink link:presentationLink 022 - Disclosure - Note 2 - Inventories - Inventories (Details) link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Note 3 - Property and Equipment, Net (Details Textual) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note 3 - Property and Equipment, Net - Property and Equipment, Net (Details) link:calculationLink link:definitionLink link:presentationLink 025 - Disclosure - Note 4 - Senior Credit Facility and Other Long Term Debt (Details Textual) link:calculationLink link:definitionLink link:presentationLink 026 - Disclosure - Note 4 - Senior Credit Facility and Other Long Term Debt - Debt Outstanding (Details) link:calculationLink link:definitionLink link:presentationLink 027 - Disclosure - Note 4 - Senior Credit Facility and Other Long Term Debt - Interest Rates (Details) link:calculationLink link:definitionLink link:presentationLink 028 - Disclosure - Note 5 - Significant Risks and Uncertainties (Details Textual) link:calculationLink link:definitionLink link:presentationLink 029 - Disclosure - Note 6 - Leases and Other Commitments and Contingencies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 030 - Disclosure - Note 6 - Leases and Other Commitments and Contingencies - Lease Expense (Details) link:calculationLink link:definitionLink link:presentationLink 031 - Disclosure - Note 6 - Leases and Other Commitments and Contingencies - Leases and Commitments (Details) link:calculationLink link:definitionLink link:presentationLink 032 - Disclosure - Note 6 - Leases and Other Commitments and Contingencies - Supplemental Cash Flow Information (Details) link:calculationLink link:definitionLink link:presentationLink 033 - Disclosure - Note 6 - Leases and Other Commitments and Contingencies - Minimum Rental Commitment for Long-term Non-cancelable Leases (Details) link:calculationLink link:definitionLink link:presentationLink 034 - Disclosure - Note 8 - Segment Information and Disaggregated Revenue (Details Textual) link:calculationLink link:definitionLink link:presentationLink 035 - Disclosure - Note 8 - Segment Information and Disaggregated Revenue - Operations by Business Segment (Details) link:calculationLink link:definitionLink link:presentationLink 036 - Disclosure - Note 8 - Segment Information and Disaggregated Revenue - Total Assets (Details) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 8 inbp-20190930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 inbp-20190930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 inbp-20190930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information Note To Financial Statement Details Textual us-gaap_DerivativeGainLossOnDerivativeNet Change in fair value of derivative liabilities Significant Accounting Policies Note 1 - Principles of Consolidation and Basis of Presentation 2021, Operating Lease us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Note 2 - Inventories Note 3 - Property and Equipment, Net 2025, Total Amount of lessee's undiscounted obligation for lease payments for operating lease and finance lease, due in sixth fiscal year following latest fiscal year. Note 4 - Senior Credit Facility and Other Long Term Debt 2025, Capital Lease Obligation inbp_FinanceLeaseLiabilityPaymentsDueYearSix Amount of lessee's undiscounted obligation for lease payments for finance lease, due in sixth fiscal year following latest fiscal year. Note 6 - Leases and Other Commitments and Contingencies Note 8 - Segment Information and Disaggregated Revenue Note 1 - Principles of Consolidation and Basis of Presentation - Antidilutive Securities Excluded From Weighted Average Diluted Common Shares Outstanding (Details) Note 2 - Inventories - Inventories (Details) Note 3 - Property and Equipment, Net - Property and Equipment, Net (Details) us-gaap_LongTermLineOfCredit Less: Revolving Advances Note 4 - Senior Credit Facility and Other Long Term Debt - Debt Outstanding (Details) Note 4 - Senior Credit Facility and Other Long Term Debt - Interest Rates (Details) Note 6 - Leases and Other Commitments and Contingencies - Lease Expense (Details) Stock based compensation Lessee, Leases [Policy Text Block] Note 6 - Leases and Other Commitments and Contingencies - Leases and Commitments (Details) 2020, remaining operating lease us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Total current liabilities Note 6 - Leases and Other Commitments and Contingencies - Supplemental Cash Flow Information (Details) Schedule of Debt [Table Text Block] Note 6 - Leases and Other Commitments and Contingencies - Minimum Rental Commitment for Long-term Non-cancelable Leases (Details) Note 8 - Segment Information and Disaggregated Revenue - Operations by Business Segment (Details) Note 8 - Segment Information and Disaggregated Revenue - Total Assets (Details) Earnings Per Share, Policy [Policy Text Block] Notes To Financial Statements Notes To Financial Statements [Abstract] us-gaap_Revenues Revenues, Total PNC Equipment Finance LLC [Member] Represents information pertaining to PNC Equipment Finance LLC. Depreciation Depreciation, Total us-gaap_DepreciationDepletionAndAmortization Depreciation and amortization Current portion of long term debt, net Current portion of long term debt, net us-gaap_AssetsCurrent Total current assets 2025, Operating Lease inbp_LesseeOperatingLeaseLiabilityPaymentsDueYearSix Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth fiscal year following latest fiscal year. Advances under revolving credit facility Treasury stock, shares aquired (in shares) Common Stock, $0.002 par value; 50,000,000 shares authorized; 29,600,843 shares issued and 29,565,943 shares outstanding, respectively Adjustments to reconcile net income to net cash from operating activities: Common stock, shares authorized (in shares) Common stock, shares issued (in shares) us-gaap_LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate Common stock, par value (in dollars per share) inbp_NumberOfConsecutiveMonthlyInstallments Number of Consecutive Monthly Installments Represents the number of consecutive monthly payments for a term loan. Revenue from Contract with Customer [Policy Text Block] inbp_NumberOfConsecutiveMonthlyInstallmentsFixedAmount Number of Consecutive Monthly Installments, Fixed Amount Represents the number of consecutive monthly installments that have a fixed amount. Statistical Measurement [Domain] Operating cash flows from operating leases Maximum [Member] Minimum [Member] Accounts payable (includes $71and $67 due to related party) Revolving Credit Facility [Member] Financing cash flows from finance lease obligations The cash outflow for the obligation including interest for a lease meeting the criteria for capitalization (with maturities exceeding one year or beyond the operating cycle of the entity, if longer). Other current assets Statistical Measurement [Axis] Operating cash flows from finance leases us-gaap_OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net, Total Credit Facility [Axis] Credit Facility [Domain] us-gaap_PaymentsForRent Payments for Rent Interest paid us-gaap_PolicyTextBlockAbstract Accounting Policies Income taxes paid Property, Plant and Equipment Disclosure [Text Block] Geographical [Axis] Geographical [Domain] Property, Plant and Equipment [Table Text Block] Inventories Total us-gaap_PaymentsToAcquireProductiveAssets Capital Expenditures Sales, net Sales, net us-gaap_PaymentsToAcquirePropertyPlantAndEquipment Purchase of property and equipment Add: Equivalent shares outstanding - Stock Options (in shares) Customer [Axis] Customer [Domain] Reconciliation of Assets from Segment to Consolidated [Table Text Block] Current Liabilities: Total Assets Total Assets Cash flows provided by operating activities: Schedule of Segment Reporting Information, by Segment [Table Text Block] Statement [Line Items] Accounts receivable, net us-gaap_NumberOfReportableSegments Number of Reportable Segments Additional paid-in capital Land and Building [Member] Stockholders' Equity : Leasehold Improvements [Member] Other income Property, Plant and Equipment, Type [Axis] us-gaap_NonoperatingIncomeExpense Total other expense, net Segment Reporting Disclosure [Text Block] Property, Plant and Equipment, Type [Domain] Current Assets: Net income Net income inbp_DebtInstrumentDebtDefaultInterestRateBasicSpread Debt Instrument, Debt Default, Interest Rate Basic Spread Percentage points added to the interest rate in case of debt instrument defaulted. us-gaap_Liabilities Total liabilities us-gaap_NetCashProvidedByUsedInFinancingActivities Net cash used in financing activities Commitments and Contingencies inbp_LineOfCreditFacilityCovenantAggregateRevolvingAdvanceAppraisedLiquidationValueInventoryAdvanceRate Line of Credit Facility, Covenan,t Aggregate Revolving Advance, Appraised Liquidation Value, Inventory Advance Rate The percentage of appraised net orderly liquidation value of eligible inventory that used to calculate the aggregate amount of revolving advances that can be made to the company. us-gaap_OperatingIncomeLoss Operating income Share-based Payment Arrangement, Option [Member] us-gaap_NetCashProvidedByUsedInOperatingActivities Net cash provided by operating activities us-gaap_NetCashProvidedByUsedInInvestingActivities Net cash used in investing activities Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease Net increase in cash Antidilutive Securities [Axis] Gross Profit Gross profit Antidilutive Securities, Name [Domain] Base Rate [Member] us-gaap_SaleLeasebackTransactionImputedInterestRate Sale Leaseback Transaction, Imputed Interest Rate Cost of sales Counterparty Name [Axis] us-gaap_SaleLeasebackTransactionMonthlyRentalPayments Sale Leaseback Transaction, Monthly Rental Payments Counterparty Name [Domain] us-gaap_DueToRelatedPartiesCurrentAndNoncurrent Due to Related Parties, Total Commitments and Contingencies Disclosure [Text Block] us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Less: Accumulated depreciation and amortization Property and equipment, net Total Schedule of Debt Interest Rates [Table Text Block] Tabular disclosure of information pertaining to debt interest rates. Property and equipment, gross Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Operating lease obligations The increase (decrease) during the reporting period in operating lease liabilities. Other, net Cash flows from investing activities: Retained Earnings [Member] First American Equipment Finance [Member] Represents information about First American Equipment Finance. Convertible Debt [Member] Treasury Stock [Member] Additional Paid-in Capital [Member] Common Stock [Member] Related Party Transactions Disclosure [Text Block] Accrued expenses and other liabilities us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income before income taxes Income tax expense, net Equity Components [Axis] Equity Component [Domain] Total outstanding debt Capitalized lease obligations Capital Lease Obligations, Total us-gaap_IncreaseDecreaseInAccountsPayable Accounts payable Amortization of operating lease right-of-use assets Amount of amortization expense attributable to right-of-use asset from operating lease. Notes Payable Term Loan [Member] Represents information pertaining to a term loan. inbp_LineOfCreditFacilityCovenantMaximumAggregateRevolvingadvance Line of Credit Facility Covenant Maximum Aggregate Revolving Advance The maximum amount of aggregate revolving advances that can be made under the credit facility. us-gaap_SeniorNotes Senior Notes, Total Revolving Advances [Member] Represents the revolving advances. inbp_LineOfCreditFacilityCovenantAggregateRevolvingAdvanceReceivablesAdvancerate Line of Credit Facility Covenant Aggregate Revolving Advance Receivables Advance Rate The maximum percentage of eligible accounts receivable used to calculate the aggregate amount of revolving advances that can be made to the company. inbp_LineOfCreditFacilityCovenantAggregateRevolvingAdvanceInventoryAdvancerate Line of Credit Facility Covenant Aggregate Revolving Advance Inventory Advance Rate The inventory advance rate used to calculate the aggregate amount of revolving advances that can be made to the company. inbp_LineOfCreditFacilityCovenantPrepaymentProvisionsPercentageOfExcessCashflow Line of Credit Facility Covenant Prepayment Provisions Percentage of Excess Cash flow The prepayment requirement as a percentage of excess cashflow for each fiscal year. us-gaap_LineOfCredit Long-term Line of Credit, Total 2023, Total inbp_LesseeOperatingLeaseAndFinanceLeaseLiabilityPaymentsDueYearFour Amount of lessee's undiscounted obligation for lease payments for operating lease and finance lease, due in forth fiscal year following latest fiscal year. 2022, Total inbp_LesseeOperatingLeaseAndFinanceLeaseLiabilityPaymentsDueYearThree Amount of lessee's undiscounted obligation for lease payments for operating lease and finance lease, due in third fiscal year following latest fiscal year. 2021, Total inbp_LesseeOperatingLeaseAndFinanceLeaseLiabilityPaymentsDueYearTwo Amount of lessee's undiscounted obligation for lease payments for operating lease and finance lease, due in second fiscal year following latest fiscal year. 2020, remaining total Amount of lessee's undiscounted obligation for lease payments for operating lease and finance lease, due in remainder of fiscal year following latest fiscal year ended. Cash Cash at beginning of period Cash at end of period inbp_LesseeOperatingLeaseAndFinanceLeaseLiabilityPaymentsDue Total minimum lease payments, Total Amount of lessee's undiscounted obligation for lease payments for operating lease and finance lease. us-gaap_DeferredFinanceCostsNet Prepaid financing costs Thereafter, Total inbp_LesseeOperatingLeaseAndFinanceLeaseLiabilityPaymentsDueAfterYearSix Amount of lessee's undiscounted obligation for lease payments for operating and finance lease, due after sixth fiscal year following latest fiscal year. 2024, Total inbp_LesseeOperatingLeaseAndFinanceLeaseLiabilityPaymentsDueYearFive Amount of lessee's undiscounted obligation for lease payments for operating lease and finance lease, due in fifth fiscal year following latest fiscal year. Lessee, Operating Lease and Finance Lease, Liability, Maturity [Table Text Block] Tabular disclosure of undiscounted cash flows of lessee's operating lease and finance lease liability. Total Present value of lessee's discounted obligation for lease payments from operating lease and finance lease. inbp_LesseeOperatingLeaseAndFinanceLeaseLiabilityUndiscountedExcessAmount Imputed interest, Total Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease and finance lease. us-gaap_RepaymentsOfLongTermCapitalLeaseObligations Repayments under finance lease obligations us-gaap_IncreaseDecreaseInSecurityDeposits Security deposits and other assets Transportation Equipment [Member] Machinery and Equipment [Member] Installment Note with PNC Bank [Member] Represents the Installment Note with PNC Bank. Amendment Flag Vitamin Realty LLC [Member] Represents information pertaining to Vitamin Realty LLC. Accounting Policies [Abstract] Basis of Accounting, Policy [Policy Text Block] us-gaap_DebtInstrumentPeriodicPayment Debt Instrument, Periodic Payment, Total New Accounting Pronouncements, Policy [Policy Text Block] Concentration Risk Disclosure [Text Block] Reclassification, Policy [Policy Text Block] us-gaap_SharesOutstanding Balance (in shares) Balance (in shares) Common stock, shares outstanding (in shares) Capitalized lease obligations, interest rate Capital lease obligation interest rate. Maturity Date Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format. Capitalized lease obligations, maturity start date The earliest maturity date when capitalized lease obligations are reported. Two Customers [Member] Indicates that the reporting entity has two major customers. Current Fiscal Year End Date us-gaap_DebtInstrumentBasisSpreadOnVariableRate1 Debt Instrument, Basis Spread on Variable Rate Major Customer 1 [Member] Represents one of the major customers of the company. Major Customer 2 [Member] Represents one of the major customers of the company. Contract Manufacturing [Member] A specified segment of the reporting entity. Interest Rate EX-101.PRE 11 inbp-20190930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 R10.htm IDEA: XBRL DOCUMENT

Note 4 - Senior Credit Facility and Other Long Term Debt

3 Months Ended

Sep. 30, 2019

Notes to Financial Statements

Debt Disclosure [Text Block]

Note

Senior Credit Facility and other Long Term Debt

As of

September 30, 2019

and

June 30, 2019,

the Company had the following debt outstanding:

	Principal Amount						Interest Rate			Maturity Date
	As of September 30, 2019			As of June 30, 2019
Revolving advances under Senior Credit
Facility with PNC Bank, National Association	$	4,799		$	5,834			*		5/15/2024
Installment Note with PNC Bank		3,069			3,542			*		5/15/2024
Installment Note with PNC Equipment Finance		-			8			4.57	%	7/29/2019
Capitalized lease obligations		209			269			4.01% - 9.38	%	11/01/2019 - 2/1/2021
Total outstanding debt		8,077			9,653
Less: Revolving Advances		(4,799	)		(5,834	)
Prepaid financing costs		(48	)		(50	)
Current portion of long term debt, net		(1,053	)		(1,047	)
Long term debt, net	$	2,177		$	2,722

* See table below

SENIOR CREDIT FACILITY

May 15, 2019,

the Company, MDC, AgroLabs, IHT, IHT Properties Corp. (“IHT Properties”) and Vitamin Factory (collectively, the “Borrowers”) amended the Revolving Credit, Term Loan and Security Agreement (the “Amended Loan Agreement”) with PNC Bank, National Association as agent and lender (“PNC”) and the other lenders party thereto entered into on

June 27, 2012,

as amended on

February 19, 2016

and

May 15, 2019.

The Amended Loan Agreement provides for a total of

$11,585

in senior secured financing (the “Senior Credit Facility”) as follows: (i) discretionary advances (“Revolving Advances”) based on eligible accounts receivable and eligible inventory in the maximum amount of

$8,000

(the “Revolving Credit Facility”), and (ii) a term loan in the amount of

$3,585

(the “Term Loan”). The Senior Credit Facility is secured by all assets of the Borrowers, including, without limitation, machinery and equipment, real estate owned by IHT Properties, and common stock of iBio owned by the Company. Revolving Advances bear interest at PNC’s Base Rate or the Eurodollar Rate, at Borrowers’ option, plus

2.50%.

The Term Loan bears interest at PNC’s Base Rate or the Eurodollar Rate at Borrowers’ option, plus

3.00%.

As of

September 30, 2019

and

June 30, 2019,

the Company had amounts outstanding utilizing the Eurodollar Rate of

$4,000

and

$4,250

under the Revolving Advances and

$2,674

and

$3,455

under the Term Note, respectively, with interest rates as of

September 30, 2019

and

June 30, 2019

as follows (based on the respective base rate plus

2.50%

on Revolving Advances and

3.00%

on the Term Note in effect as of the respective dates):

	September 30,			June 30,
	2019			2019

Revolving Credit Facility:
Base Rate Interest		5.00	%		5.50	%
Eurodollar Rate		4.554	%		4.881	%
Term Loan:
Base Rate Interest		5.25	%		5.75	%
Eurodollar Rate	5.05363% and 5.04588%			5.381% and 5.3838%

Upon and after the occurrence of any event of default under the Amended Loan Agreement, and during the continuation thereof, interest shall be payable at the interest rate then applicable plus

2%.

The Senior Credit Facility matures on

May 15, 2024 (

the “Senior Maturity Date”).

eighty-four

(

) consecutive monthly installments of principal, the

first

eighty-three

(

) of which shall be in the amount of

$43,

commencing on the

first

business day of

June, 2019,

and continuing on the

first

business day of each month thereafter, with a final payment of any unpaid balance of principal and interest payable on the Senior Maturity Date. The foregoing is subject to customary mandatory prepayment provisions and acceleration upon the occurrence of any event of default under the Amended Loan Agreement or earlier termination of the Amended Loan Agreement pursuant to the terms thereof.

The Revolving Advances are subject to the terms and conditions set forth in the Amended Loan Agreement and are made in aggregate amounts at any time equal to the lesser of (

)

$8,000

or (y) an amount equal to the sum of: (i) up to

85%,

subject to the provisions in the Amended Loan Agreement, of eligible accounts receivables (“Receivables Advance Rate”), plus (ii) up to the lesser of (A)

75%,

subject to the provisions in the Amended Loan Agreement, of the value of the eligible inventory (“Inventory Advance Rate” and together with the Receivables Advance Rate, collectively, the “Advance Rates”), (B)

85%

of the appraised net orderly liquidation value of eligible inventory (as evidenced by the most recent inventory appraisal reasonably satisfactory to PNC in its sole discretion exercised in good faith) and (C) the inventory sublimit in the aggregate at any

one

time (“Inventory Advance Rate” and together with the Receivables Advance Rate, collectively, the “Advance Rates”), minus (iii) the aggregate Maximum Undrawn Amount of all outstanding Letters of Credit, minus (iv) such reserves as PNC

may

reasonably deem proper and necessary from time to time.

twenty-five

percent (

25%

) of Excess Cash Flow for each fiscal year commencing with the fiscal year ended

June 30, 2016,

payable upon delivery of the financial statements to PNC referred to in and required by the Amended Loan Agreement for such fiscal year but in any event

not

later than

one hundred twenty

(

120

) days after the end of each such fiscal year, which amount shall be applied ratably to the outstanding principal installments of the Term Loan in the inverse order of the maturities thereof. The Amended Loan Agreement also contains customary representations and warranties, covenants and events of default, including, without limitation, (i) a fixed charge coverage ratio maintenance requirement and (ii) an event of default tied to any change of control as defined in the Amended Loan Agreement. As of

September 30, 2019,

the Company was in compliance with the fixed charge coverage ratio maintenance requirement and with the required annual payments of

25%

of the Excess Cash Flow for each fiscal year commencing with the fiscal year ended

June 30, 2016.

OTHER LONG TERM DEBT

Capitalized Lease Obligations.

November 1, 2019,

the capitalized lease obligation entered into by the Company on

December 22, 2017

with First American Equipment Finance in the amount of

$143,

which lease was secured by certain machinery and equipment, was satisfied with all payments being made under the capitalized lease obligation. The monthly lease payment was approximately

and had an imputed interest rate of

6.56%.

XML 13 R14.htm IDEA: XBRL DOCUMENT

Note 8 - Segment Information and Disaggregated Revenue

3 Months Ended

Sep. 30, 2019

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

Note

Segment Information

and Disaggregated Revenue

The Company has divided its operations into

three

reportable segments as follows: Contract Manufacturing, Branded Proprietary Products and Other Nutraceutical Businesses. The international sales, concentrated primarily in Europe and Canada, for the

three

months ended

September 30, 2019

and

2018

were

$1,053

and

$1,239,

respectively.

Financial information relating to the

three

months ended

September 30, 2019

and

2018

operations by business segment and disaggregated revenues was as follows:

		Sales, Net						Segment
		U.S.		International				Gross					Capital
		Customers		Customers		Total		Profit (Loss)			Depreciation		Expenditures
Contract	2019	$	9,974	$	1,010	$	10,984	$	1,250		$	90	$	58
Manufacturing	2018		8,655		1,197		9,852		1,083			65		18

Branded Proprietary	2019		2		10		12		(3	)		-		-
Products	2018		71		7		78		21			-		-

Other Nutraceutical	2019		377		33		410		152			1		-
Businesses	2018		339		35		374		115			1		-

Total Company	2019		10,353		1,053		11,406		1,399			91		58
	2018		9,065		1,239		10,304		1,219			66		18

	Total Assets as of
	September 30,		June 30,
	2019		2019

Contract Manufacturing	$	17,575	$	17,580
Branded Proprietary Products		413		427
Other Nutraceutical Businesses		1,653		1,783
Total Company	$	19,641	$	19,790

XML 14 R18.htm IDEA: XBRL DOCUMENT

Note 3 - Property and Equipment, Net (Tables)

3 Months Ended

Sep. 30, 2019

Notes Tables

Property, Plant and Equipment [Table Text Block]

	September 30,			June 30,
	2019			2019

Land and building	$	1,250		$	1,250
Leasehold improvements		1,282			1,282
Machinery and equipment		6,338			6,280
Transportation equipment		6			6
		8,876			8,818
Less: Accumulated depreciation and amortization		(7,131	)		(7,040	)
Total	$	1,745		$	1,778

XML 15 R37.htm IDEA: XBRL DOCUMENT

Note 8 - Segment Information and Disaggregated Revenue - Total Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Jun. 30, 2019
Total Assets	$ 19,641	$ 19,790
Contract Manufacturing [Member]
Total Assets	17,575	17,580
Branded Proprietary Products [Member]
Total Assets	413	427
Other Nutraceutical Business [Member]
Total Assets	$ 1,653	$ 1,783

XML 16 R33.htm IDEA: XBRL DOCUMENT

Note 6 - Leases and Other Commitments and Contingencies - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Operating cash flows from operating leases	$ 165	$ 118
Operating cash flows from finance leases	5	4
Financing cash flows from finance lease obligations	60	50
Unrelated Party [Member]
Operating cash flows from operating leases	24	24
Operating cash flows from finance leases	5	4
Financing cash flows from finance lease obligations	60	50
Vitamin Realty LLC [Member]
Operating cash flows from operating leases	141	94
Operating cash flows from finance leases
Financing cash flows from finance lease obligations

ZIP 17 0001437749-19-022660-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-19-022660-xbrl.zip M4$L#!!0 ( ')[;4])[B?@4:\ "6P#0 1 :6YB<"TR,#$Y,#DS,"YX M;6SLO6MWV\BQ+OP]:^4_]*O$._99I(P+K_;89\FRG2C'MG0D37+RR:L)-$5D M0("#!B1Q?OU;U0!(@"1X)]B@>J_L,85;5U4_=>E+5?_ROY^'+GED 7=\[\.9 M?JZ=$>99ONUX#Q_.?KVK7]Q=7EV=$1Y2SZ:N[[$/9YY_]K\__OE/O_Q_]?K? MF<<"&C*;],;D?A!Y-@L^^T-&_M^GVV^D3K3.NZ9^\YW\>G])#$WOUG6]KAOU M^L=?GGN!Z[S#_Q*@P./BI_/A;!"&HW=OWSX]/9WCE7,_>'AK:)KYUO&0!HN= MQ<^O_^0[RX^\,!A/WA!/KFMZW=0GKT5! *(H>B^YN^!% MFSF+WX$;;X446' J!L.1H%O1U;(+3\8G4=< MM*)U36WZRB/CX>)6XGOXBCG3#O<;AMY>)NGXB?0%U_%^6_(TWNY1/ND7CSH6 M7TR3N(4DZ7F2/-_SHN'B-NPP>!N.1^PM/%2'IUC@6.E[W+$6-P0W%C3#@ZFL M^I3WQ/?AXH+>X^$H*/@TW%G0>V&L)39H28Z/V\]__^J B![XN>4/TZ MY8N>@V_J;__?]V]WUH -:7U619^YL\E;8'T(^05;?^,_W\I; 6X5>'6]3]#Z/! M%\_^#'9SDY;TYMG'>EUKP:6XK:*/3IO][%O1Z(3C2[@>4/<*C,7S_V'CC9 "\M- =32]U=0:<5,+ M/SK7IC\<^MY=Z%N_W0UHP/AU% K/#V8I1X#S<^+-S3-B,\L9@@Y\.+OZ\77" M*9 3>4[\O'#N=2Z^";+N-EO-;L/,4;:DZ3DR8^#?LI$?A'#_+J3A9@@#G_7Q M/XSG"%CXT=FFOX!;>8"[?P_\IW 1(^HMUG?='+V8LE79YL&[\""2T#A@Q]L MUB28J!_@$ZEE,3<)U\3'LB3DOC[;]"U[<#@ QPM_T.%F1@M4Z^K'_9>_WU[< M?_E,/EU=W_SCXO;[!;GZ<9EM/M_";/MW ^:Z6PC;T!<(._NQN88 QNZGB#L> MXYL!JGOV,0RB?$/9C\4MH5]Z=TE'3DA=YP]F?V,0#UWW7.>!AA" 7T%[ /WP M=M: .9DF?]Y2[X%=/#N\_MWQG&$T_,Z&/19D];"1T-4T0<^Z6G-.%4=1 &Y4 M.]<:&ICV#<@Z#!_T>2T^NL5\=,W._OGX#B8@0/U$@X.HTZBO M(?\9,C8B'R$/38B,LC_S'Q7,B*@,*/.I=_$0,(8WYL$V=5Z"T4[+ M*(:;D?"]*0>%S*=B0@GI:_75-[ KU_W+@-E.^)5:,'8(QX+;6_;HNX_@3B[L M1PR7^7PG=KIQB-6(9;:0F1Q%9="-'P6+B5_]X8?LWTXXN/EQ^8EZORUBH",? M T#ME]\C9Q1'JQ[*_MNWRT4J9*0!9[MN=#@ MA.-[\+.<6JB=_-,X>T>P\2_0Y*'CW>+,PG@1 TW-[&14(YD%J$=BF 6#=,?] M<(;.,!U@[43X)4[0L&"$Y&%L($C\U0LR5,^KC"4-,+>F !13N M3O\2JAI:251UIE1U#@*'AGX8."P@?!]P:!A%@C?T PM^&57F?JGZYM">L$TW M=(P6A7^.&(Z>[YSGPI@L2Y"N;Z[D5YX58-N?6?SOE7<]PA$'.*,<30Y;,[HN MD%:C;1;V(<0EK:F\-J!H7WQLT.O 1V&O Q_&KGR(6SBT=D(1# U1>Y9$Y+M; MA6)XMPNM7=-H3QE=2/+V+-T$/L@)E,"%L>6%9T\<]*C+/W M13M\)5O-(M/WT6@>E:GK?M^QV,;L- O9T0[%SC)RBAUWLVT<@J#6H?6@5:CP M9JO5.1A+A]:#5J%Z'T:YUV9J.SUH%ZMUXU#L+".G4"W-MM[=D" .DKIE0PHC M?.]A^C"_ISV7W0-EGUS?^FV3V2\8B_V/&[ZWG4?"P['+X 6'CUPZ?D<!B%^Y]5[DEQR63^],M/2#&'_0X>C M][]'?OC^7I#X TB\11*G-VI$W*H1S@*G_YZ@C.J.9X,$WQ%M] R-0HOQ?Y\< M.QR\(Z <%TP101704KR(Z#7L:A;IZ[SX+TC/3\,_>'N1,URF6G;3ML^2!OB M<:_'1Z+[WH:V% U;/N+%^W!F3, BNBV1NL5P2+%_J>?A)Z[T_,!F03WN9WAL M]$RX[SHV"1YZK[4:P?^]R7171J5RY/UMAJB_S= R)450$A/R#G]F&$_X%JW= MHM;4_3Y8%48N.&\G2!XG7/N(AUKKCJH0M_=7^.V]M2!^0 MAOGQBZ#JKZN),5XE4\H)Q,5L=FD$KC6++V["-=SO9R77GE@\Z^YX V@PS#_I M^<&0NG$+9DTW6EF0+!")YS\%F/,2_WMVO/XZ,HIDH$$AN0C)C69#X5CAN/(X M-FJM=DRZ#45>A5ZJXI>HUE]],HYE"E_&4>VH4R< M%*'&, 6P67^K624,UD8,'=XK=^6S:XNVS"E7K13D* JB]$/IA]*/:DU** 51 M"B*-@AC:B2J(G,/)(ZV,*3NRAB*:H(BV'V$6^;PFRKQDOA$C92RMZZT*Q*6F M"E&JE9ZC6G7DR M3WRGN5DSS%4U.8[2/[/S6!*@2 8:%)(+U]V:J[:^*!PK',N/8Z/6[JY*7E-( M5DB6'\EFK=5:55VF DC>RU!%E=!0)30.0,.IFY"5]0(K8#_D1(X,-)PZ>E=F MJRCT*O3*B]Y510@4>A5ZI47ORFJ %4!O11=)9!MYJ(H71\C'/)I]D2P?<]5V M77GR+Y5G50HB7\4+I1]*/UZR?NBKL@F5@B@%>+W1NSCSYL*S)_E_T\P_?H\OW@-4/KF^]=O'/_^) MD%^2MSAG3+Q[SX+A=?\2N JH%1(+?L +MZP/??;3T/1N76O7-3WYV:V;VL]; MZCVPBV>'U[]#B\-H^)T->RPX(X[]XQWFAKT-\0F1=U\X^ MKJ4V*7Q# =JUZXY,ZW7,E?*8+?61-"][B9+UYRRDFHTHOV%I$JB/F7Z_YB*\ M@L6+@,4M8HV" M&3'*J,0OVL K') K'9 O!_L-H0)B'TXSD MGY''B*G5I%5A:8RKO$4&*UE54&%*84IAZD5A2E785:#:.ZCN_9"Z%8*3JJ:K M[JMJNK(.C0S- $L6I+MVUK0K+V[SG/2;XF0I,7&$HYC4(64*QIOF ZS,H%,X M5CB6'\=Z0^%8X;CZ.&YV5Q5>JP".JYR\+->()%=#\N4.0ZI3'J<<>JXJ(5 ML!)R(D<&&DX=OM7^QK M?)$;;*KQA3(3RLM7ZQE_'% M/6"%T7[( C7*$(+:Y'#Y*MB4C1AZB7YS41E%Y4R5?ASG %-=PK(*2D.4ADBC M(L1:TU 5@"N+( -4U465O"M+'S-6D<_ ?NK%ISV,ORX&HZBD-D MFY %C*][PIM,"JLF1:HV*?+:J(#]*3[0ZXW2"Z47!]$+LUN%T%)IAM*,TCU& M%7*\E6(HQ2A;,1J5./EA \U0ZTI[&=AM ;WUWTOAV?-=^_UT&6L.B M^O^!! MY4I38H(IL?VHY[(%MD3FL[ V8J2$!3()H^A9 VBJ72E*5R30%;.FFQ).QRAU M4>HBH[H86EZ-TWQCEC MUR,6T!!:_88[_"X\^ZOC4<]BXL]O#NTYKA..O],P HF.[_%[]X"@3ZYO_?;Q MSW\BY)>-/W:3["+\'#%B@0S@<[>L_^',^6EH>K>N=>NF=D9L9CG08?S#6=T\ M(X[]XSH+4W3MN O0]+N3%U@FMQ_ M& WNG.>M�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htm IDEA: XBRL DOCUMENT v3.19.3

Note 2 - Inventories
3 Months Ended

Sep. 30, 2019

Notes to Financial Statements

Inventory Disclosure [Text Block]
Note

2
. Inventories

Inventories are stated at the lower of cost or net realizable value using the
first
-in,
first
-out method and consist of the following:

September 30,

June 30,

2019

2019

Raw materials
$
6,642
$
4,550

Work-in-process

1,823

2,325

Finished goods

1,426

1,944

Total
$
9,891
$
8,819

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-URI http://asc.fasb.org/topic&trid=2126998
+ Details

Name: us-gaap_InventoryDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 19 R4.htm IDEA: XBRL DOCUMENT v3.19.3

Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) - USD ($)
$ in Thousands

Sep. 30, 2019

Jun. 30, 2019

Operating lease right-of-use assets $ 3,169 $ 3,284

Accounts payable, due to related parties 71 67

Current portion of operating lease liabilities 474 470

Operating lease liabilities $ 2,702 $ 2,822

Common stock, par value (in dollars per share) $ 0.002 $ 0.002

Common stock, shares authorized (in shares) 50,000,000 50,000,000

Common stock, shares issued (in shares) 29,600,843 29,600,843

Common stock, shares outstanding (in shares) 29,565,943 29,565,943

Treasury stock, shares aquired (in shares) 34,900 34,900

Vitamin Realty LLC [Member]

Operating lease right-of-use assets $ 3,126 $ 3,236

Current portion of operating lease liabilities 454 450

Operating lease liabilities $ 2,678 $ 2,793

X

- Definition
Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(k)(1))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_AccountsPayableRelatedPartiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiabilityCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiabilityNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's right to use underlying asset under operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseRightOfUseAsset

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29,30)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655
+ Details

Name: us-gaap_TreasuryStockShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inbp_VitaminRealtyLLCMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 20 R22.htm IDEA: XBRL DOCUMENT v3.19.3

Note 1 - Principles of Consolidation and Basis of Presentation - Antidilutive Securities Excluded From Weighted Average Diluted Common Shares Outstanding (Details) - shares
3 Months Ended

Sep. 30, 2019

Sep. 30, 2018

Anti-dilutive shares (in shares) 50,000 150,000

Share-based Payment Arrangement, Option [Member]

Anti-dilutive shares (in shares) 50,000 150,000

X

- Definition
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 21 R26.htm IDEA: XBRL DOCUMENT v3.19.3

Note 4 - Senior Credit Facility and Other Long Term Debt (Details Textual) - USD ($)
$ in Thousands
3 Months Ended

May 15, 2019

Dec. 22, 2017

Sep. 30, 2019

Jun. 30, 2019

Capital Lease Obligations, Total $ 209 $ 269

First American Equipment Finance [Member]

Capital Lease Obligations, Total $ 143

Sale Leaseback Transaction, Monthly Rental Payments $ 6

Sale Leaseback Transaction, Imputed Interest Rate 6.56%

Amended Loan Agreement [Member]

Senior Notes, Total $ 11,585

Debt Instrument, Debt Default, Interest Rate Basic Spread 2.00%

Line of Credit Facility Covenant Prepayment Provisions Percentage of Excess Cash flow 25.00%

Amended Loan Agreement [Member] | Term Loan [Member]

Debt Instrument, Face Amount $ 3,585

Loans Payable, Noncurrent, Total $ 2,674 3,455

Number of Consecutive Monthly Installments 84

Number of Consecutive Monthly Installments, Fixed Amount 83

Debt Instrument, Periodic Payment, Total $ 43

Line of Credit Facility Covenant Prepayment Provisions Percentage of Excess Cash flow 25.00%

Amended Loan Agreement [Member] | Term Loan [Member] | Eurodollar [Member]

Debt Instrument, Basis Spread on Variable Rate 3.00%

Amended Loan Agreement [Member] | Term Loan [Member] | Base Rate [Member]

Debt Instrument, Basis Spread on Variable Rate 3.00%

Amended Loan Agreement [Member] | Revolving Credit Facility [Member]

Line of Credit Facility, Maximum Borrowing Capacity $ 8,000

Long-term Line of Credit, Total $ 4,000 $ 4,250

Line of Credit Facility Covenant Maximum Aggregate Revolving Advance $ 8,000,000

Line of Credit Facility Covenant Aggregate Revolving Advance Receivables Advance Rate 85.00%

Line of Credit Facility Covenant Aggregate Revolving Advance Inventory Advance Rate 75.00%

Line of Credit Facility, Covenan,t Aggregate Revolving Advance, Appraised Liquidation Value, Inventory Advance Rate 85.00%

Amended Loan Agreement [Member] | Revolving Credit Facility [Member] | Eurodollar [Member]

Debt Instrument, Basis Spread on Variable Rate 2.50%

Amended Loan Agreement [Member] | Revolving Credit Facility [Member] | Base Rate [Member]

Debt Instrument, Basis Spread on Variable Rate 2.50%

X

- Definition
Percentage points added to the interest rate in case of debt instrument defaulted.
+ References
No definition available.
+ Details

Name: inbp_DebtInstrumentDebtDefaultInterestRateBasicSpread

Namespace Prefix: inbp_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The percentage of appraised net orderly liquidation value of eligible inventory that used to calculate the aggregate amount of revolving advances that can be made to the company.
+ References
No definition available.
+ Details

Name: inbp_LineOfCreditFacilityCovenantAggregateRevolvingAdvanceAppraisedLiquidationValueInventoryAdvanceRate

Namespace Prefix: inbp_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The inventory advance rate used to calculate the aggregate amount of revolving advances that can be made to the company.
+ References
No definition available.
+ Details

Name: inbp_LineOfCreditFacilityCovenantAggregateRevolvingAdvanceInventoryAdvancerate

Namespace Prefix: inbp_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum percentage of eligible accounts receivable used to calculate the aggregate amount of revolving advances that can be made to the company.
+ References
No definition available.
+ Details

Name: inbp_LineOfCreditFacilityCovenantAggregateRevolvingAdvanceReceivablesAdvancerate

Namespace Prefix: inbp_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum amount of aggregate revolving advances that can be made under the credit facility.
+ References
No definition available.
+ Details

Name: inbp_LineOfCreditFacilityCovenantMaximumAggregateRevolvingadvance

Namespace Prefix: inbp_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: instant

X

- Definition
The prepayment requirement as a percentage of excess cashflow for each fiscal year.
+ References
No definition available.
+ Details

Name: inbp_LineOfCreditFacilityCovenantPrepaymentProvisionsPercentageOfExcessCashflow

Namespace Prefix: inbp_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Represents the number of consecutive monthly payments for a term loan.
+ References
No definition available.
+ Details

Name: inbp_NumberOfConsecutiveMonthlyInstallments

Namespace Prefix: inbp_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: instant

X

- Definition
Represents the number of consecutive monthly installments that have a fixed amount.
+ References
No definition available.
+ Details

Name: inbp_NumberOfConsecutiveMonthlyInstallmentsFixedAmount

Namespace Prefix: inbp_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal through the balance sheet date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(16))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84164817&loc=d3e45280-112737
+ Details

Name: us-gaap_CapitalLeaseObligations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Percentage points added to the reference rate to compute the variable rate on the debt instrument.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentBasisSpreadOnVariableRate1

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Face (par) amount of debt instrument at time of issuance.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400
+ Details

Name: us-gaap_DebtInstrumentFaceAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of the required periodic payments including both interest and principal payments.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823
+ Details

Name: us-gaap_DebtInstrumentPeriodicPayment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(16))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(16))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910
+ Details

Name: us-gaap_LineOfCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(b),22(b))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermLoansPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The financing cost related to leases that have been recorded under the deposit method, as a financing or as a capital leases in connection with the transaction involving the sale of property to another party and the lease of the property back to the seller.
+ References
No definition available.
+ Details

Name: us-gaap_SaleLeasebackTransactionImputedInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of the monthly rental payments due under the lease entered into in connection with the transactions involving the sale of property to another party and the lease of the property back to the seller.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 40
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=77913982&loc=d3e50796-112755
+ Details

Name: us-gaap_SaleLeasebackTransactionMonthlyRentalPayments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.16(a))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.16)
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_SeniorNotes

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: srt_CounterpartyNameAxis=inbp_FirstAmericanEquipmentFinanceMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=inbp_AmendedLoanAgreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=inbp_TermLoanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_VariableRateAxis=us-gaap_EurodollarMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_VariableRateAxis=us-gaap_BaseRateMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 22 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3 html 146 288 1 true 43 0 false 5 false false R1.htm 000 - Document - Document And Entity Information Sheet http://healthproductscorp.us/20190930/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://healthproductscorp.us/20190930/role/statement-condensed-consolidated-statements-of-operations-unaudited Condensed Consolidated Statements of Operations (Unaudited) Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://healthproductscorp.us/20190930/role/statement-condensed-consolidated-balance-sheets-unaudited Condensed Consolidated Balance Sheets (Unaudited) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) Sheet http://healthproductscorp.us/20190930/role/statement-condensed-consolidated-balance-sheets-unaudited-parentheticals Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Stockholders' (Deficiency) Equity Sheet http://healthproductscorp.us/20190930/role/statement-condensed-consolidated-statements-of-stockholders-deficiency-equity Condensed Consolidated Statements of Stockholders' (Deficiency) Equity Statements 5 false false R6.htm 005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://healthproductscorp.us/20190930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 006 - Disclosure - Note 1 - Principles of Consolidation and Basis of Presentation Sheet http://healthproductscorp.us/20190930/role/statement-note-1-principles-of-consolidation-and-basis-of-presentation Note 1 - Principles of Consolidation and Basis of Presentation Notes 7 false false R8.htm 007 - Disclosure - Note 2 - Inventories Sheet http://healthproductscorp.us/20190930/role/statement-note-2-inventories Note 2 - Inventories Notes 8 false false R9.htm 008 - Disclosure - Note 3 - Property and Equipment, Net Sheet http://healthproductscorp.us/20190930/role/statement-note-3-property-and-equipment-net Note 3 - Property and Equipment, Net Notes 9 false false R10.htm 009 - Disclosure - Note 4 - Senior Credit Facility and Other Long Term Debt Sheet http://healthproductscorp.us/20190930/role/statement-note-4-senior-credit-facility-and-other-long-term-debt Note 4 - Senior Credit Facility and Other Long Term Debt Notes 10 false false R11.htm 010 - Disclosure - Note 5 - Significant Risks and Uncertainties Sheet http://healthproductscorp.us/20190930/role/statement-note-5-significant-risks-and-uncertainties Note 5 - Significant Risks and Uncertainties Notes 11 false false R12.htm 011 - Disclosure - Note 6 - Leases and Other Commitments and Contingencies Sheet http://healthproductscorp.us/20190930/role/statement-note-6-leases-and-other-commitments-and-contingencies Note 6 - Leases and Other Commitments and Contingencies Notes 12 false false R13.htm 012 - Disclosure - Note 7 - Related Party Transactions Sheet http://healthproductscorp.us/20190930/role/statement-note-7-related-party-transactions Note 7 - Related Party Transactions Notes 13 false false R14.htm 013 - Disclosure - Note 8 - Segment Information and Disaggregated Revenue Sheet http://healthproductscorp.us/20190930/role/statement-note-8-segment-information-and-disaggregated-revenue Note 8 - Segment Information and Disaggregated Revenue Notes 14 false false R15.htm 014 - Disclosure - Significant Accounting Policies (Policies) Sheet http://healthproductscorp.us/20190930/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies 15 false false R16.htm 015 - Disclosure - Note 1 - Principles of Consolidation and Basis of Presentation (Tables) Sheet http://healthproductscorp.us/20190930/role/statement-note-1-principles-of-consolidation-and-basis-of-presentation-tables Note 1 - Principles of Consolidation and Basis of Presentation (Tables) Tables http://healthproductscorp.us/20190930/role/statement-note-1-principles-of-consolidation-and-basis-of-presentation 16 false false R17.htm 016 - Disclosure - Note 2 - Inventories (Tables) Sheet http://healthproductscorp.us/20190930/role/statement-note-2-inventories-tables Note 2 - Inventories (Tables) Tables http://healthproductscorp.us/20190930/role/statement-note-2-inventories 17 false false R18.htm 017 - Disclosure - Note 3 - Property and Equipment, Net (Tables) Sheet http://healthproductscorp.us/20190930/role/statement-note-3-property-and-equipment-net-tables Note 3 - Property and Equipment, Net (Tables) Tables http://healthproductscorp.us/20190930/role/statement-note-3-property-and-equipment-net 18 false false R19.htm 018 - Disclosure - Note 4 - Senior Credit Facility and Other Long Term Debt (Tables) Sheet http://healthproductscorp.us/20190930/role/statement-note-4-senior-credit-facility-and-other-long-term-debt-tables Note 4 - Senior Credit Facility and Other Long Term Debt (Tables) Tables http://healthproductscorp.us/20190930/role/statement-note-4-senior-credit-facility-and-other-long-term-debt 19 false false R20.htm 019 - Disclosure - Note 6 - Leases and Other Commitments and Contingencies (Tables) Sheet http://healthproductscorp.us/20190930/role/statement-note-6-leases-and-other-commitments-and-contingencies-tables Note 6 - Leases and Other Commitments and Contingencies (Tables) Tables http://healthproductscorp.us/20190930/role/statement-note-6-leases-and-other-commitments-and-contingencies 20 false false R21.htm 020 - Disclosure - Note 8 - Segment Information and Disaggregated Revenue (Tables) Sheet http://healthproductscorp.us/20190930/role/statement-note-8-segment-information-and-disaggregated-revenue-tables Note 8 - Segment Information and Disaggregated Revenue (Tables) Tables http://healthproductscorp.us/20190930/role/statement-note-8-segment-information-and-disaggregated-revenue 21 false false R22.htm 021 - Disclosure - Note 1 - Principles of Consolidation and Basis of Presentation - Antidilutive Securities Excluded From Weighted Average Diluted Common Shares Outstanding (Details) Sheet http://healthproductscorp.us/20190930/role/statement-note-1-principles-of-consolidation-and-basis-of-presentation-antidilutive-securities-excluded-from-weighted-average-diluted-common-shares-outstanding-details Note 1 - Principles of Consolidation and Basis of Presentation - Antidilutive Securities Excluded From Weighted Average Diluted Common Shares Outstanding (Details) Details 22 false false R23.htm 022 - Disclosure - Note 2 - Inventories - Inventories (Details) Sheet http://healthproductscorp.us/20190930/role/statement-note-2-inventories-inventories-details Note 2 - Inventories - Inventories (Details) Details 23 false false R24.htm 023 - Disclosure - Note 3 - Property and Equipment, Net (Details Textual) Sheet http://healthproductscorp.us/20190930/role/statement-note-3-property-and-equipment-net-details-textual Note 3 - Property and Equipment, Net (Details Textual) Details http://healthproductscorp.us/20190930/role/statement-note-3-property-and-equipment-net-tables 24 false false R25.htm 024 - Disclosure - Note 3 - Property and Equipment, Net - Property and Equipment, Net (Details) Sheet http://healthproductscorp.us/20190930/role/statement-note-3-property-and-equipment-net-property-and-equipment-net-details Note 3 - Property and Equipment, Net - Property and Equipment, Net (Details) Details 25 false false R26.htm 025 - Disclosure - Note 4 - Senior Credit Facility and Other Long Term Debt (Details Textual) Sheet http://healthproductscorp.us/20190930/role/statement-note-4-senior-credit-facility-and-other-long-term-debt-details-textual Note 4 - Senior Credit Facility and Other Long Term Debt (Details Textual) Details http://healthproductscorp.us/20190930/role/statement-note-4-senior-credit-facility-and-other-long-term-debt-tables 26 false false R27.htm 026 - Disclosure - Note 4 - Senior Credit Facility and Other Long Term Debt - Debt Outstanding (Details) Sheet http://healthproductscorp.us/20190930/role/statement-note-4-senior-credit-facility-and-other-long-term-debt-debt-outstanding-details Note 4 - Senior Credit Facility and Other Long Term Debt - Debt Outstanding (Details) Details 27 false false R28.htm 027 - Disclosure - Note 4 - Senior Credit Facility and Other Long Term Debt - Interest Rates (Details) Sheet http://healthproductscorp.us/20190930/role/statement-note-4-senior-credit-facility-and-other-long-term-debt-interest-rates-details Note 4 - Senior Credit Facility and Other Long Term Debt - Interest Rates (Details) Details 28 false false R29.htm 028 - Disclosure - Note 5 - Significant Risks and Uncertainties (Details Textual) Sheet http://healthproductscorp.us/20190930/role/statement-note-5-significant-risks-and-uncertainties-details-textual Note 5 - Significant Risks and Uncertainties (Details Textual) Details http://healthproductscorp.us/20190930/role/statement-note-5-significant-risks-and-uncertainties 29 false false R30.htm 029 - Disclosure - Note 6 - Leases and Other Commitments and Contingencies (Details Textual) Sheet http://healthproductscorp.us/20190930/role/statement-note-6-leases-and-other-commitments-and-contingencies-details-textual Note 6 - Leases and Other Commitments and Contingencies (Details Textual) Details http://healthproductscorp.us/20190930/role/statement-note-6-leases-and-other-commitments-and-contingencies-tables 30 false false R31.htm 030 - Disclosure - Note 6 - Leases and Other Commitments and Contingencies - Lease Expense (Details) Sheet http://healthproductscorp.us/20190930/role/statement-note-6-leases-and-other-commitments-and-contingencies-lease-expense-details Note 6 - Leases and Other Commitments and Contingencies - Lease Expense (Details) Details 31 false false R32.htm 031 - Disclosure - Note 6 - Leases and Other Commitments and Contingencies - Leases and Commitments (Details) Sheet http://healthproductscorp.us/20190930/role/statement-note-6-leases-and-other-commitments-and-contingencies-leases-and-commitments-details Note 6 - Leases and Other Commitments and Contingencies - Leases and Commitments (Details) Details 32 false false R33.htm 032 - Disclosure - Note 6 - Leases and Other Commitments and Contingencies - Supplemental Cash Flow Information (Details) Sheet http://healthproductscorp.us/20190930/role/statement-note-6-leases-and-other-commitments-and-contingencies-supplemental-cash-flow-information-details Note 6 - Leases and Other Commitments and Contingencies - Supplemental Cash Flow Information (Details) Details 33 false false R34.htm 033 - Disclosure - Note 6 - Leases and Other Commitments and Contingencies - Minimum Rental Commitment for Long-term Non-cancelable Leases (Details) Sheet http://healthproductscorp.us/20190930/role/statement-note-6-leases-and-other-commitments-and-contingencies-minimum-rental-commitment-for-longterm-noncancelable-leases-details Note 6 - Leases and Other Commitments and Contingencies - Minimum Rental Commitment for Long-term Non-cancelable Leases (Details) Details 34 false false R35.htm 034 - Disclosure - Note 8 - Segment Information and Disaggregated Revenue (Details Textual) Sheet http://healthproductscorp.us/20190930/role/statement-note-8-segment-information-and-disaggregated-revenue-details-textual Note 8 - Segment Information and Disaggregated Revenue (Details Textual) Details http://healthproductscorp.us/20190930/role/statement-note-8-segment-information-and-disaggregated-revenue-tables 35 false false R36.htm 035 - Disclosure - Note 8 - Segment Information and Disaggregated Revenue - Operations by Business Segment (Details) Sheet http://healthproductscorp.us/20190930/role/statement-note-8-segment-information-and-disaggregated-revenue-operations-by-business-segment-details Note 8 - Segment Information and Disaggregated Revenue - Operations by Business Segment (Details) Details 36 false false R37.htm 036 - Disclosure - Note 8 - Segment Information and Disaggregated Revenue - Total Assets (Details) Sheet http://healthproductscorp.us/20190930/role/statement-note-8-segment-information-and-disaggregated-revenue-total-assets-details Note 8 - Segment Information and Disaggregated Revenue - Total Assets (Details) Details 37 false false All Reports Book All Reports inbp-20190930.xml inbp-20190930.xsd inbp-20190930_cal.xml inbp-20190930_def.xml inbp-20190930_lab.xml inbp-20190930_pre.xml http://fasb.org/us-gaap/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 http://xbrl.sec.gov/country/2017-01-31 http://fasb.org/srt/2019-01-31 true true XML 23 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} EXCEL 24 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 25 R23.htm IDEA: XBRL DOCUMENT v3.19.3

Note 2 - Inventories - Inventories (Details) - USD ($)
$ in Thousands

Sep. 30, 2019

Jun. 30, 2019

Raw materials $ 6,642 $ 4,550

Work-in-process 1,823 2,325

Finished goods 1,426 1,944

Total $ 9,891 $ 8,819

X

- Definition
Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.BB)
-URI http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InventoryFinishedGoodsNetOfReserves

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 35
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116846819&loc=d3e3927-108312

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InventoryNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.BB)
-URI http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(a)(4))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InventoryRawMaterialsNetOfReserves

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.BB)
-URI http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(a)(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InventoryWorkInProcessNetOfReserves

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 26 R27.htm IDEA: XBRL DOCUMENT v3.19.3

Note 4 - Senior Credit Facility and Other Long Term Debt - Debt Outstanding (Details) - USD ($)
$ in Thousands
3 Months Ended

Sep. 30, 2019

Jun. 30, 2019

Capitalized lease obligations $ 209 $ 269

Total outstanding debt 8,077 9,653

Prepaid financing costs (48) (50)

Current portion of long term debt, net (1,053) (1,047)

Long term debt, net 2,177 2,722

Convertible Debt [Member]

Current portion of long term debt, net $ (1,053) (1,047)

Minimum [Member]

Capitalized lease obligations, interest rate 4.01%

Capitalized lease obligations, maturity start date Nov. 01, 2019

Maximum [Member]

Capitalized lease obligations, interest rate 9.38%

Capitalized lease obligations, maturity end date Feb. 01, 2021

Revolving Advances [Member]

Notes Payable $ 4,799 5,834

Interest Rate ^[1]

Maturity Date May 15, 2024

Less: Revolving Advances $ (4,799) (5,834)

Installment Note with PNC Bank [Member]

Notes Payable $ 3,069 3,542

Interest Rate ^[1]

Maturity Date May 15, 2024

PNC Equipment Finance LLC [Member]

Notes Payable $ 8

Interest Rate 4.57%

Maturity Date Jul. 29, 2019

[1] See table below

X

- Definition
Capital lease obligation interest rate.
+ References
No definition available.
+ Details

Name: inbp_CapitalizedLeaseObligationInterestRate

Namespace Prefix: inbp_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
The latest maturity date when capital lease obligations are reported.
+ References
No definition available.
+ Details

Name: inbp_CapitalizedLeaseObligationMaturityEndDate

Namespace Prefix: inbp_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The earliest maturity date when capitalized lease obligations are reported.
+ References
No definition available.
+ Details

Name: inbp_CapitalizedLeaseObligationMaturityStartDate

Namespace Prefix: inbp_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.
+ References
No definition available.
+ Details

Name: inbp_DebtInstrumentMaturityDate1

Namespace Prefix: inbp_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal through the balance sheet date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(16))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84164817&loc=d3e45280-112737
+ Details

Name: us-gaap_CapitalLeaseObligations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 6
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109500613&loc=SL6036836-161870

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtInstrumentInterestRateEffectivePercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.17)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399
+ Details

Name: us-gaap_DeferredFinanceCostsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (b)(3)
-URI http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(16))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(16))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19,20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermDebtCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermDebtNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=99376301&loc=d3e1336-112600

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=99376301&loc=d3e1314-112600
+ Details

Name: us-gaap_LongTermLineOfCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(16))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(16))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_NotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LineOfCreditFacilityAxis=inbp_RevolvingAdvancesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LineOfCreditFacilityAxis=inbp_InstallmentNoteWithPNCBankMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LineOfCreditFacilityAxis=inbp_PNCEquipmentFinanceLLCMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 27 R19.htm IDEA: XBRL DOCUMENT v3.19.3

Note 4 - Senior Credit Facility and Other Long Term Debt (Tables)
3 Months Ended

Sep. 30, 2019

Notes Tables

Schedule of Debt [Table Text Block]

Principal Amount

Interest Rate

Maturity Date

As of September 30, 2019

As of June 30, 2019

Revolving advances under Senior Credit

Facility with PNC Bank, National Association
$
4,799
$
5,834

*

5/15/2024

Installment Note with PNC Bank

3,069

3,542

*

5/15/2024

Installment Note with PNC Equipment Finance

-

8

4.57
%
7/29/2019

Capitalized lease obligations

209

269

4.01% - 9.38
%
11/01/2019 - 2/1/2021

Total outstanding debt

8,077

9,653

Less: Revolving Advances

(4,799
)
(5,834
)

Prepaid financing costs

(48
)
(50
)

Current portion of long term debt, net

(1,053
)
(1,047
)

Long term debt, net
$
2,177
$
2,722

* See table below

Schedule of Debt Interest Rates [Table Text Block]

September 30,

June 30,

2019

2019

Revolving Credit Facility:

Base Rate Interest

5.00
%

5.50
%

Eurodollar Rate

4.554
%

4.881
%

Term Loan:

Base Rate Interest

5.25
%

5.75
%

Eurodollar Rate

5.05363% and 5.04588%

5.381% and 5.3838%

X

- Definition
Tabular disclosure of information pertaining to debt interest rates.
+ References
No definition available.
+ Details

Name: inbp_ScheduleOfDebtInterestRatesTableTextBlock

Namespace Prefix: inbp_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfDebtTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 28 R11.htm IDEA: XBRL DOCUMENT v3.19.3

Note 5 - Significant Risks and Uncertainties
3 Months Ended

Sep. 30, 2019

Notes to Financial Statements

Concentration Risk Disclosure [Text Block]
Note
5.
Significant Risks and Uncertainties

(
a
) Major Customers.
For the
three
months ended
September 30, 2019
and
2018,
approximately
91%
and
89%
of consolidated net sales, respectively, were derived from
two
customers. These
two
customers are in the Company’s Contract Manufacturing Segment and represented approximately
66%
and
29%
and
61%
and
29%
in the
three
months ended
September 30, 2019
and
2018,
respectively. Accounts receivable from these
two
major customers represented approximately
87%
and
88%
of total net accounts receivable as of
September 30
and
June 30, 2019,
respectively. The loss of any of these customers could have an adverse effect on the Company’s operations. Major customers are those customers who account for more than
10%
of net sales.

(
b
) Other Business Risks.
Approximately
72%
of the Company’s employees are covered by a union contract and are employed in its New Jersey facilities. The contract was renewed on
September 1, 2018
and will expire on
August 31, 2021.

X

- Definition
The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-URI http://asc.fasb.org/topic&trid=2134479
+ Details

Name: us-gaap_ConcentrationRiskDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 29 R15.htm IDEA: XBRL DOCUMENT v3.19.3

Significant Accounting Policies (Policies)
3 Months Ended

Sep. 30, 2019

Accounting Policies [Abstract]

Basis of Accounting, Policy [Policy Text Block]
Basis of Presentation of Interim Financial Statements

The accompanying condensed consolidated financial statements for the interim periods are unaudited and include the accounts of Integrated BioPharma, Inc., a Delaware corporation (together with its subsidiaries, the “Company”). The interim condensed consolidated financial statements have been prepared in conformity with Rule
8
-
03
of Regulation S-
X
of the Securities and Exchange Commission (“SEC”) and therefore do
not
include information or footnotes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States of America. However, all adjustments (consisting only of normal recurring adjustments) which are, in the opinion of management, necessary for a fair presentation of the financial position and operating results for the periods presented have been included. These condensed consolidated financial statements should be read in conjunction with the financial statements and notes thereto, together with Management’s Discussion and Analysis of Financial Condition and Results of Operations, contained in the Company’s Annual Report on Form
10
-K for the fiscal year ended
June 30, 2019 (
“Form
10
-K”), as filed with the SEC. The
June 30, 2019
balance sheet was derived from audited financial statements, but does
not
include all disclosures required by accounting principles generally accepted in the United States of America. The preparation of the unaudited condensed financial statements in conformity with these accounting principles requires management to make estimates and assumptions that affect the amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of expenses during the period reported. Ultimate results could differ from the estimates of management. The results of operations for the
three
months ended
September 30, 2019
are
not
necessarily indicative of the results for the full fiscal year ending
June 30, 2020
or for any other period.

Reclassification, Policy [Policy Text Block]
Reclassifications.
Certain prior year amounts have been reclassified to conform to the current period presentation.

Nature of Operations [Policy Text Block]
Nature of Operations

The Company is engaged primarily in manufacturing, distributing, marketing and sales of vitamins, nutritional supplements and herbal products. The Company’s customers are located primarily in the United States, Luxembourg and Canada. The Company was previously known as Integrated Health Technologies, Inc. and, prior to that, as Chem International, Inc. The Company was reincorporated in its current form in Delaware in
1995.
The Company continues to do business as Chem International, Inc. with certain of its customers and certain vendors.

The Company’s business segments include: (a) Contract Manufacturing operated by Manhattan Drug Company, Inc. (“MDC”), which manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers and specialized health-care providers; (b) Branded Proprietary Products operated by AgroLabs, Inc. (“AgroLabs”), which distributes healthful nutritional products for sale through major mass market, grocery and drug and vitamin retailers, under the following brands: Peaceful Sleep, Green Envy, FiberCal, Wheatgrass and other products which are being introduced into the market (these are referred to as our branded proprietary nutraceutical business and/or products); and (c) Other Nutraceutical Businesses which includes the operations of (i) The Vitamin Factory (the “Vitamin Factory”), which sells private label MDC products, as well as our AgroLabs products, through the Internet, (ii) IHT Health Products, Inc. (“IHT”) a distributor of fine natural botanicals, including multi minerals produced under a license agreement, (iii) MDC Warehousing and Distribution, Inc., a service provider for warehousing and fulfilment services and (iv) Chem International, Inc. (“Chem”), a distributor of certain raw materials for DSM Nutritional Products LLC.

New Accounting Pronouncements, Policy [Policy Text Block]
Accounting Pronouncements Recently Adopted

In
October, 2016,
the FASB issued ASU
No.

2016
-
16,
“Income Taxes (Topic
740
): Intra-Entity Transfers of Assets Other than Inventory,” which eliminates the requirement to defer recognition of income taxes on intra-entity transfers until the asset is sold to an outside party. The new guidance requires the recognition of current and deferred income taxes on intra-entity transfers of assets other than inventory, such as intellectual property and property, plant and equipment, when the transfer occurs. The guidance was effective for the Company on
July 1, 2019.
The standard requires a “modified retrospective” adoption, meaning the standard is applied through a cumulative adjustment in retained earnings as of the beginning of the period of adoption. This new guidance did
not
have a material impact on the Company’s Condensed Consolidated Financial Statements.

In
July 2017,
the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”)
2017
-
11,
"Earnings Per Share (Topic
260
) Distinguishing Liabilities from Equity (Topic
480
) Derivatives and Hedging (Topic
815
)," which addresses the complexity of accounting for certain financial instruments with down round features. The amendments were effective for the Company on
July 1, 2019
for the fiscal year ended
June 30, 2020,
and the interim periods within it. This new guidance did
not
have a material impact on the Company’s Condensed Consolidated Financial Statements.

Aside from the adoption of ASUs, as described above, there have been
no
material changes during fiscal year
2020
in the Company’s significant accounting policies to those previously disclosed in the Company’s Annual Report on Form
10
-K for the fiscal year ended
June 30, 2019.

Revenue from Contract with Customer [Policy Text Block]
Revenue Recognition.
The Company recognizes product sales revenue, the prices of which are fixed and determinable, when title and risk of loss have transferred to the customer, when estimated provisions for product returns, rebates, charge-backs and other sales allowances are reasonably determinable, and when collectability is reasonably assured. Accruals for these items are presented in the consolidated financial statements as reductions to sales. The Company’s net sales represent gross sales invoiced to customers, less certain related charges for discounts, returns, rebates, charge-backs and other allowances. Cost of sales includes the cost of raw materials and all labor and overhead associated with the manufacturing and packaging of the products. Gross margins are affected by, among other things, changes in the relative sales mix among our products and valuation and/or charge off of slow moving, expired or obsolete inventories. To perform revenue recognition for arrangements within the scope of ASC
606,
the Company performs the following
five
steps:

●

identification of the promised goods or services in the contract;

●

determination of whether the promised goods or serves are performance obligations including whether they are distinct in the context of the contract;

●

measurement of the transaction price, including the constraint on variable consideration;

●

allocation of the transaction price to the performance obligations based on estimated selling prices; and

●

recognition of revenue when (or as) the Company satisfies each performance obligation. A performance obligation is a promise to transfer a distinct good or service to the customer and is the unit of account in ASC
606.

Lessee, Leases [Policy Text Block]
Leases.
We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets, other current liabilities, and operating lease liabilities on our consolidated balance sheets. Finance leases are included in property and equipment, current portion of long term debt, and long-term debt obligation on our consolidated statement of financial condition.



Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As most of our leases do
not
provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. The operating lease ROU asset also includes any lease payments made and excludes lease incentives and initial direct costs incurred. Our lease terms
may
include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term.

We have lease agreements with lease and non-lease components, which are generally accounted for separately. For certain equipment leases, such as vehicles, we account for the lease and non-lease components as a single lease component.

Earnings Per Share, Policy [Policy Text Block]
Earnings Per Share.
Basic earnings per common share amounts are based on weighted average number of common shares outstanding. Diluted earnings per share amounts are based on the weighted average number of common shares outstanding, plus the incremental shares that would have been outstanding upon the assumed exercise of all potentially dilutive stock options, warrants and convertible debt, subject to anti-dilution limitations using the treasury stock method and if converted method.

The following options and potentially dilutive shares for convertible notes payable were
not
included in the computation of weighted average diluted common shares outstanding as the effect of doing so would be anti-dilutive for the
three
months ended
September 30, 2019
and
2018:

Three Months Ended

September 30,

2019

2018

Anti-dilutive stock options
50,000

150,000

Total anti-dilutive shares

50,000

150,000

X

- Definition
Disclosure of accounting policy for nature of operations.
+ References
No definition available.
+ Details

Name: inbp_NatureOfOperationsPolicyTextBlock

Namespace Prefix: inbp_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).
+ References
No definition available.
+ Details

Name: us-gaap_BasisOfAccountingPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257
+ Details

Name: us-gaap_EarningsPerSharePolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for leasing arrangement entered into by lessee.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918666-209980
+ Details

Name: us-gaap_LesseeLeasesPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.
+ References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755
+ Details

Name: us-gaap_PriorPeriodReclassificationAdjustmentDescription

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for revenue from contract with customer.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI http://asc.fasb.org/topic&trid=49130388
+ Details

Name: us-gaap_RevenueFromContractWithCustomerPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 30 R36.htm IDEA: XBRL DOCUMENT v3.19.3

Note 8 - Segment Information and Disaggregated Revenue - Operations by Business Segment (Details) - USD ($)
$ in Thousands
3 Months Ended

Sep. 30, 2019

Sep. 30, 2018

Sales, net $ 11,406 $ 10,304

Gross Profit 1,399 1,219

Depreciation 91 66

Capital Expenditures 58 18

Contract Manufacturing [Member]

Sales, net 10,984 9,852

Gross Profit 1,250 1,083

Depreciation 90 65

Capital Expenditures 58 18

Branded Proprietary Products [Member]

Sales, net 12 78

Gross Profit (3) 21

Depreciation

Capital Expenditures

Other Nutraceutical Business [Member]

Sales, net 410 374

Gross Profit 152 115

Depreciation 1 1

Capital Expenditures

UNITED STATES

Sales, net 10,353 9,065

UNITED STATES | Contract Manufacturing [Member]

Sales, net 9,974 8,655

UNITED STATES | Branded Proprietary Products [Member]

Sales, net 2 71

UNITED STATES | Other Nutraceutical Business [Member]

Sales, net 377 339

Non-US [Member]

Sales, net 1,053 1,239

Non-US [Member] | Contract Manufacturing [Member]

Sales, net 1,010 1,197

Non-US [Member] | Branded Proprietary Products [Member]

Sales, net 10 7

Non-US [Member] | Other Nutraceutical Business [Member]

Sales, net $ 33 $ 35

X

- Definition
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_Depreciation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1,2)
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_GrossProfit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquireProductiveAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045
+ Details

Name: us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=inbp_ContractManufacturingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=inbp_BrandedProprietaryProductsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=inbp_OtherNutraceuticalBusinessMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_StatementGeographicalAxis=country_US

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_StatementGeographicalAxis=us-gaap_NonUsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 31 R32.htm IDEA: XBRL DOCUMENT v3.19.3

Note 6 - Leases and Other Commitments and Contingencies - Leases and Commitments (Details) - USD ($)
$ in Thousands

Sep. 30, 2019

Jun. 30, 2019

Operating lease right-of-use assets $ 3,169 $ 3,284

Current portion operating lease obligations 474 470

Operating lease obligations 2,702 2,822

Remaining cash commitment 3,572 3,719

Machinery and Equipment Leases [Member]

Operating lease right-of-use assets 24 26

Current portion operating lease obligations 11 11

Operating lease obligations 13 15

Remaining cash commitment 25 27

Office Equipment Leases [Member]

Operating lease right-of-use assets 19 22

Current portion operating lease obligations 9 9

Operating lease obligations 11 14

Remaining cash commitment 20 24

Vitamin Realty LLC [Member]

Operating lease right-of-use assets 3,126 3,236

Current portion operating lease obligations 454 450

Operating lease obligations 2,678 2,793

Remaining cash commitment $ 3,527 $ 3,668

X

- Definition
Amount of remaining lease commitment.
+ References
No definition available.
+ Details

Name: inbp_LeaseCommitmentAmount

Namespace Prefix: inbp_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiabilityCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiabilityNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's right to use underlying asset under operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseRightOfUseAsset

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=inbp_MachineryAndEquipmentLeasesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=inbp_OfficeEquipmentLeasesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inbp_VitaminRealtyLLCMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 32 R5.htm IDEA: XBRL DOCUMENT v3.19.3

Condensed Consolidated Statements of Stockholders' (Deficiency) Equity - USD ($)
$ in Thousands

Common Stock [Member]

Additional Paid-in Capital [Member]

Retained Earnings [Member]

Treasury Stock [Member]

Total

Balance (in shares) at Jun. 30, 2018 21,170,074 34,900

Balance at Jun. 30, 2018 $ 42 $ 44,773 $ (49,952) $ (99) $ (5,236)

Net income 159 159

Shares issued upon conversion of CD Financial, LLC Convertible Note, net (in shares) 8,230,769

Shares issued upon conversion of CD Financial, LLC Convertible Note, net $ 17 5,256 5,273

Balance (in shares) at Sep. 30, 2018 29,400,843 34,900

Balance at Sep. 30, 2018 $ 59 50,029 (49,793) $ (99) 196

Balance (in shares) at Jun. 30, 2019 29,600,843 34,900

Balance at Jun. 30, 2019 $ 59 50,197 (48,264) $ (99) 1,893

Stock compensation expense for employee stock options 15 15

Net income 312 312

Balance (in shares) at Sep. 30, 2019 29,600,843 34,900

Balance at Sep. 30, 2019 $ 59 $ 50,212 $ (47,952) $ (99) $ 2,220

X

- Definition
Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.
+ References
No definition available.
+ Details

Name: us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of shares issued which are neither cancelled nor held in the treasury.
+ References
No definition available.
+ Details

Name: us-gaap_SharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares issued during the period as a result of the conversion of convertible securities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-30)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The gross value of stock issued during the period upon the conversion of convertible securities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 33 R1.htm IDEA: XBRL DOCUMENT v3.19.3

Document And Entity Information - shares
3 Months Ended

Sep. 30, 2019

Nov. 13, 2019

Document Information [Line Items]

Entity Registrant Name INTEGRATED BIOPHARMA INC

Entity Central Index Key 0001016504

Current Fiscal Year End Date --06-30

Entity Filer Category Non-accelerated Filer

Entity Current Reporting Status Yes

Entity Emerging Growth Company false

Entity Small Business true

Entity Common Stock, Shares Outstanding (in shares) 29,565,943

Entity Shell Company false

Document Type 10-Q

Document Period End Date Sep. 30, 2019

Document Fiscal Year Focus 2020

Document Fiscal Period Focus Q1

Amendment Flag false

X

- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition
Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: dei_DocumentInformationLineItems

Namespace Prefix: dei_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
No definition available.
+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityCurrentReportingStatus

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityEmergingGrowthCompany

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityShellCompany

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicates that the company is a Smaller Reporting Company (SRC).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntitySmallBusiness

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

XML 34 R9.htm IDEA: XBRL DOCUMENT v3.19.3

Note 3 - Property and Equipment, Net
3 Months Ended

Sep. 30, 2019

Notes to Financial Statements

Property, Plant and Equipment Disclosure [Text Block]
Note
3
. Property and Equipment, net

Property and equipment, net consists of the following:

September 30,

June 30,

2019

2019

Land and building
$
1,250
$
1,250

Leasehold improvements

1,282

1,282

Machinery and equipment

6,338

6,280

Transportation equipment

6

6

8,876

8,818

Less: Accumulated depreciation and amortization

(7,131
)
(7,040
)

Total
$
1,745
$
1,778

Depreciation and amortization expense recorded on property and equipment for the
three
months ended
September 30, 2019
and
2018
was
$91
and
$66,
respectively.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-URI http://asc.fasb.org/topic&trid=2155823
+ Details

Name: us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 35 R21.htm IDEA: XBRL DOCUMENT v3.19.3

Note 8 - Segment Information and Disaggregated Revenue (Tables)
3 Months Ended

Sep. 30, 2019

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Sales, Net

Segment

U.S.

International

Gross

Capital

Customers

Customers

Total

Profit (Loss)

Depreciation

Expenditures

Contract

2019

$

9,974

$

1,010

$

10,984

$

1,250

$

90

$

58

Manufacturing

2018

8,655

1,197

9,852

1,083

65

18

Branded Proprietary

2019

2

10

12

(3

)

-

-

Products

2018

71

7

78

21

-

-

Other Nutraceutical

2019

377

33

410

152

1

-

Businesses

2018

339

35

374

115

1

-

Total Company

2019

10,353

1,053

11,406

1,399

91

58

2018

9,065

1,239

10,304

1,219

66

18

Reconciliation of Assets from Segment to Consolidated [Table Text Block]

Total Assets as of

September 30,

June 30,

2019

2019

Contract Manufacturing

$

17,575
$
17,580

Branded Proprietary Products

413

427

Other Nutraceutical Businesses

1,653

1,783

Total Company

$

19,641
$
19,790

X

- Definition
Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8924-108599
+ Details

Name: us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599
+ Details

Name: us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 36 R25.htm IDEA: XBRL DOCUMENT v3.19.3

Note 3 - Property and Equipment, Net - Property and Equipment, Net (Details) - USD ($)
$ in Thousands

Sep. 30, 2019

Jun. 30, 2019

Jun. 30, 2018

Property and equipment, gross $ 8,876 $ 8,818

Less: Accumulated depreciation and amortization (7,131) (7,040)

Total 1,745 $ 1,778 1,778

Land and Building [Member]

Property and equipment, gross 1,250 1,250

Leasehold Improvements [Member]

Property and equipment, gross 1,282 1,282

Machinery and Equipment [Member]

Property and equipment, gross 6,338 6,280

Transportation Equipment [Member]

Property and equipment, gross $ 6 $ 6

X

- Definition
Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.14)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.13)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PropertyPlantAndEquipmentGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(14))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(8))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndBuildingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_TransportationEquipmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 37 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 38 R29.htm IDEA: XBRL DOCUMENT v3.19.3

Note 5 - Significant Risks and Uncertainties (Details Textual)
3 Months Ended 12 Months Ended

Sep. 30, 2019

Sep. 30, 2018

Jun. 30, 2019

Revenue Benchmark [Member] | Customer Concentration Risk [Member]

Number of Major Customers 2 2

Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Contract Manufacturing [Member]

Number of Major Customers 2 2

Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Two Customers [Member]

Concentration Risk, Percentage 91.00% 89.00%

Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Major Customer 1 [Member] | Contract Manufacturing [Member]

Concentration Risk, Percentage 66.00% 61.00%

Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Major Customer 2 [Member] | Contract Manufacturing [Member]

Concentration Risk, Percentage 29.00% 29.00%

Accounts Receivable [Member] | Customer Concentration Risk [Member]

Concentration Risk, Percentage 2.00% 2.00%

Accounts Receivable [Member] | Customer Concentration Risk [Member] | Two Customers [Member]

Concentration Risk, Percentage 87.00% 88.00%

Number of Employees, Geographic Area [Member] | Unionized Employees Concentration Risk [Member]

Concentration Risk, Percentage 72.00%

X

- Definition
Represents the number of major customers accounting for 10% or more of the specified concentration risk benchmark, which includes, but not limited to, sales revenue, accounts receivable, etc.
+ References
No definition available.
+ Details

Name: inbp_NumberOfMajorCustomers

Namespace Prefix: inbp_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=118260190&loc=d3e13531-108611

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118260190&loc=d3e13537-108611

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592
+ Details

Name: us-gaap_ConcentrationRiskPercentage1

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=inbp_ContractManufacturingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_MajorCustomersAxis=inbp_TwoCustomersMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_MajorCustomersAxis=inbp_MajorCustomer1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_MajorCustomersAxis=inbp_MajorCustomer2Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_NumberOfEmployeesGeographicAreaMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByTypeAxis=us-gaap_UnionizedEmployeesConcentrationRiskMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 40 R34.htm IDEA: XBRL DOCUMENT v3.19.3

Note 6 - Leases and Other Commitments and Contingencies - Minimum Rental Commitment for Long-term Non-cancelable Leases (Details) - USD ($)
$ in Thousands

Sep. 30, 2019

Jun. 30, 2019

2020, remaining capital lease $ 144

2020, remaining total 595

2021, Capital Lease Obligation 90

2021, Total 676

2022, Capital Lease Obligation

2022, Total 573

2023, Capital Lease Obligation

2023, Total 565

2024, Capital Lease Obligation

2024, Total 563

2025, Capital Lease Obligation

2025, Total 533

Thereafter, Capital Lease Obligation

Thereafter, Total 311

Total minimum lease payments, Capital Lease Obligation 234

Total minimum lease payments, Total 3,816

Imputed interest, Capital Lease Obligation (25)

Imputed interest, Total (421)

Total, Capital Lease Obligation 209

Total 3,395

Vitamin Realty LLC [Member]

2020, remaining operating lease 424

2021, Operating Lease 565

2022, Operating Lease 565

2023, Operating Lease 565

2024, Operating Lease 563

2025, Operating Lease 533

Thereafter, Operating Lease 311

Total minimum lease payments, Operating Lease 3,526

Imputed interest, Operating Lease (394)

Total, Operating Lease 3,132 $ 3,243

Unrelated Party [Member]

2020, remaining operating lease 27

2021, Operating Lease 21

2022, Operating Lease 8

2023, Operating Lease

2024, Operating Lease

2025, Operating Lease

Thereafter, Operating Lease

Total minimum lease payments, Operating Lease 56

Imputed interest, Operating Lease (2)

Total, Operating Lease $ 54

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for finance lease, due in sixth fiscal year following latest fiscal year.
+ References
No definition available.
+ Details

Name: inbp_FinanceLeaseLiabilityPaymentsDueYearSix

Namespace Prefix: inbp_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease and finance lease.
+ References
No definition available.
+ Details

Name: inbp_LesseeOperatingLeaseAndFinanceLeaseLiabilityPaymentsDue

Namespace Prefix: inbp_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating and finance lease, due after sixth fiscal year following latest fiscal year.
+ References
No definition available.
+ Details

Name: inbp_LesseeOperatingLeaseAndFinanceLeaseLiabilityPaymentsDueAfterYearSix

Namespace Prefix: inbp_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease and finance lease, due in fifth fiscal year following latest fiscal year.
+ References
No definition available.
+ Details

Name: inbp_LesseeOperatingLeaseAndFinanceLeaseLiabilityPaymentsDueYearFive

Namespace Prefix: inbp_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease and finance lease, due in forth fiscal year following latest fiscal year.
+ References
No definition available.
+ Details

Name: inbp_LesseeOperatingLeaseAndFinanceLeaseLiabilityPaymentsDueYearFour

Namespace Prefix: inbp_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease and finance lease, due in sixth fiscal year following latest fiscal year.
+ References
No definition available.
+ Details

Name: inbp_LesseeOperatingLeaseAndFinanceLeaseLiabilityPaymentsDueYearSix

Namespace Prefix: inbp_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease and finance lease, due in third fiscal year following latest fiscal year.
+ References
No definition available.
+ Details

Name: inbp_LesseeOperatingLeaseAndFinanceLeaseLiabilityPaymentsDueYearThree

Namespace Prefix: inbp_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease and finance lease, due in second fiscal year following latest fiscal year.
+ References
No definition available.
+ Details

Name: inbp_LesseeOperatingLeaseAndFinanceLeaseLiabilityPaymentsDueYearTwo

Namespace Prefix: inbp_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease and finance lease, due in remainder of fiscal year following latest fiscal year ended.
+ References
No definition available.
+ Details

Name: inbp_LesseeOperatingLeaseAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear

Namespace Prefix: inbp_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease and finance lease.
+ References
No definition available.
+ Details

Name: inbp_LesseeOperatingLeaseAndFinanceLeaseLiabilityUndiscountedExcessAmount

Namespace Prefix: inbp_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth fiscal year following latest fiscal year.
+ References
No definition available.
+ Details

Name: inbp_LesseeOperatingLeaseLiabilityPaymentsDueYearSix

Namespace Prefix: inbp_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease and finance lease.
+ References
No definition available.
+ Details

Name: inbp_OperatingLeaseAndFinanceLeaseLiability

Namespace Prefix: inbp_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Present value of lessee's discounted obligation for lease payments from finance lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_FinanceLeaseLiability

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for finance lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_FinanceLeaseLiabilityPaymentsDue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for finance lease, due after fifth fiscal year following latest fiscal year.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for finance lease, due in fifth fiscal year following latest fiscal year.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for finance lease, due in fourth fiscal year following latest fiscal year.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for finance lease, due in third fiscal year following latest fiscal year.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for finance lease, due in second fiscal year following latest fiscal year.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for finance lease, due in remainder of fiscal year following latest fiscal year ended.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fifth fiscal year following latest fiscal year.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth fiscal year following latest fiscal year.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth fiscal year following latest fiscal year.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third fiscal year following latest fiscal year.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second fiscal year following latest fiscal year.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease having an initial or remaining lease term in excess of one year due in remainder of fiscal year following latest fiscal year.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiability

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inbp_VitaminRealtyLLCMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_CounterpartyNameAxis=inbp_UnrelatedPartyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 41 R30.htm IDEA: XBRL DOCUMENT v3.19.3

Note 6 - Leases and Other Commitments and Contingencies (Details Textual)
$ in Thousands
3 Months Ended

May 19, 2014

USD ($)

ft²

Jan. 05, 2012

USD ($)

ft²

Sep. 30, 2019

USD ($)

Sep. 30, 2018

USD ($)

Jun. 30, 2019

USD ($)

Operating Leases, Rent Expense, Net, Total $ 257 $ 245

Unrelated Party [Member]

Operating Lease, Liability, Total $ 54

Lessee, Operating Lease, Discount Rate 3.75% 3.76%

Operating Lease, Weighted Average Remaining Lease Term 6 years 36 days 6 years 146 days

Manhattan Drug Company [Member]

Payments for Rent $ 533

AgroLabs [Member]

Area of Real Estate Property | ft² 2,700

Payments for Rent $ 27

Chairman, Chief Executive Office and Major Stockholder [Member]

Percent of Ownership for Warehouse and Office Facilities Leased 100.00%

Vitamin Realty LLC [Member]

Operating Leases, Rent Expense, Net, Total $ 207 $ 202

Due to Related Parties, Total 71 $ 67

Operating Lease, Liability, Total $ 3,132 $ 3,243

Minimum [Member]

Lessee, Lease, Term of Contract 1 year

Minimum [Member] | Manhattan Drug Company [Member]

Area of Real Estate Property | ft² 74,898

Maximum [Member]

Lessee, Lease, Term of Contract 8 years

Maximum [Member] | Manhattan Drug Company [Member]

Area of Real Estate Property | ft² 76,161

X

- Definition
Term of lessee's operating and finance leases, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: inbp_LesseeLeaseTermOfContract

Namespace Prefix: inbp_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Represents the percentage of ownership for warehouse and office facilities leased.
+ References
No definition available.
+ Details

Name: inbp_PercentOfOwnershipForWarehouseAndOfficeFacilitiesLeased

Namespace Prefix: inbp_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Area of a real estate property.
+ References
No definition available.
+ Details

Name: us-gaap_AreaOfRealEstateProperty

Namespace Prefix: us-gaap_

Data Type: num:areaItemType

Balance Type: na

Period Type: instant

X

- Definition
Carrying amount as of the balance sheet date of obligations due all related parties.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(k)(1))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.17)
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.15(3),(4))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_DueToRelatedPartiesCurrentAndNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Discount rate used by lessee to determine present value of operating lease payments.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (c)(3)
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseDiscountRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiability

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 55
-Paragraph 53
-URI http://asc.fasb.org/extlink&oid=77888399&loc=SL77918982-209971

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (g)(3)
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980
+ Details

Name: us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: instant

X

- Definition
Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=77902758&loc=d3e41499-112717
+ Details

Name: us-gaap_OperatingLeasesRentExpenseNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Cash payments to lessor's for use of assets under operating leases.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585
+ Details

Name: us-gaap_PaymentsForRent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: srt_CounterpartyNameAxis=inbp_UnrelatedPartyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: dei_LegalEntityAxis=inbp_ManhattanDrugCompanyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: dei_LegalEntityAxis=inbp_AgrolabsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inbp_ChairmanChiefExecutiveOfficeAndMajorStockholderMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inbp_VitaminRealtyLLCMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 42 R13.htm IDEA: XBRL DOCUMENT v3.19.3

Note 7 - Related Party Transactions
3 Months Ended

Sep. 30, 2019

Notes to Financial Statements

Related Party Transactions Disclosure [Text Block]
Note
7.
Related Party Transactions

See Note
6
(a). Leases for related party lease transactions.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-URI http://asc.fasb.org/topic&trid=2122745
+ Details

Name: us-gaap_RelatedPartyTransactionsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 43 R17.htm IDEA: XBRL DOCUMENT v3.19.3

Note 2 - Inventories (Tables)
3 Months Ended

Sep. 30, 2019

Notes Tables

Schedule of Inventory, Current [Table Text Block]

September 30,

June 30,

2019

2019

Raw materials
$
6,642
$
4,550

Work-in-process

1,823

2,325

Finished goods

1,426

1,944

Total
$
9,891
$
8,819

X

- Definition
Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(c))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(b))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766
+ Details

Name: us-gaap_ScheduleOfInventoryCurrentTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 44 R7.htm IDEA: XBRL DOCUMENT v3.19.3

Note 1 - Principles of Consolidation and Basis of Presentation
3 Months Ended

Sep. 30, 2019

Notes to Financial Statements

Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
Note
1.
Principles of Consolidation and Basis of Presentation

Basis of Presentation of Interim Financial Statements

The accompanying condensed consolidated financial statements for the interim periods are unaudited and include the accounts of Integrated BioPharma, Inc., a Delaware corporation (together with its subsidiaries, the “Company”). The interim condensed consolidated financial statements have been prepared in conformity with Rule
8
-
03
of Regulation S-
X
of the Securities and Exchange Commission (“SEC”) and therefore do
not
include information or footnotes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States of America. However, all adjustments (consisting only of normal recurring adjustments) which are, in the opinion of management, necessary for a fair presentation of the financial position and operating results for the periods presented have been included. These condensed consolidated financial statements should be read in conjunction with the financial statements and notes thereto, together with Management’s Discussion and Analysis of Financial Condition and Results of Operations, contained in the Company’s Annual Report on Form
10
-K for the fiscal year ended
June 30, 2019 (
“Form
10
-K”), as filed with the SEC. The
June 30, 2019
balance sheet was derived from audited financial statements, but does
not
include all disclosures required by accounting principles generally accepted in the United States of America. The preparation of the unaudited condensed financial statements in conformity with these accounting principles requires management to make estimates and assumptions that affect the amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of expenses during the period reported. Ultimate results could differ from the estimates of management. The results of operations for the
three
months ended
September 30, 2019
are
not
necessarily indicative of the results for the full fiscal year ending
June 30, 2020
or for any other period.

Reclassifications.
Certain prior year amounts have been reclassified to conform to the current period presentation.

Nature of Operations

The Company is engaged primarily in manufacturing, distributing, marketing and sales of vitamins, nutritional supplements and herbal products. The Company’s customers are located primarily in the United States, Luxembourg and Canada. The Company was previously known as Integrated Health Technologies, Inc. and, prior to that, as Chem International, Inc. The Company was reincorporated in its current form in Delaware in
1995.
The Company continues to do business as Chem International, Inc. with certain of its customers and certain vendors.

The Company’s business segments include: (a) Contract Manufacturing operated by Manhattan Drug Company, Inc. (“MDC”), which manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers and specialized health-care providers; (b) Branded Proprietary Products operated by AgroLabs, Inc. (“AgroLabs”), which distributes healthful nutritional products for sale through major mass market, grocery and drug and vitamin retailers, under the following brands: Peaceful Sleep, Green Envy, FiberCal, Wheatgrass and other products which are being introduced into the market (these are referred to as our branded proprietary nutraceutical business and/or products); and (c) Other Nutraceutical Businesses which includes the operations of (i) The Vitamin Factory (the “Vitamin Factory”), which sells private label MDC products, as well as our AgroLabs products, through the Internet, (ii) IHT Health Products, Inc. (“IHT”) a distributor of fine natural botanicals, including multi minerals produced under a license agreement, (iii) MDC Warehousing and Distribution, Inc., a service provider for warehousing and fulfilment services and (iv) Chem International, Inc. (“Chem”), a distributor of certain raw materials for DSM Nutritional Products LLC.



Accounting Policies

Accounting Pronouncements Recently Adopted

In
October, 2016,
the FASB issued ASU
No.

2016
-
16,
“Income Taxes (Topic
740
): Intra-Entity Transfers of Assets Other than Inventory,” which eliminates the requirement to defer recognition of income taxes on intra-entity transfers until the asset is sold to an outside party. The new guidance requires the recognition of current and deferred income taxes on intra-entity transfers of assets other than inventory, such as intellectual property and property, plant and equipment, when the transfer occurs. The guidance was effective for the Company on
July 1, 2019.
The standard requires a “modified retrospective” adoption, meaning the standard is applied through a cumulative adjustment in retained earnings as of the beginning of the period of adoption. This new guidance did
not
have a material impact on the Company’s Condensed Consolidated Financial Statements.

In
July 2017,
the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”)
2017
-
11,
"Earnings Per Share (Topic
260
) Distinguishing Liabilities from Equity (Topic
480
) Derivatives and Hedging (Topic
815
)," which addresses the complexity of accounting for certain financial instruments with down round features. The amendments were effective for the Company on
July 1, 2019
for the fiscal year ended
June 30, 2020,
and the interim periods within it. This new guidance did
not
have a material impact on the Company’s Condensed Consolidated Financial Statements.

Aside from the adoption of ASUs, as described above, there have been
no
material changes during fiscal year
2020
in the Company’s significant accounting policies to those previously disclosed in the Company’s Annual Report on Form
10
-K for the fiscal year ended
June 30, 2019.

Significant Accoun
ting P
olicies

Revenue Recognition.
The Company recognizes product sales revenue, the prices of which are fixed and determinable, when title and risk of loss have transferred to the customer, when estimated provisions for product returns, rebates, charge-backs and other sales allowances are reasonably determinable, and when collectability is reasonably assured. Accruals for these items are presented in the consolidated financial statements as reductions to sales. The Company’s net sales represent gross sales invoiced to customers, less certain related charges for discounts, returns, rebates, charge-backs and other allowances. Cost of sales includes the cost of raw materials and all labor and overhead associated with the manufacturing and packaging of the products. Gross margins are affected by, among other things, changes in the relative sales mix among our products and valuation and/or charge off of slow moving, expired or obsolete inventories. To perform revenue recognition for arrangements within the scope of ASC
606,
the Company performs the following
five
steps:

●

identification of the promised goods or services in the contract;

●

determination of whether the promised goods or serves are performance obligations including whether they are distinct in the context of the contract;

●

measurement of the transaction price, including the constraint on variable consideration;

●

allocation of the transaction price to the performance obligations based on estimated selling prices; and

●

recognition of revenue when (or as) the Company satisfies each performance obligation. A performance obligation is a promise to transfer a distinct good or service to the customer and is the unit of account in ASC
606.

Leases.
We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets, other current liabilities, and operating lease liabilities on our consolidated balance sheets. Finance leases are included in property and equipment, current portion of long term debt, and long-term debt obligation on our consolidated statement of financial condition.



Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As most of our leases do
not
provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. The operating lease ROU asset also includes any lease payments made and excludes lease incentives and initial direct costs incurred. Our lease terms
may
include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term.

We have lease agreements with lease and non-lease components, which are generally accounted for separately. For certain equipment leases, such as vehicles, we account for the lease and non-lease components as a single lease component.

Earnings Per Share.
Basic earnings per common share amounts are based on weighted average number of common shares outstanding. Diluted earnings per share amounts are based on the weighted average number of common shares outstanding, plus the incremental shares that would have been outstanding upon the assumed exercise of all potentially dilutive stock options, warrants and convertible debt, subject to anti-dilution limitations using the treasury stock method and if converted method.

The following options and potentially dilutive shares for convertible notes payable were
not
included in the computation of weighted average diluted common shares outstanding as the effect of doing so would be anti-dilutive for the
three
months ended
September 30, 2019
and
2018:

Three Months Ended

September 30,

2019

2018

Anti-dilutive stock options
50,000

150,000

Total anti-dilutive shares

50,000

150,000

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-URI http://asc.fasb.org/topic&trid=2122149

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-URI http://asc.fasb.org/topic&trid=2197479
+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 45 R3.htm IDEA: XBRL DOCUMENT v3.19.3

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands

Sep. 30, 2019

Jun. 30, 2019

Current Assets:

Cash $ 525 $ 475

Accounts receivable, net 3,355 4,439

Inventories 9,891 8,819

Other current assets 312 346

Total current assets 14,083 14,079

Property and equipment, net 1,745 1,778

Operating lease right-of-use assets 3,169 3,284

Deferred tax assets, net 549 534

Security deposits and other assets 95 115

Total Assets 19,641 19,790

Current Liabilities:

Advances under revolving credit facility 4,799 5,834

Accounts payable (includes $71and $67 due to related party) 5,106 3,855

Accrued expenses and other current liabilities 1,110 1,147

Current portion of long term debt, net 1,053 1,047

Current portion of operating lease liabilities 474 470

Total current liabilities 12,542 12,353

Operating lease liabilities 2,702 2,822

Long term debt, net 2,177 2,722

Total liabilities 17,421 17,897

Commitments and Contingencies

Stockholders' Equity :

Common Stock, $0.002 par value; 50,000,000 shares authorized; 29,600,843 shares issued and 29,565,943 shares outstanding, respectively 59 59

Additional paid-in capital 50,212 50,197

Accumulated deficit (47,952) (48,264)

Less: Treasury stock, at cost, 34,900 shares (99) (99)

Total Stockholders' Equity 2,220 1,893

Total Liabilities and Stockholders' Equity $ 19,641 $ 19,790

X

- Definition
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccountsPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=118952595&loc=d3e4428-111522

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 45
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=118952595&loc=d3e4531-111522
+ Details

Name: us-gaap_AccountsReceivableNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.
+ References
No definition available.
+ Details

Name: us-gaap_AccruedLiabilitiesAndOtherLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910
+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6801-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.9)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765
+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.(a),19)
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.17)
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=118942415&loc=d3e14326-108349
+ Details

Name: us-gaap_CommitmentsAndContingencies

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting and classified as noncurrent.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=116821951&loc=d3e31917-109318

Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319

Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=116821951&loc=d3e31931-109318
+ Details

Name: us-gaap_DeferredTaxAssetsLiabilitiesNetNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.17)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DepositsAssetsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 35
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116846819&loc=d3e3927-108312

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InventoryNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19-26)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(23))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(25))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(32))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.21)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(13))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(19))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LinesOfCreditCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19,20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermDebtCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermDebtNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiabilityCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiabilityNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's right to use underlying asset under operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseRightOfUseAsset

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of current assets classified as other.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.8)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(14))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(8))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(23)(a)(4))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29,30)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655
+ Details

Name: us-gaap_TreasuryStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 46 R35.htm IDEA: XBRL DOCUMENT v3.19.3

Note 8 - Segment Information and Disaggregated Revenue (Details Textual)
$ in Thousands
3 Months Ended

Sep. 30, 2019

USD ($)

Sep. 30, 2018

USD ($)

Number of Reportable Segments 3

Europe and Canada [Member]

Revenues, Total $ 1,053 $ 1,239

X

- Definition
Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.
+ References
No definition available.
+ Details

Name: us-gaap_NumberOfReportableSegments

Namespace Prefix: us-gaap_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(1))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_Revenues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: srt_StatementGeographicalAxis=inbp_EuropeAndCanadaMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 47 R31.htm IDEA: XBRL DOCUMENT v3.19.3

Note 6 - Leases and Other Commitments and Contingencies - Lease Expense (Details) - USD ($)
$ in Thousands
3 Months Ended

Sep. 30, 2019

Sep. 30, 2018

Operating lease costs $ 174 $ 163

Amortization of right-of use assets 27 17

Interest on operating lease liabilities 5 4

Total finance lease cost 32 21

Unrelated Party [Member]

Operating lease costs 39 22

Amortization of right-of use assets 27 17

Interest on operating lease liabilities 5 4

Total finance lease cost 32 21

Vitamin Realty LLC [Member]

Operating lease costs 135 141

Amortization of right-of use assets

Interest on operating lease liabilities

Total finance lease cost

X

- Definition
Amount of expense on finance lease liability.
+ References
No definition available.
+ Details

Name: inbp_FinanceLeaseExpense

Namespace Prefix: inbp_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of interest expense on operating lease liability.
+ References
No definition available.
+ Details

Name: inbp_OperatingLeaseInterestExpense

Namespace Prefix: inbp_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of amortization expense attributable to right-of-use asset from finance lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918638-209977

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 55
-Paragraph 53
-URI http://asc.fasb.org/extlink&oid=77888399&loc=SL77918982-209971
+ Details

Name: us-gaap_FinanceLeaseRightOfUseAssetAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 55
-Paragraph 53
-URI http://asc.fasb.org/extlink&oid=77888399&loc=SL77918982-209971

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980
+ Details

Name: us-gaap_OperatingLeaseCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: srt_CounterpartyNameAxis=inbp_UnrelatedPartyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inbp_VitaminRealtyLLCMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 48 R12.htm IDEA: XBRL DOCUMENT v3.19.3

Note 6 - Leases and Other Commitments and Contingencies
3 Months Ended

Sep. 30, 2019

Notes to Financial Statements

Commitments and Contingencies Disclosure [Text Block]
Note
6.
Leases and other Commitments and Contingencies

(a)
Leases.
The Company has operating and finance leases for its corporate and sales offices, warehousing and packaging facilities and certain machinery and equipment, including office equipment. The Company’s leases have remaining terms of less than
1
year to less than
8
years.

The components of lease expense for the
three
months ended
September 30, 2019
and
2018,
were as follows:

2019

2018

Related Party - Vitamin Realty

Other Leases

Totals

Related Party - Vitamin Realty

Other Leases

Totals

Operating lease costs
$
135
$
39
$
174
$
141
$
22
$
163

Finance Operating Lease Costs:

Amortization of right-of use assets
$
-
$
27
$
27
$
-
$
17
$
17

Interest on operating lease liabilities

-

5

5

-

4

4

Total finance lease cost
$
-
$
32
$
32
$
-
$
21
$
21

Operating
Lease
Liabilities

Related Party
Operating
L
e
ase
Liabilities
.
Warehouse and office facilities are leased from Vitamin Realty Associates, LLC (“Vitamin Realty”), which is
100%
owned by the Company’s chairman, and a major stockholder and certain of his family members, who are the Co-Chief Executive Officers and directors of the Company. On
January 5, 2012,
MDC entered into a
second
amendment of lease (the “Second Lease Amendment”) with Vitamin Realty for its office and warehouse space in New Jersey increasing its rentable square footage from an aggregate of
74,898
square feet to
76,161
square feet and extending the expiration date to
January 31, 2026.
This Second Lease Amendment provides for minimum annual rental payments of
$533,
plus increases in real estate taxes and building operating expenses. On
May 19, 2014,
AgroLabs entered into an amendment to the lease agreement entered into on
January 5, 2012,
with Vitamin Realty for an additional
2,700
square feet of warehouse space in New Jersey, the term of which was to expire on
January 31, 2019
to extend the expiration date to
June 1, 2024.
This additional lease provides for minimum lease payments of
$27
with annual increases plus the proportionate share of operating expenses.

Rent expense, lease amortization costs and interest expense for the
three
months ended
September 30, 2019
and
2018
on these leases were
$207
and
$202
respectively, and are included in cost of sales, selling and administrative expenses and interest expense in the accompanying Condensed Consolidated Statements of Operations. As of
September 30, 2019
and
June 30, 2019,
the Company had outstanding current obligations to Vitamin Realty of
$71
and
$67,
respectively, included in accounts payable in the accompanying Condensed Consolidated Balance Sheet. Additionally, the Company has operating lease obligations of
$3,132
and
$3,243
with Vitamin Realty as noted in the accompany Condensed Consolidated Balance Sheet as of
September 30, 2019
and
June 30, 2019,
respectively.

Other
Operating
Lease
Liabilities
.
The Company has entered into certain non-cancelable operating lease agreements expiring up through
May, 2023,
related to machinery and equipment and office equipment.

As of
September 30, 2019,
the Company’s right-of-use assets, lease obligations and remaining cash commitment on these leases were as follows:

Right-of-use Assets

Current Portion of Operating Lease Obligations

Operating Lease Obligations

Remaining Cash Commitment

Vitamin Realty Leases
$
3,126
$
454
$
2,678
$
3,527

Machinery and equipment leases

24

11

13

25

Office equipment leases

19

9

11

20

$
3,169
$
474
$
2,702
$
3,572

As of
June 30, 2019,
the Company’s ROU assets, lease obligations and remaining cash commitment on these leases were as follows:

Right-of-use Assets

Current Portion Operating Lease Obligations

Operating Lease Obligations

Remaining Cash Commitment

Vitamin Realty Leases
$
3,236
$
450
$
2,793
$
3,668

Machinery and equipment leases

26

11

15

27

Office equipment leases

22

9

14

24

$
3,284
$
470
$
2,822
$
3,719

As of
September 30, 2019
and
June 30, 2019,
the Company’s weighted average discount rate and remaining term on lease liabilities were approximately
3.75%
and
3.76%
and
6.1
years and
6.4
years, respectively.

Supplemental cash flows information related to leases for the
three
months ended
September 30, 2019,
is was follows:

Related Party - Vitamin Realty

Other Leases

Totals

Cash paid for amounts included in the measurement of lease liabilities:

Operating cash flows from operating leases
$
141
$
24
$
165

Operating cash flows from finance leases

-

5

5

Financing cash flows from finance lease obligations

-

60

60

Supplemental cash flows information related to leases for the
three
months ended
September 30, 2018,
is was follows:

Related Party - Vitamin Realty

Other Leases

Totals

Cash paid for amounts included in the measurement of lease liabilities:

Operating cash flows from operating leases
$
94
$
24
$
118

Operating cash flows from finance leases

-

4

4

Financing cash flows from finance lease obligations

-

50

50

The Company did
not
enter into any lease commitments in the
three
months ended
September 30, 2019.

Maturities of operating lease liabilities as of
September 30, 2019
were as follows:

Operating

Related Party

Capitalized

Lease

Operating Lease

Lease

Year ending June 30,

Commitment

Commitment

Obligations

Total

2020, remaining
$
27
$
424
$
144
$
595

2021

21

565

90

676

2022

8

565

-

573

2023

-

565

-

565

2024

-

563

-

563

2025

-

533

-

533

Thereafter

-

311

-

311

Total minimum lease payments

56

3,526

234

3,816

Imputed interest

(2
)
(394
)
(25
)
(421
)

Total
$
54
$
3,132
$
209
$
3,395

Total rent expense, lease amortization costs and interest expense, including real estate taxes and maintenance charges, was approximately
$257
and
$245
for the
three
months ended
September 30, 2019
and
2018,
respectively. Rent and lease amortization and interest expense is included in cost of sales, selling and administrative expenses and interest expense in the accompanying Condensed Consolidated Statements of Operations.

(
b
) Legal Proceedings.

The Company is subject, from time to time, to claims by
third
parties under various legal theories. The defense of such claims, or any adverse outcome relating to any such claims, could have a material adverse effect on the Company’s liquidity, financial condition and cash flows.

X

- Definition
The entire disclosure for commitments and contingencies.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-URI http://asc.fasb.org/topic&trid=2127136

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-URI http://asc.fasb.org/topic&trid=2144648
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 49 R16.htm IDEA: XBRL DOCUMENT v3.19.3

Note 1 - Principles of Consolidation and Basis of Presentation (Tables)
3 Months Ended

Sep. 30, 2019

Notes Tables

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]

Three Months Ended

September 30,

2019

2018

Anti-dilutive stock options
50,000

150,000

Total anti-dilutive shares

50,000

150,000

X

- Definition
Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 50 R6.htm IDEA: XBRL DOCUMENT v3.19.3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended

Sep. 30, 2019

Sep. 30, 2018

Cash flows provided by operating activities:

Net income $ 312 $ 159

Adjustments to reconcile net income to net cash from operating activities:

Depreciation and amortization 91 91

Amortization of operating lease right-of-use assets 116 112

Stock based compensation 15

Change in deferred tax assets (5) 31

Unrealized loss on investments 24

Other, net 5 8

Changes in operating assets and liabilities:

Accounts receivable 1,084 415

Inventories (1,073) (1,858)

Other current assets 8

Security deposits and other assets 18 (52)

Accounts payable 1,251 1,861

Accrued expenses and other liabilities (37) (70)

Operating lease obligations (116) (112)

Net cash provided by operating activities 1,685 593

Cash flows from investing activities:

Purchase of property and equipment (58) (18)

Cash contribution in AgroSport LLC (8)

Net cash used in investing activities (58) (26)

Cash flows from financing activities:

Advances under revolving credit facility 11,040 10,204

Repayments of advances under revolving credit facility (12,075) (10,400)

Repayments under term note payables (482) (184)

Repayments under finance lease obligations (60) (50)

Net cash used in financing activities (1,577) (430)

Net increase in cash 50 137

Cash at beginning of period 475 228

Cash at end of period 525 365

Interest paid 123 201

Income taxes paid $ 2

X

- Definition
The increase (decrease) during the reporting period in operating lease liabilities.
+ References
No definition available.
+ Details

Name: inbp_IncreaseDecreaseInOperatingLeaseLiabilities

Namespace Prefix: inbp_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of amortization expense attributable to right-of-use asset from operating lease.
+ References
No definition available.
+ Details

Name: inbp_OperatingLeaseRightofuseAssetAmortization

Namespace Prefix: inbp_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.
+ References
No definition available.
+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.7)
-URI http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319
+ Details

Name: us-gaap_DeferredIncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_DepreciationDepletionAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585
+ Details

Name: us-gaap_IncomeTaxesPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInInventories

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOperatingCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in other expenses incurred but not yet paid.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInOtherAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase (decrease) in current assets classified as other.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInOtherCurrentAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in security deposits.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInSecurityDeposits

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 17
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3367-108585

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585
+ Details

Name: us-gaap_InterestPaidNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).
+ References
No definition available.
+ Details

Name: us-gaap_OtherOperatingActivitiesCashFlowStatement

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquireEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_ProceedsFromLinesOfCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_RepaymentsOfLinesOfCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow for the obligation for a lease meeting the criteria for capitalization (with maturities exceeding one year or beyond the operating cycle of the entity, if longer).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585
+ Details

Name: us-gaap_RepaymentsOfLongTermCapitalLeaseObligations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow for a borrowing supported by a written promise to pay an obligation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585
+ Details

Name: us-gaap_RepaymentsOfNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of noncash expense for share-based payment arrangement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of investments, not including unrealized gains or losses on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, held at each balance sheet date and included in earnings for the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_UnrealizedGainLossOnInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 51 R2.htm IDEA: XBRL DOCUMENT v3.19.3

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended

Sep. 30, 2019

Sep. 30, 2018

Sales, net $ 11,406 $ 10,304

Cost of sales 10,007 9,085

Gross profit 1,399 1,219

Selling and administrative expenses 923 814

Operating income 476 405

Interest expense (124) (200)

Change in fair value of derivative liabilities 9

Other income 21

Unrealized loss on investments (24)

Total other expense, net (127) (191)

Income before income taxes 349 214

Income tax expense, net 37 55

Net income $ 312 $ 159

Basic net income per common share (in dollars per share) $ 0.01 $ 0.01

Diluted net income per common share (in dollars per share) $ 0.01 $ 0.01

Weighted average common shares outstanding - basic (in shares) 29,565,943 27,218,786

Add: Equivalent shares outstanding - Stock Options (in shares) 1,158,690 744,818

Weighted average common shares outstanding - diluted (in shares) 30,724,633 27,963,604

X

- Definition
The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2(a),(d))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_CostOfGoodsAndServicesSold

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-Subparagraph (b)(1)
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959
+ Details

Name: us-gaap_DerivativeGainLossOnDerivativeNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256
+ Details

Name: us-gaap_EarningsPerShareBasic

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263
+ Details

Name: us-gaap_EarningsPerShareDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1,2)
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_GrossProfit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(1)(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 20
-Section 45
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 28A
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1500-109256

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of the cost of borrowed funds accounted for as interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (210.5-03(11))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.9)
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260
+ Details

Name: us-gaap_InterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.7)
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_NonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of income (expense) related to nonoperating activities, classified as other.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.9)
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_OtherNonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045
+ Details

Name: us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 30
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.4)
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_SellingGeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of investments, not including unrealized gains or losses on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, held at each balance sheet date and included in earnings for the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_UnrealizedGainLossOnInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1505-109256
+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1448-109256

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 52 R28.htm IDEA: XBRL DOCUMENT v3.19.3

Note 4 - Senior Credit Facility and Other Long Term Debt - Interest Rates (Details)

Sep. 30, 2019

Jun. 30, 2019

Revolving Credit Facility [Member] | Base Rate [Member]

Interest rate 5.00% 5.50%

Revolving Credit Facility [Member] | Eurodollar [Member]

Interest rate 4.554% 4.881%

Term Loan [Member] | Base Rate [Member]

Interest rate 5.25% 5.75%

Term Loan [Member] | Eurodollar [Member] | Minimum [Member]

Interest rate 5.05363% 5.381%

Term Loan [Member] | Eurodollar [Member] | Maximum [Member]

Interest rate 5.04588% 5.3838%

X

- Definition
The effective interest rate at the end of the reporting period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(b),22(b))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_VariableRateAxis=us-gaap_BaseRateMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_VariableRateAxis=us-gaap_EurodollarMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreditFacilityAxis=inbp_TermLoanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 53 R20.htm IDEA: XBRL DOCUMENT v3.19.3

Note 6 - Leases and Other Commitments and Contingencies (Tables)
3 Months Ended

Sep. 30, 2019

Notes Tables

Lease, Cost [Table Text Block]

2019

2018

Related Party - Vitamin Realty

Other Leases

Totals

Related Party - Vitamin Realty

Other Leases

Totals

Operating lease costs
$
135
$
39
$
174
$
141
$
22
$
163

Finance Operating Lease Costs:

Amortization of right-of use assets
$
-
$
27
$
27
$
-
$
17
$
17

Interest on operating lease liabilities

-

5

5

-

4

4

Total finance lease cost
$
-
$
32
$
32
$
-
$
21
$
21

Leases and Remaining Commitments [Table Text Block]

Right-of-use Assets

Current Portion of Operating Lease Obligations

Operating Lease Obligations

Remaining Cash Commitment

Vitamin Realty Leases
$
3,126
$
454
$
2,678
$
3,527

Machinery and equipment leases

24

11

13

25

Office equipment leases

19

9

11

20

$
3,169
$
474
$
2,702
$
3,572

Right-of-use Assets

Current Portion Operating Lease Obligations

Operating Lease Obligations

Remaining Cash Commitment

Vitamin Realty Leases
$
3,236
$
450
$
2,793
$
3,668

Machinery and equipment leases

26

11

15

27

Office equipment leases

22

9

14

24

$
3,284
$
470
$
2,822
$
3,719

Supplemental Cash Flow Information, Leases [Table Text Block]

Related Party - Vitamin Realty

Other Leases

Totals

Cash paid for amounts included in the measurement of lease liabilities:

Operating cash flows from operating leases
$
141
$
24
$
165

Operating cash flows from finance leases

-

5

5

Financing cash flows from finance lease obligations

-

60

60

Related Party - Vitamin Realty

Other Leases

Totals

Cash paid for amounts included in the measurement of lease liabilities:

Operating cash flows from operating leases
$
94
$
24
$
118

Operating cash flows from finance leases

-

4

4

Financing cash flows from finance lease obligations

-

50

50

Lessee, Operating Lease and Finance Lease, Liability, Maturity [Table Text Block]

Operating

Related Party

Capitalized

Lease

Operating Lease

Lease

Year ending June 30,

Commitment

Commitment

Obligations

Total

2020, remaining
$
27
$
424
$
144
$
595

2021

21

565

90

676

2022

8

565

-

573

2023

-

565

-

565

2024

-

563

-

563

2025

-

533

-

533

Thereafter

-

311

-

311

Total minimum lease payments

56

3,526

234

3,816

Imputed interest

(2
)
(394
)
(25
)
(421
)

Total
$
54
$
3,132
$
209
$
3,395

X

- Definition
A tabular disclosure of leases and remaining lease commitments.
+ References
No definition available.
+ Details

Name: inbp_LeasesAndRemainingCommitmentsTableTextBlock

Namespace Prefix: inbp_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of undiscounted cash flows of lessee's operating lease and finance lease liability.
+ References
No definition available.
+ Details

Name: inbp_LesseeOperatingLeaseAndFinanceLeaseLiabilityMaturityTableTextBlock

Namespace Prefix: inbp_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
A tabular disclosure of supplemental cash flow information related to leases.
+ References
No definition available.
+ Details

Name: inbp_SupplementalCashFlowInformationLeasesTableTextBlock

Namespace Prefix: inbp_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980
+ Details

Name: us-gaap_LeaseCostTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 54 R24.htm IDEA: XBRL DOCUMENT v3.19.3

Note 3 - Property and Equipment, Net (Details Textual) - USD ($)
$ in Thousands
3 Months Ended

Sep. 30, 2019

Sep. 30, 2018

Depreciation, Total $ 91 $ 66

X

- Definition
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_Depreciation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) - USD ($) $ in Thousands	Sep. 30, 2019	Jun. 30, 2019
Operating lease right-of-use assets	$ 3,169	$ 3,284
Accounts payable, due to related parties	71	67
Current portion of operating lease liabilities	474	470
Operating lease liabilities	$ 2,702	$ 2,822
Common stock, par value (in dollars per share)	$ 0.002	$ 0.002
Common stock, shares authorized (in shares)	50,000,000	50,000,000
Common stock, shares issued (in shares)	29,600,843	29,600,843
Common stock, shares outstanding (in shares)	29,565,943	29,565,943
Treasury stock, shares aquired (in shares)	34,900	34,900
Vitamin Realty LLC [Member]
Operating lease right-of-use assets	$ 3,126	$ 3,236
Current portion of operating lease liabilities	454	450
Operating lease liabilities	$ 2,678	$ 2,793

Note 1 - Principles of Consolidation and Basis of Presentation - Antidilutive Securities Excluded From Weighted Average Diluted Common Shares Outstanding (Details) - shares	3 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Anti-dilutive shares (in shares)	50,000	150,000
Share-based Payment Arrangement, Option [Member]
Anti-dilutive shares (in shares)	50,000	150,000

Note 4 - Senior Credit Facility and Other Long Term Debt (Details Textual) - USD ($) $ in Thousands			3 Months Ended
	May 15, 2019	Dec. 22, 2017	Sep. 30, 2019	Jun. 30, 2019
Capital Lease Obligations, Total			$ 209	$ 269
First American Equipment Finance [Member]
Capital Lease Obligations, Total		$ 143
Sale Leaseback Transaction, Monthly Rental Payments		$ 6
Sale Leaseback Transaction, Imputed Interest Rate		6.56%
Amended Loan Agreement [Member]
Senior Notes, Total	$ 11,585
Debt Instrument, Debt Default, Interest Rate Basic Spread	2.00%
Line of Credit Facility Covenant Prepayment Provisions Percentage of Excess Cash flow			25.00%
Amended Loan Agreement [Member] \| Term Loan [Member]
Debt Instrument, Face Amount	$ 3,585
Loans Payable, Noncurrent, Total			$ 2,674	3,455
Number of Consecutive Monthly Installments	84
Number of Consecutive Monthly Installments, Fixed Amount	83
Debt Instrument, Periodic Payment, Total	$ 43
Line of Credit Facility Covenant Prepayment Provisions Percentage of Excess Cash flow	25.00%
Amended Loan Agreement [Member] \| Term Loan [Member] \| Eurodollar [Member]
Debt Instrument, Basis Spread on Variable Rate	3.00%
Amended Loan Agreement [Member] \| Term Loan [Member] \| Base Rate [Member]
Debt Instrument, Basis Spread on Variable Rate			3.00%
Amended Loan Agreement [Member] \| Revolving Credit Facility [Member]
Line of Credit Facility, Maximum Borrowing Capacity	$ 8,000
Long-term Line of Credit, Total			$ 4,000	$ 4,250
Line of Credit Facility Covenant Maximum Aggregate Revolving Advance	$ 8,000,000
Line of Credit Facility Covenant Aggregate Revolving Advance Receivables Advance Rate	85.00%
Line of Credit Facility Covenant Aggregate Revolving Advance Inventory Advance Rate	75.00%
Line of Credit Facility, Covenan,t Aggregate Revolving Advance, Appraised Liquidation Value, Inventory Advance Rate	85.00%
Amended Loan Agreement [Member] \| Revolving Credit Facility [Member] \| Eurodollar [Member]
Debt Instrument, Basis Spread on Variable Rate	2.50%
Amended Loan Agreement [Member] \| Revolving Credit Facility [Member] \| Base Rate [Member]
Debt Instrument, Basis Spread on Variable Rate			2.50%

Note 2 - Inventories - Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Jun. 30, 2019
Raw materials	$ 6,642	$ 4,550
Work-in-process	1,823	2,325
Finished goods	1,426	1,944
Total	$ 9,891	$ 8,819

Note 5 - Significant Risks and Uncertainties	3 Months Ended
Note 5 - Significant Risks and Uncertainties	Sep. 30, 2019
Notes to Financial Statements
Concentration Risk Disclosure [Text Block]	Note 5. Significant Risks and Uncertainties ( a ) Major Customers. For the three months ended September 30, 2019 and 2018, approximately 91% and 89% of consolidated net sales, respectively, were derived from two customers. These two customers are in the Company’s Contract Manufacturing Segment and represented approximately 66% and 29% and 61% and 29% in the three months ended September 30, 2019 and 2018, respectively. Accounts receivable from these two major customers represented approximately 87% and 88% of total net accounts receivable as of September 30 and June 30, 2019, respectively. The loss of any of these customers could have an adverse effect on the Company’s operations. Major customers are those customers who account for more than 10% of net sales. ( b ) Other Business Risks. Approximately 72% of the Company’s employees are covered by a union contract and are employed in its New Jersey facilities. The contract was renewed on September 1, 2018 and will expire on August 31, 2021.

Condensed Consolidated Statements of Stockholders' (Deficiency) Equity - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Treasury Stock [Member]	Total
Balance (in shares) at Jun. 30, 2018	21,170,074			34,900
Balance at Jun. 30, 2018	$ 42	$ 44,773	$ (49,952)	$ (99)	$ (5,236)
Net income			159		159
Shares issued upon conversion of CD Financial, LLC Convertible Note, net (in shares)	8,230,769
Shares issued upon conversion of CD Financial, LLC Convertible Note, net	$ 17	5,256			5,273
Balance (in shares) at Sep. 30, 2018	29,400,843			34,900
Balance at Sep. 30, 2018	$ 59	50,029	(49,793)	$ (99)	196
Balance (in shares) at Jun. 30, 2019	29,600,843			34,900
Balance at Jun. 30, 2019	$ 59	50,197	(48,264)	$ (99)	1,893
Stock compensation expense for employee stock options		15			15
Net income			312		312
Balance (in shares) at Sep. 30, 2019	29,600,843			34,900
Balance at Sep. 30, 2019	$ 59	$ 50,212	$ (47,952)	$ (99)	$ 2,220

Document And Entity Information - shares	3 Months Ended
Document And Entity Information - shares	Sep. 30, 2019	Nov. 13, 2019
Document Information [Line Items]
Entity Registrant Name	INTEGRATED BIOPHARMA INC
Entity Central Index Key	0001016504
Current Fiscal Year End Date	--06-30
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Common Stock, Shares Outstanding (in shares)		29,565,943
Entity Shell Company	false
Document Type	10-Q
Document Period End Date	Sep. 30, 2019
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Amendment Flag	false

Note 3 - Property and Equipment, Net - Property and Equipment, Net (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Jun. 30, 2019	Jun. 30, 2018
Property and equipment, gross	$ 8,876		$ 8,818
Less: Accumulated depreciation and amortization	(7,131)		(7,040)
Total	1,745	$ 1,778	1,778
Land and Building [Member]
Property and equipment, gross	1,250		1,250
Leasehold Improvements [Member]
Property and equipment, gross	1,282		1,282
Machinery and Equipment [Member]
Property and equipment, gross	6,338		6,280
Transportation Equipment [Member]
Property and equipment, gross	$ 6		$ 6

Note 6 - Leases and Other Commitments and Contingencies - Minimum Rental Commitment for Long-term Non-cancelable Leases (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Jun. 30, 2019
2020, remaining capital lease	$ 144
2020, remaining total	595
2021, Capital Lease Obligation	90
2021, Total	676
2022, Capital Lease Obligation
2022, Total	573
2023, Capital Lease Obligation
2023, Total	565
2024, Capital Lease Obligation
2024, Total	563
2025, Capital Lease Obligation
2025, Total	533
Thereafter, Capital Lease Obligation
Thereafter, Total	311
Total minimum lease payments, Capital Lease Obligation	234
Total minimum lease payments, Total	3,816
Imputed interest, Capital Lease Obligation	(25)
Imputed interest, Total	(421)
Total, Capital Lease Obligation	209
Total	3,395
Vitamin Realty LLC [Member]
2020, remaining operating lease	424
2021, Operating Lease	565
2022, Operating Lease	565
2023, Operating Lease	565
2024, Operating Lease	563
2025, Operating Lease	533
Thereafter, Operating Lease	311
Total minimum lease payments, Operating Lease	3,526
Imputed interest, Operating Lease	(394)
Total, Operating Lease	3,132	$ 3,243
Unrelated Party [Member]
2020, remaining operating lease	27
2021, Operating Lease	21
2022, Operating Lease	8
2023, Operating Lease
2024, Operating Lease
2025, Operating Lease
Thereafter, Operating Lease
Total minimum lease payments, Operating Lease	56
Imputed interest, Operating Lease	(2)
Total, Operating Lease	$ 54

Note 6 - Leases and Other Commitments and Contingencies (Details Textual) $ in Thousands			3 Months Ended
	May 19, 2014 USD ($) ft²	Jan. 05, 2012 USD ($) ft²	Sep. 30, 2019 USD ($)	Sep. 30, 2018 USD ($)	Jun. 30, 2019 USD ($)
Operating Leases, Rent Expense, Net, Total			$ 257	$ 245
Unrelated Party [Member]
Operating Lease, Liability, Total			$ 54
Lessee, Operating Lease, Discount Rate			3.75%		3.76%
Operating Lease, Weighted Average Remaining Lease Term			6 years 36 days		6 years 146 days
Manhattan Drug Company [Member]
Payments for Rent		$ 533
AgroLabs [Member]
Area of Real Estate Property \| ft²	2,700
Payments for Rent	$ 27
Chairman, Chief Executive Office and Major Stockholder [Member]
Percent of Ownership for Warehouse and Office Facilities Leased			100.00%
Vitamin Realty LLC [Member]
Operating Leases, Rent Expense, Net, Total			$ 207	$ 202
Due to Related Parties, Total			71		$ 67
Operating Lease, Liability, Total			$ 3,132		$ 3,243
Minimum [Member]
Lessee, Lease, Term of Contract			1 year
Minimum [Member] \| Manhattan Drug Company [Member]
Area of Real Estate Property \| ft²		74,898
Maximum [Member]
Lessee, Lease, Term of Contract			8 years
Maximum [Member] \| Manhattan Drug Company [Member]
Area of Real Estate Property \| ft²		76,161

Note 7 - Related Party Transactions	3 Months Ended
Note 7 - Related Party Transactions	Sep. 30, 2019
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	Note 7. Related Party Transactions See Note 6 (a). Leases for related party lease transactions.

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2019	Jun. 30, 2019
Current Assets:
Cash	$ 525	$ 475
Accounts receivable, net	3,355	4,439
Inventories	9,891	8,819
Other current assets	312	346
Total current assets	14,083	14,079
Property and equipment, net	1,745	1,778
Operating lease right-of-use assets	3,169	3,284
Deferred tax assets, net	549	534
Security deposits and other assets	95	115
Total Assets	19,641	19,790
Current Liabilities:
Advances under revolving credit facility	4,799	5,834
Accounts payable (includes $71and $67 due to related party)	5,106	3,855
Accrued expenses and other current liabilities	1,110	1,147
Current portion of long term debt, net	1,053	1,047
Current portion of operating lease liabilities	474	470
Total current liabilities	12,542	12,353
Operating lease liabilities	2,702	2,822
Long term debt, net	2,177	2,722
Total liabilities	17,421	17,897
Commitments and Contingencies
Stockholders' Equity :
Common Stock, $0.002 par value; 50,000,000 shares authorized; 29,600,843 shares issued and 29,565,943 shares outstanding, respectively	59	59
Additional paid-in capital	50,212	50,197
Accumulated deficit	(47,952)	(48,264)
Less: Treasury stock, at cost, 34,900 shares	(99)	(99)
Total Stockholders' Equity	2,220	1,893
Total Liabilities and Stockholders' Equity	$ 19,641	$ 19,790

Note 8 - Segment Information and Disaggregated Revenue (Details Textual) $ in Thousands	3 Months Ended
	Sep. 30, 2019 USD ($)	Sep. 30, 2018 USD ($)
Number of Reportable Segments	3
Europe and Canada [Member]
Revenues, Total	$ 1,053	$ 1,239

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash flows provided by operating activities:
Net income	$ 312	$ 159
Adjustments to reconcile net income to net cash from operating activities:
Depreciation and amortization	91	91
Amortization of operating lease right-of-use assets	116	112
Stock based compensation	15
Change in deferred tax assets	(5)	31
Unrealized loss on investments	24
Other, net	5	8
Changes in operating assets and liabilities:
Accounts receivable	1,084	415
Inventories	(1,073)	(1,858)
Other current assets		8
Security deposits and other assets	18	(52)
Accounts payable	1,251	1,861
Accrued expenses and other liabilities	(37)	(70)
Operating lease obligations	(116)	(112)
Net cash provided by operating activities	1,685	593
Cash flows from investing activities:
Purchase of property and equipment	(58)	(18)
Cash contribution in AgroSport LLC		(8)
Net cash used in investing activities	(58)	(26)
Cash flows from financing activities:
Advances under revolving credit facility	11,040	10,204
Repayments of advances under revolving credit facility	(12,075)	(10,400)
Repayments under term note payables	(482)	(184)
Repayments under finance lease obligations	(60)	(50)
Net cash used in financing activities	(1,577)	(430)
Net increase in cash	50	137
Cash at beginning of period	475	228
Cash at end of period	525	365
Interest paid	123	201
Income taxes paid		$ 2

Note 4 - Senior Credit Facility and Other Long Term Debt - Interest Rates (Details)	Sep. 30, 2019	Jun. 30, 2019
Revolving Credit Facility [Member] \| Base Rate [Member]
Interest rate	5.00%	5.50%
Revolving Credit Facility [Member] \| Eurodollar [Member]
Interest rate	4.554%	4.881%
Term Loan [Member] \| Base Rate [Member]
Interest rate	5.25%	5.75%
Term Loan [Member] \| Eurodollar [Member] \| Minimum [Member]
Interest rate	5.05363%	5.381%
Term Loan [Member] \| Eurodollar [Member] \| Maximum [Member]
Interest rate	5.04588%	5.3838%